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ABSTRACT 
 
During embryonic development, cells respond to extracellular signals to establish 
proper tissue organization. Semaphorins (Semas) are a large class of secreted and 
transmembrane proteins that signal through Plexin (Plxn) receptors to guide migrating 
cells to their correct position and thus play critical roles in the development of various 
tissues including the nervous and cardiovascular systems. We have previously shown that 
Sema6A-PlxnA2 signaling is essential for visual system development, as decreasing 
endogenous Sema6A or PlxnA2 in zebrafish results in decreased cohesion of the early 
eye field, impaired retinal lamination, and smaller eye size. However, the molecular 
mechanisms governing these phenotypes are unknown. This dissertation describes the 
elucidation of functionally-relevant mechanisms of Sema6A-PlxnA signaling during eye 
development using biochemical and proteomic approaches in cell culture systems and the 
zebrafish as an in vivo vertebrate model of eye development. 
 
We first describe our investigations on the receptor-proximal mechanisms of 
Sema6A-PlxnA signaling. The Src-family tyrosine kinase Fyn was known to bind to and 
phosphorylate PlxnA receptors. However, the specific sites of phosphorylation and their 
function were unknown. Using mass spectrometry, we identified highly-conserved, Fyn-
induced PlxnA tyrosine phosphorylation sites. Mutation of these tyrosines to 
phenylalanine nearly eliminated Fyn-dependent PlxnA phosphorylation. Furthermore, 
unlike mRNA encoding wild type human PlxnA2, mRNA encoding the tyrosine-to-
phenylalanine mutant PlxnA2 could not rescue the smaller eye size phenotype caused by 
endogenous PlxnA2 knockdown in zebrafish. This suggests that Fyn-dependent PlxnA2 
phosphorylation is critical for proper vertebrate eye development. 
 
Next, we report the discovery and functional characterization of a naturally-
released soluble ectodomain of Sema6A (sSema6A). We show that sSema6A production 
is increased by PKC activity. The identification of several PKC-dependent 
phosphorylation sites in the intracellular region of Sema6A suggests a mechanism for 
PKC-dependent release of sSema6A. Importantly, we show that sSema6A is functional as 
it promotes the cohesion of zebrafish early eye field explants. This is the first report of a 
soluble ectodomain of the Sema6 class and suggests that Sema6A can have regulated, 
long-range signaling capacity in addition to its canonical contact-mediated functions. 
 
Finally, we present our findings characterizing the role in eye development of 
CRMP2, a downstream effector of Sema-Plxn signaling. CRMP2 is known to be critical 
for lamination of the cerebral cortex, leading us to hypothesize that CRMP2 could also be 
involved in the lamination of the retina. Using morpholino-based knockdown of 
endogenous zebrafish Crmp2, we show that Crmp2 has a critical function in visual 
system development. Crmp2 knockdown results in smaller eye size, impaired retinal 
lamination and a weakened optic tract.  
 
Together, this dissertation describes important novel Sema6A-PlxnA signaling 
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CHAPTER 1: INTRODUCTION 
 
1.1. Dissertation Outline 
 
This dissertation investigates the functionally-relevant mechanisms of 
Semaphorin-Plexin (Sema-Plxn) signaling in zebrafish eye development. Chapter 1 gives 
a literature review, beginning with a historical perspective, to introduce Semas as 
neuronal guidance cues and describes what is currently known in the field of Sema 
functioning and signal transduction. This chapter includes a mini-review on the 
phenomena of Sema ectodomain release from the cell surface. Chapter 2 characterizes the 
receptor proximal mechanisms of Sema signaling by describing phosphorylation of the 
Sema6A receptors PlxnA1 and PlxnA2. Chapter 3 characterizes a novel soluble Sema6A 
variant that is functional in early eye development. Chapter 4 investigates Sema6A-
PlxnA downstream signaling by studying the microtubule-associated protein CRMP2 and 
reveals a novel CRMP2 role in eye development. A summary of the major research 
findings is found in Chapter 5, in addition to a critical analysis of the results. This chapter 
also includes a detailed discussion on the remaining questions and proposes future 
experiments to address them.  
 
1.2. Significance of Study 
During embryonic development, cellular responses to extracellular cues are 
critical, but not yet fully understood, in establishing the trillions of synaptic connections 
that form a functional nervous system. Studies have identified important signaling 
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molecules involved in establishing neuronal positioning and axonal pathfinding, critical 
processes for proper cortical brain development [1]. However, less is known about the 
signaling events required for correct development of non-cortical areas of the brain, such 
as the retina, as well as the functional consequences of disrupting signaling mechanisms 
involved in retinal development. 
 
We have previously shown that one such signaling pathway, Semaphorin6A-
PlexinA2 (Sema6A-PlxnA2), is critical for vertebrate eye development [2]. Current 
working models propose that the repulsive guidance cue Sema6A binds to PlxnA 
receptors on the growth cone of migrating neurons, which subsequently activates the 
tyrosine kinase Fyn. This initiates signaling cascades that ultimately regulate cellular 
adhesion and cytoskeletal dynamics, crucial events that navigate the axon to its proper 
synaptic partner. However, the majority of studies have investigated this signaling 
cascade out of the context of Sema6A binding. Furthermore, little is known about the in 
vivo molecular mechanisms underlying this critical signaling pathway. This dissertation 
aimed to elucidate the functionally-relevant mechanisms of Sema6A-PlxnA signaling 
during eye development. 
 
Using biochemical and proteomic approaches in cell culture systems and the 
zebrafish as an in vivo model, the reports herein describe and characterize novel 
molecular mechanisms of Sema6A-PlxnA signaling and their functional significance in 
vertebrate eye development. 
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1.3. Extracellular Cues Guide the Migrating Axon 
Proper nervous system development depends on correct cellular migration and 
synaptogenesis. Immature neurons are guided to their final location and synaptic targets 
by extracellular cues in a remarkably accurate fashion. The growth cone, a dynamic 
structure at the distal end of the axon, has the critical function to detect and respond to 
molecules in the environment. The growth cone is made up of actin and microtubule 
filaments with long extensions called filapodia that can extend 50 – 75 m to explore the 
extracellular environment [3]. The growth cone has the machinery necessary to translate 
the extracellular signal to a change in the cytoskeleton, which guides the axon to its 
ultimate synaptic target by moving forward, collapsing, or changing direction. This 
complex cellular machinery includes transmembrane receptors, adaptor proteins, kinases 
and cytoskeletal regulatory proteins [4]. How the axon responds to extracellular cues and 
integrates these signals is critical in determining the ultimate synaptic location. 
 
Ramón y Cajal first hypothesized that axon guidance is mediated by extracellular 
factors [5]. He applied the chemotaxis theory to migrating neurons and suggested that 
positive and negative chemotaxis could take place in the retina and other brain regions, 
and that these chemicals were secreted by other cells [5]. It was not until over fifty years 
later that direct evidence arose that gave credence to Ramón y Cajal’s hypothesis. These 
studies identified long-range cues as Ramón y Cajal suggested, as well as contact-
mediated signals critical to axonal guidance. 
 
Evidence of local, contact-mediated cues was found with the identification of 
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pioneer axons in the developing limb of grasshopper embryos. Bate (1976) observed a 
pair of pioneer neurons that establish peripheral nerve pathways [6]. Interestingly, these 
neurons did not take the shortest course to their target. Instead, they made distinct turns 
along the way after making contact with other cells. This seminal paper had two main 
conclusions: 1) something is guiding the pioneer axons to their correct target via 
repulsion from incorrect areas and 2) this guidance cue is acting at the local level. These 
findings triggered the field to identify these local guidance molecules. The next several 
decades resulted in the identification of numerous membrane-bound and secreted 
molecules, expressed in different locations and at different times, that are critical for 
axonal pathfinding. 
 
Netrins were the first guidance molecules to be identified. In the 1970’s, Brenner 
studied the genome of C. elegans and screened and mapped the “uncoordinated” (unc) 
mutants [7]. The unc mutants affected movement and Brenner hypothesized that the 
corresponding genes have a role in the nervous system and he proposed that many of the 
unc mutants affected the formation of proper nervous system connections. For example, 
the unc-5 mutant lacks the dorsal nerve cord [7]. The unc-5 gene was further described 
and found to be a receptor for unc-6, and both are necessary for axonal guidance of dorsal 
migrating neurons in C. elegans [8]. The mammalian homologues to unc-6, netrin-1 and 
netrin-2, were characterized in vitro and in vivo and were found to promote axonal 
outgrowth of commissural axons [9, 10]. Netrins have since been shown to be secreted 
molecules that act bifunctionally: for example, as an attractant for retinal ganglion cells 
and as a repellant for trochlear motor neurons [11]. 
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The bifunctionality of netrins occurs due to differential receptor expression. When 
netrin binds to the DCC receptor, the growth cone displays attractive growth. This is due 
to adaptor proteins on the DCC receptor that regulate the Rho family GTPases Cdc42 and 
Rac1, which promote actin nucleation and branching by activating N-WASP and Arp2/3 
[12]. Conversely, if the growth cone expresses the unc-5 receptor, netrin binding will 
cause repulsion of the growth cone. The differential expression of receptors gives a 
relatively few number of guidance cues the flexibility to elicit multiple growth cone 
behaviors, including attraction and repulsion. 
 
Slits are another family of secreted guidance cues that are involved in neuronal 
migration and axonal pathfinding. They act primarily as repulsive signals through the 
Robo receptor. Slit-Robo signaling inhibits Cdc42 through the GTPase activating protein 
(GAP) srGAP resulting in growth cone repulsion [12]. The repulsive role of slits is best 
characterized during midline crossing of commissural axons. Interestingly, Robo receptor 
expression levels vary as the growth cone of commissural axons moves through the 
extracellular environment. Robo is expressed in low levels as commissural axons cross 
the midline. Subsequent up-regulation of the Robo receptor prevents the commissural 
axons from incorrectly re-crossing the midline [13]. This illustrates the importance of 
spatiotemporal regulation of guidance cue receptors to achieve accurate axonal 
pathfinding.  
 
Slits are also involved in establishing the location of the optic chiasm and 
directing retinal ganglion cells across the midline [14]. The retinal ganglion cells in 
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mutant mice lacking the slit1 and slit2 genes exhibit abnormal axon guidance and an 
ectopic optic chiasm develops [14]. This suggests that the repulsive signaling of slits 
provides a barrier for the optic nerve, keeping the retinal ganglion cells from aberrantly 
migrating along the pathfinding route. 
 
In addition to long-range guidance cues such as netrins and slits, there are 
membrane-bound molecules that act via cell-cell contact, including ephrins. Ephrins are 
GPI-linked (ephrinA class) or transmembrane (ephrinB class) molecules. Ephrin 
signaling is involved in many developmental processes, including tissue organization, 
axon formation and growth cone guidance [15]. Ephrins regulate these processes via 
repulsion to maintain tissue patterns. For example, the developing hindbrain forms 
segmentations, rhombomeres, which later become cranial nerve origins [16]. The cells in 
adjacent rhombomeres must remain segmented in order for correct hindbrain 
development and this segmentation is facilitated by ephrin and Eph receptor expression. 
Rhombomere 5 expresses Eph receptors, while the adjacent rhombomeres, 4 and 6, 
express ephrin [17]. Thus, ephrin signaling is critical in tissue organization during 
development. 
 
Ephrin signaling occurs when ephrins bind to Eph receptors, which are receptor 
tyrosine kinases. Eph receptors dimerize, autophosphorylate, and activate upon ligand 
binding. Eph receptor activation recruits adaptor proteins to transduce ephrin signaling. 
Ephexin is a unique GEF that, in the absence of Ephrins, activates the Rho-family of 
GTPases RhoA, Rac1 and Cdc42 [18]. However, upon ligand binding, Ephexin activity 
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toward RhoA is increased, while GEF activity toward Rac1 and Cdc42 is inhibited [18]. 
RhoA activation and Rac1/Cdc42 inhibition ultimately leads to actin depolarization and 
growth cone collapse. Interestingly, as the EphrinB molecules are transmembrane 
proteins, bidirectional signaling can occur [19]. Reverse signaling is transduced via 
Ephrin phosphorylation-dependent and/or PDZ-dependent protein recruitment [20]. Upon 
Eph binding, Src-family kinases (SFKs) become activated and mediate EphrinB tyrosine 
phosphorylation [21]. This subsequently recruits the adaptor protein Grb4 via its SH2 
domain and initiates Pak1-mediated cytoskeletal reorganization [17]. PDZ-domain 
containing proteins, such as syntenin, can also be recruited to EphrinB proteins via a 
PDZ-binding motif on the C-terminus of EphrinB to initiate signaling and mediate 
synapse development [22, 23]. Bidirectional signaling, therefore, is an energy-efficient 
mechanism that enables tissues to produce multiple cellular outcomes from one ligand-
receptor interaction. 
 
Semaphorins (Semas) are another large family of guidance cues that are critical 
for nervous system development. There are currently 28 known Sema molecules, 
expressed in invertebrates and vertebrates (Figure 1.1). Semas are membrane-bound, 
transmembrane or secreted molecules that typically signal through Plexin (Plxn) 
receptors to regulate axonal pathfinding.  
 
The Sema3A-PlxnA signaling pathway is the best characterized. PlxnA contains a 
GAP domain and influences actin and integrin dynamics through small GTPases [24]. 
Additionally, the cytosolic tyrosine kinase, Fyn, binds and phosphorylates PlxnA 
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receptors [25], which may transduce Sema3-PlxnA signaling. Fyn can also phosphorylate 
and activate the serine/threonine kinase Cdk5 that ultimately regulates microtubule 
dynamics [12]. Cdk5 phosphorylates the family of microtubule associated proteins 
collapsin response mediator proteins (CRMPs) [26, 27]. This initial phosphorylation 
event primes GSK3 to processively phosphorylate CRMPs, leading to a decrease in 
microtubule affinity and destabilization of the microtubule, ultimately resulting in growth 
cone collapse [26]. 
 
Although Semas are best known for their roles in axonal guidance, they also 
function in cellular processes such as immune system activation, proliferation, 
differentiation and angiogenesis [28, 29]. The various cellular functions of Semas are due 
to binding to distinct receptors [30-32]. Semas thus have diverse roles in development 
and Sema signaling can be transduced through combinations of multiple ligands and 
receptors on various cell types. 
 
Identifying the cellular players and mechanisms involved in these signaling 
pathways is crucial to advancing our understanding of neuronal migration and represents 
one long-term research goal of this dissertation work. As Sema pathways play a critical 
role in axonal guidance during brain and eye development, the remainder of the chapter 
focuses on Sema signaling, with an emphasis on the major signaling proteins involved 
and the currently known molecular mechanisms underlying Sema signal transduction. 
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1.4. Semaphorin Signaling 
 
1.4.1. The Semaphorin Family of Guidance Cues 
The first Sema (Sema-1a) was characterized in the early 1990’s as an axon 
guidance cue in the developing limb bud of the grasshopper [33]. Since then, over twenty 
Semas have been discovered. These molecules are categorized into eight classes, based 
on C-terminal sequence homology (Figure 1.1) [34]. Sema-1 and Sema-2 are found 
exclusively in invertebrates, while classes 3-6 are expressed in vertebrates. There is an 
additional class found only in viruses (SemaV). Interestingly, while there are only four 
known invertebrate Semas, there are 22 Semas expressed in vertebrates [35], suggesting 
that Semas have critical and diverse roles in vertebrate development. 
 
As Semas critically regulate the cytoskeleton, they have crucial roles for many 
cellular processes that depend on cytoskeletal dynamics including migration, 
proliferation, and differentiation. Thus, many Semas have overlapping roles in the 
nervous system, endothelial system, and immune system [29]. Nonetheless, different 
Sema classes have predominant roles in specific tissues, as summarized in Table 1.1. 
While typically repulsive, Semas act as inhibitory or permissive cues in neuronal and 
endothelial cell migration [29, 30].  The “immune Semas,” including Sema classes 4, 5 
and 7, are involved in regulating immune cell responses [36].  
 
The defining feature of all Semas is the presence of the semaphorin (sema) 
domain. The sema domain is an approximately 500 amino acid extracellular domain on 
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Figure 1.1. The Invertebrate and Vertebrate Semaphorins are Categorized based on 
Sequence Homology. A phylogenetic tree illustrating the similarities among the 28 
Semas, classified into 8 classes based on sequence similarities. The letters in parentheses 
indicate the animal of the sequence used in the alignment. D, Drosophila; M, mouse; V, 
viral; Z, zebrafish (Sema4E has not yet been identified in mammals). Re-printed from 
Biomed Central (BMC) Open Access Publishing from Yazdani & Terman 2006. Authors 




Table 1.1. Semas are a large class of invertebrate and vertebrate proteins that play 
roles in numerous systems. This table lists the 8 classes of Semas and each of the class 
members. Semas classes are expressed throughout embryonic development and the major 
systems are described in which the functional role of each Sema class has been highly 
characterized. 
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the N-terminus [33]. It is a variant of the seven-blade -propeller, composed of twisted -
sheets in a circular arrangement, and plays a role in protein-protein interactions [37]. The 
sema domain, although necessary for Sema activity, is not sufficient. Koppel & Raper 
(1998) found that Sema3A must be a dimer in order to have collapsing activity in 
embryonic chicken dorsal root ganglion explants [38]. It is now known that all Sema 
family members, secreted and membrane-bound, can form homodimers. The sema 
domain mediates specificity and receptor binding and is necessary for binding to Plxn 
receptors [37]. 
 
1.4.2. Plexins are the Major Semaphorin Receptors 
Plexins are transmembrane proteins that are highly expressed in the developing 
nervous system [39]. There are nine mammalian Plxns, classified into four families, 
PlxnA-D [40] (Figure 1.2). PlxnA family members are the most widely studied and are 
expressed in the developing spinal cord, cortex, and retina [41]. PlxnA molecules are also 
expressed in the hippocampus and regulate guidance of mossy fibers to their synaptic 
targets, pyramidal cells [42]. PlxnA2 is the most common PlxnA in the developing cortex 
and is involved in the lamination and axonal guidance of cortical neurons [43]. While 
PlxnA molecules appear to be most highly expressed in nervous tissue, PlxnB-D family 
members are found primarily in bone and immune cells, and knockout mouse studies 





Figure 1.2. The Structural Domains of Vertebrate Semaphorins and their 
Receptors. Semaphorins are a large family of secreted, transmembrane, and GPI-linked 
molecules. The vertebrate secreted Sema class, Sema3, requires neuropilins as co-
receptors. All Semas are characterized by an extracellular Sema and PSI domain and are 
classified into 8 classes based on the presence of other domains, including Ig-like 
domains and thrombospondin repeats. There are nine Plxn receptors characterized by an 
extracellular sema domain, PSI domain, and a glycine-proline-rich region and contain a 
split GAP domain in the intracellular region. Arrows indicate the Sema proteins that bind 
to the specified Plxn receptor. Sema: Semaphorin domain; PSI: plexin-semaphorin-
integrin domain; G-P: glycine-proline rich domain; Ig: Immunoglobulin-like domain; 
CUB: complement binding domain; FV/FVIII: FV/FVIII coagulation factor-like domain; 
MAM: Meprin-A5-Mu domain. Re-printed with permission from Springer Nature 
Publishing from Negishi & Oinuma 2015 under license number 4510920424543. 
Adapted and modified by Sarah E. Emerson and Riley M. St. Clair. 
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Plxn family members have a highly conserved cytoplasmic domain, yet these  
evolutionary conserved molecules have little sequence similarity with other proteins [40]. 
This may suggest that novel cellular players or novel signaling mechanisms are involved 
in these pathways. Therefore, many cellular signaling biologists and developmental 
neuroscientists have been interested in elucidating the Sema-Plxn signaling pathways.  
 
The Sema-Plxn structural interaction has been well characterized through crystal 
structure analysis and in vitro binding assays. Two independent research groups 
concurrently resolved the first structure of the mouse extracellular Sema6A-PlxnA2 
complex as well as the unbound molecules [45, 46]. When unbound, Sema6A is in a 
“face-to-face” homodimer, which remains in this conformation upon binding to PlxnA2 
(Figure 1.3A, C) [45, 46]. In contrast, unbound PlxnA2 is in an inhibitory “head-on” 
conformation (Figure 1.3B) [45]. Upon Sema6A binding, the PlxnA2 monomers are 
dissociated from each other and independently bind to the Sema6A homodimer via the 
sema domains of both Sema6A and PlxnA2 [45, 46]. Interestingly, the same binding 
interface is used for the PlxnA2-PlxnA2 interaction and the Sema6A-bound complex, 
suggesting that PlxnA2 undergoes a “partner exchange” to bind Sema6A [45]. Mutating 
residues in the interface disrupt Sema6A-PlxnA2 binding and thus no longer induce DRG 
growth cone collapse [45, 46]. 
 
While Plxns are the major signal transducing receptor for transmembrane Semas, 
class 3 secreted Semas require Neuropilin (Np) co-receptors [46, 47]. Nps are a small 
family of transmembrane molecules made up of Np1 and Np2 [47]. While Nps are  
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Figure 1.3. Crystal Structures of Sema-Plxn Signaling Complexes. Crystal structures 
of unbound and complexed Sema6A and PlxnA2 ectodomains, each with a cartoon 
schematic inset. A. Sema6A ectodomains form a “face-to-face” homodimer through their 
sema domains. B. PlxnA2 sema domains form a “head-on” homodimer. C. The Sema6A-
PlxnA2 complex involves the two independent PlxnA2 molecules binding to the Sema6A 
homodimer. D. The Sema3A-PlxnA2-Np1 complex indicates that the Sema-Plxn binding 
interface is conserved in secreted Sema classes, while the Np1 co-receptor acts as a 
stabilizing bridge between Sema3A and PlxnA2 sema domains. Adapted from and re-
printed with permission from Springer Nature Publishing from Nogi et al. 2010 (Figures 
1.3A-C) and Janssen et al. 2012 (Figure 1.3D) under license numbers 4560951339161 
and 4560960094307, respectively. 
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primarily expressed during neuronal development, they are also expressed during the 
development of non-neuronal tissues such as the cardiovascular system [47, 48]. It is now 
known that Nps can bind to various Plxn receptors to enable binding of various Sema3 
class members [47]. Interestingly, Np1 was first identified as a necessary but not 
sufficient component of Sema3A-mediated repulsion [47-49]. Indeed, the transmembrane 
and short cytoplasmic tail of Np1 are not necessary for Sema3A binding or activity [50]. 
However, truncation mutants of PlxnA proteins lacking the cytoplasmic domain inhibits 
Sema3A-mediated growth cone collapse [47]. Together, these studies reveal that Plxns 
and Nps form a receptor complex for secreted Sema3 proteins, with Plxns mediating 
signal transduction.  
 
 Crystal structure analysis gives insight into the role of Nps in the Sema3 
receptor complex. Mouse Sema3A-PlxnA2-Np1 was resolved to illustrate that Np1 forms 
a stabilizing bridge between the sema domains of Sema3A and PlxnA2 (Figure 1.3D) 
[51]. Without Np1, Sema3A has a weak affinity for PlxnA2 whereas Np1 can directly 
bind to both Sema3A and PlxnA2 in in vitro binding assays [51].  This suggests that Np1 
and PlxnA2 can form complexes at the cell surface independent of Sema3A ligand 
binding. Indeed, the expression of Np co-receptors couldconfer Sema specificity to the 
same Plxn receptor. For example, PlxnA1 or PlxnA2 expression allows cells to be 
responsive to Sema6A and not Sema3A, while PlxnA1 or PlxnA2 co-expressed with Np1 
enables Sema3A binding and responsiveness [47, 51, 52]. This difference occurs due to 
the reduced affinity of Sema3A for PlxnA2, while Sema6A has a strong affinity for 
PlxnA2 without the Np1 co-receptor [51]. The weak Sema3A-PlxnA2 interaction may 
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stem from subtle conformational differences between Sema3A and Sema6A: two 
extrusion loops of the Sema3A sema domain are larger than in the homologous 
extrusions of Sema6A, which enables Np1 binding [51]. Furthermore, amino acid 
differences in the Np1-binding interface result in a charge differences that could further 
support Sema3A-Np1 binding while inhibiting Sema6A-Np1 binding [51]. Importantly, 
the Sema3A-PlxnA2 binding interface is conserved in Np-independent Sema-Plxn 
interactions, such as Sema6A-PlxnA2 [51]. This suggests a conserved and canonical 
Sema-Plxn interaction across secreted and transmembrane Semas. 
 
In addition to the Sema-Plxn interaction, the cellular players involved in PlxnA 
signaling have been proposed based on in vitro and explant studies as well as mouse 
genetic experiments. Signaling pathways induced by guidance molecules ultimately 
regulate the cytoskeleton. Sema signaling can regulate integrin and cytoskeletal 
dynamics, causing depolymerization of actin filaments, destabilization of microtubules 
and a decrease in focal adhesions, ultimately resulting in growth cone collapse.  
 
1.4.3. Sema-Plxn Signaling Regulates Adhesion and Cytoskeletal Dynamics 
By regulating integrin and cytoskeletal dynamics, Semas govern cellular 
morphology and migration. Interestingly, Sema7A can bind directly to integrin receptors 
through a unique RGD integrin-binding motif to play roles in axonal guidance, immune 
cell activation and endothelial cell migration [32, 53, 54].  Classically however, Semas 
indirectly influence integrin signaling by regulating the activity of small GTPases as all 
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Plxns contain a highly conserved intracellular GAP domain [55, 56]. This GAP domain is 
homologous to Ras GAPs in both sequence and structure and necessary for Plxn-
mediated growth cone collapse [24, 57]. The intracellular region is comprised of two split 
GAP domains surrounding a Rho GTPase-binding domain (RBD), which is in an inactive 
conformation until ligand binding [45, 46]. Sema binding induces Plxn dimerization, 
however Rho GTPases such as Rac1 or Rnd1, must bind to the RBD for Plxn GAP 
activation to occur [55]. Interestingly, while the Ras-related proteins R-Ras and M-Ras 
have been shown to bind to the Plxn GAP domain in vitro, Plxn GAP activity is specific 
for the Ras homologue Rap [55]. Indeed, Rap inactivation is necessary for Sema3A-
mediated growth cone collapse [55]. 
 
By regulating Rap activity, Plxn signaling can influence integrin-mediated 
adhesion and actin dynamics. When active, GTP-bound Rap1 binds the adaptor protein 
RIAM which acts as a scaffold for the recruitment of talin to the cytoplasmic domain of 
integrins [58] (Figure 1.4). This interaction increases integrin affinity to the extracellular 
matrix promoting adhesion [59]. Thus, Plxn-mediated Rap inhibition leads to de-adhesion 
by decreasing integrin-containing focal adhesions. Independent of Plxn, Rap1 inhibition 
can be opposed by C3G, a Src-Crk-dependent Rap1 GEF, which activates Rap1 leading 
to an increase in integrin-mediated adhesion [60]. Together, this illustrates the 
importance of a tightly regulated balance of GAPs and GEFs to regulate the activity of 
small GTPases to govern cellular adhesion and migration.  
 
Plxn Rap GAP activity also regulates actin dynamics through multiple players  
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Figure 1.4. Working model of Sema-mediated regulation of cytoskeletal and integrin 
dynamics. Known and proposed effector proteins downstream of Plxn GAP activity or 
Plxn interactors. Proteins in green boxes have been shown to be involved in Sema-
induced growth cone collapse in cell culture or explant assays. Proteins in black boxes 
have not yet been linked to Sema signaling, however are hypothesized to be downstream 
based on known protein interactions. The primary literature that elucidated the given 




(Figure 1.4). Rap has been shown to inhibit RhoA activity, thus Plxn GAP activity 
activates Rho [61]. Indeed, RhoA activation occurs downstream of Sema3A and is 
necessary for Sema3A-mediated growth cone collapse [61, 62]. RhoA-mediated collapse 
may be through ROCK/LIMK regulation of cofilin as cofilin inactivation is necessary for 
Sema3A-induced growth cone collapse of dorsal root ganglion cells [63]. When active, 
cofilin severs actin filaments and increasing the number of barbed ends, leading to 
increased actin polymerization and cellular motility [64, 65]. LIMK-mediated 
phosphorylation of cofilin results in decreased cofilin activity, reduced actin turnover and 
polymerization, and an inhibition of migration [64]. Rap inactivation also inhibits Cdc42-
mediated WASP/Arp2/3 actin nucleation [66]. Thus, PlxnA GAP activity can mediate 
cytoskeletal dynamics and adhesion through small GTPases and kinases. 
 
While extensive research has focused on actin regulation, the mechanistic details 
of Sema-mediated microtubule regulation are still poorly understood. At present, the 
CRMP family of microtubule associated proteins are the major cellular players 
implicated in Sema-induced microtubule destabilization.  The tyrosine kinase Fyn 
associates with PlxnA receptors [25] and is thought to become active through 
autophosphorylation upon Sema binding. Fyn subsequently activates Cdk5 leading to 
Cdk5- and GSK3β-mediated CRMP phosphorylation [25, 26, 67] (Figure 1.4). However, 
it is currently unknown if Plxn GAP activity plays a role in this pathway. The function 
and mechanisms of CRMPs are discussed in detail in Section 1.5. 
 
While much molecular work has been carried out in the context of the canonical 
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Sema, Sema3A, it is currently unknown if the downstream mechanisms are similar in 
Sema6A signaling. It is likely, however, that signaling is conserved as both Sema6A and 
Sema3A utilize overlapping PlxnA receptors (Figure 1.2). We have previously shown 
that Sema6A and PlxnA2 are expressed in the developing zebrafish visual system and are 
critical for proper visual system development [2, 68]. Yet, the molecular mechanisms 
governing Sema6A-PlxnA2-mediated functions in eye development are currently 
unknown and represent the major objective of this dissertation work. 
 
1.4.4. Sema6A-PlxnA Signaling 
Sema6A is highly expressed in developing brain, spinal cord, ovary and kidneys 
[69]. Mouse in situ hybridization assays and Northern blots show Sema6A mRNA 
expression in the developing cortex (layers IV and VI) and deep brain structures 
including thalamus, hypothalamus, and amygdala as well as the retina and olfactory  
system, cerebellum, and motor nuclei of the brain stem [70]. It is also expressed in the 
developing mouse ventral spinal cord, dorsal root ganglion cells, gastrointestinal tract, 
kidneys, skeletal muscle and lung [71]. In contrast, the close family member Sema6B is 
primarily expressed in developing muscles and spinal cord and, unlike many Semas, 




 mice studies have shown that the repulsive activity of Sema6A is 
critical for the in vivo guidance of migrating granule cells and corticospinal tract axons as 
well as cortical lamination [73-75]. In the hippocampus, PlxnA4-expressing mossy fibers 
synapse onto CA3 pyramidal neurons which express Sema6A throughout their soma and 
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projections [42]. Interestingly, cis expression of PlxnA2 with Sema6A in a specific 
pyramidal cell region antagonizes Sema6A-PlxnA4 signaling, resulting in a permissive 
environment for mossy fiber outgrowth and synapse formation [42]. This phenomenon, 
known as cis-inhibition, allows for accurate and precise targeting of mossy fiber-
pyramidal cell synapse formation.  
 
To determine the cellular effects and downstream mechanisms of Sema6A 
signaling, biochemical studies utilize a Sema6A-FC recombinant chimeric protein, of 
which the ectodomain is fused to the FC portion of IgG. This enables Sema6A to be 
secreted from the cell in a dimer [76], overcoming the technical obstacles of stimulating 
cells with a transmembrane protein. Similar to the hippocampus, cis-inhibition modulates 
Sema6A responsiveness of sympathetic and DRG neurons, both of which express PlxnA4 
[77]. Neuron outgrowth of sympathetic neurons is impeded by Sema6A-FC in culture, 
whereas Sema6A is co-expressed with PlxnA4 on DRGs yielding DRG’s Sema6A-
resistant [77]. 
 
Zebrafish and mouse expression data (from Zfin and Mouse Genomics 
Informatics, respectively) indicate that Sema6A is expressed in zebrafish and mouse 
retinas. Similarly, we have previously shown that Sema6A is expressed throughout early 
and late zebrafish eye development [78]. As retinal ganglion cells do not respond to 
Sema3A [79], this could indicate that Sema6A-PlxnA signaling is the major Sema 
pathway involved in eye development. Indeed, Sema6A is critical for retina lamination 
[80]. Sema6A is highly expressed in the ON sublayer of the inner plexiform layer 
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influencing neurite projection of ON retinal cells, which are excited by an increase in 
light [80]. PlxnA4-expressing OFF bipolar cells, excited by a decrease in light, are 
repelled from the ON sublayer to stratify the retina [80]. In contrast, OFF retinal ganglion 
cells do not express PlxnA4 and their dendrites can pass through the Sema6A-expressing 
ON layer to synapse with the appropriate bipolar cells in the OFF layer [80]. Similarly, 
Sema6A mediates synaptic targeting of amacrine cells through PlxnA2 [81]. PlxnA2-
expressing OFF amacrine cells are repelled from entering the Sema6A-containing ON 
layer while ON amacrine cells do not express PlxnA2 and can thus migrate into the ON 
layer.  
 
Interestingly, we have previously found a novel function of Sema6A-PlxnA2 
signaling in zebrafish eye development. When Sema6A or PlxnA2 expression is 
decreased using antisense morpholino oligonucleotides (MO), the cohesion of the early 
eye field is impaired (Figure 1.5). Intriguingly, this phenotype occurs before retina 
precursor cells have differentiated and have not yet begun neurite outgrowth. 
Additionally, Sema6A or PlxnA2 MO results in a decrease in proliferative retinal 
precursor cells and a subsequent decrease in eye size later in development (Figure 1.5). 
These results suggest novel functions of Sema6A and PlxnA2, although the molecular 
mechanisms underlying these phenotypes are unknown. 
 
1.4.5. Sema6 members act as receptors for reverse signaling 
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Figure 1.5. Sema6A and PlxnA2 are critical for zebrafish eye development. 
Endogenous Sema6A or PlxnA2 were decreased by injecting antisense morpholino 
oligonucleotides (MO) at the 1-cell stage. A-F. At the 18 somite stage, during early eye 
field migration, rx3:GFP zebrafish expressing GFP in retinal precursor cells show 
ectopic cells when Sema6A or PlxnA2 is decreased. Proliferative cells were stained using 
pHH3 immunofluorescence, as shown in red and quantified in L. G-K. Brightfield images 
at 48 hours post fertilization show Sema6A or PlxnA2 MO results in smaller eye size, 
quantified in M. These phenotypes are specific to Sema6A or PlxnA2 as co-injecting WT 
mRNA constructs rescues the phenotypes. Re-printed with permission from 
Developmental Dynamics Journal (John Wiley and Sons Publishing) from Emerson et al. 
(2017) under license number 4510941106189. 
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Since the initial discovery of transmembrane Semas, scientists have been 
hypothesizing that they act as ligands, receptors, or both. However, most transmembrane 
Semas lack significant cytoplasmic domains [72], with the exception of the Sema6 class. 
Indeed, the first evidence of Sema6 class members exhibiting reverse signaling came 
from the discovery of Sema6B in mouse in 1997 [72]. Sequencing mouse Sema6B 
revealed proline-rich regions that are the preferred motifs of SH3 domains and in vitro 
pull-down assays using GST-SH3 domains of various proteins show strong c-Src binding 
as well as nck, cAbl, and rasGAP binding [72]. Further analysis in cell culture systems 
shows that Sema6B co-IPs with c-Src and that this binding occurs through the Sema6B 
cytoplasmic domain at a c-Src SH3 binding consensus sequence, RXXPXXP [72]. 
 
Sequence analysis of the Sema6A cytoplasmic domain indicates a zyxin-like 
binding domain [70]. Zyxin is a proline-rich protein that regulates actin dynamics by 
binding to Ena/VASP proteins [82]. Thus, Klostermann et al. [70] first hypothesized that 
retrograde or reverse signaling can occur through the Sema6A cytoplasmic domain to 
regulate the actin cytoskeleton. Co-immunoprecipitation and pull-down assays in cell 
culture systems showed that the Ena/VASP family member EVL (Ena/VASP-like 
protein) can directly bind to the Sema6A C-terminus at an Ena/VASP preferred 
consensus binding motif DVPPKP (amino acid positions 1010-1015) [70]. Mena 
(mammalian enabled) and the tyrosine kinase Abl can also interact with Sema6A, with 
Abl being recruited to a specific region when stimulated with PlxnA2, similar to the 
PlxnA1 ligand-dependent Abl binding of Sema6D [83, 84].  
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Functionally, Sema6A reverse signaling maintains aggregation of cerebellular 
granule cell explants and inhibits neurite outgrowth and branching [83]. Mechanistically, 
PlxnA2 binding to Sema6A is thought to induce clustering of Sema6A, as forcing 
Sema6A  intracellular domains to multimerize causes a decrease in neurite length similar 
to PlxnA2 stimulation [83]. Furthermore, Abl is necessary for Sema6A reverse signaling-
mediated neurite outgrowth inhibition [83]. Sema6D has also been shown to be capable 
of reverse signaling in PlxnA1-mediated myocardial cell migration during heart 
development [84]. Additionally, the invertebrate Sema6 orthologue Sema-1a exhibits 
reverse signaling through the invertebrate PlxnA orthologue Plex-A, to mediate 
photoreceptor and olfactory neuron axon migration [84, 85].  
 
As reverse signaling is conserved throughout invertebrates and vertebrates, cells 
may have developed ways to regulate the signaling direction. Interestingly, ectodomain 
release of transmembrane Semas has been illustrated in numerous cell types and may 
represent one mechanism of inhibiting reverse signaling. The following section contains a 
mini-review of what is currently known of the functions and mechanisms of Sema 
ectodomain release. 
 
1.5. Soluble Isoforms of Transmembrane Semas 
Semas are secreted and membrane-bound molecules classically acting as axonal 
guidance cues in nervous system development, although it is now widely appreciated that 
they have essential functions in the development of many systems including 
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cardiovascular, endothelial, and immune systems. While secreted forms enable diffusible 
or systemic roles, membrane-bound Semas mediate contact-dependent signaling. 
Interestingly, functional soluble ectodomains have been discovered in many of the 
vertebrate membrane-bound classes. While many such soluble Semas (sSemas) were first 
discovered to have critical roles regulating immune responses, emerging evidence shows 
that sSemas can govern axon guidance and endothelial cell migration (Table 1.2). This 
review highlights the discovery and function of sSema molecules as well as what is 
currently known about the mechanisms generating Sema ectodomain release. The 
potential roles and actions of Sema ectodomain shedding are discussed. 
 
1.5.1. Sema4D 
Sema4D is critical for immune and vasculature system function, playing roles in 
T-cell dependent antibody production, T and B cell proliferation, B cell aggregation, 
platelet activation, and endothelial cell migration [86-90]. Mouse genetic studies reveal 
Sema4D to be critical for T cell differentiation and the humoral immune response in 
addition to playing a role in arterial occlusion after vascular injury [88, 90, 91]. Sema4D 
signals through its low affinity receptor CD72 to mediate functions in lymphocytes and 
via its high affinity receptor PlxnB1 on endothelial cells [92, 93]. While Sema4D is 
predominantly expressed in hematopoietic tissue, Northern blot analysis indicates high 
expression in human skeletal muscle and lower levels in the brain, kidney, and small 
intestine [87]. Indeed, Sema4D has been shown to induce growth cone collapse of 
hippocampal neurons through PTEN activation by the R-Ras GAP activity of PlxnB1  
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Table 1.2. Summary of the transmembrane and membrane-bound Semas known to 
produce soluble ectodomains. This table lists all of the known invertebrate and 
vertebrate transmembrane or membrane-bound Semas and whether or not a soluble 
ectodomain has been shown to be released from the plasma membrane. The function of 
the soluble ectodomain fragment is listed, if known. rsSema indicates that a recombinant 
ectodomain was used in functional studies, rather than the naturally-released sSema 
product.  
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[94]. Sema4D is also critical for synaptogenesis of inhibitory neurons in the hippocampus 
via PlxnB1 [95, 96].  
 
Sema4D was the first transmembrane Sema identified to have a functional soluble 
ectodomain [97-100]. The 120 kDa soluble Sema4D isoform (sSema4D) was discovered 
to be released from activated human lymphocytes and primary mouse lymphocyte 
cultures [97-99]. sSema4D is also present in vivo, as sSema4D was detected in the sera of 
mice immunized with a T cell-dependent antigen [99]. sSema4D stimulation inhibits 
migration of human monocytes and immature dendritic cells and blocks pro-
inflammatory cytokine production in these cell types [100, 101]. sSema4D is shed from 
activated platelets and plays a role in thrombus formation [90]. Interestingly, while 
Sema4D ectodomain shedding can occur in neurons, it is not necessary for Sema4D-
mediated synaptogenesis in the hippocampus [95]. 
 
Mechanistically, metalloproteases are implicated in sSema4D release, as the light 
metal chelators EDTA and EGTA inhibited greater than 50% of sSema4D shedding in a 
human T cell line and ADAM17 is necessary for Sema4D shedding in platelets [90, 98]. 
While general pharmaceutical inhibition of matrix metalloproteases (MMPs) did not 
affect shedding in lymphocytes, MT1-MMP is necessary to produce sSema4D in 
carcinoma cell lines and tumors [98, 102]. Inhibiting lysosome degradation does not 
impair sSema4D release, giving further evidence of ectodomain release occurring on the 
cell membrane [98]. This could suggest that Sema4D is cleaved at the plasma membrane 
and not in internal vesicles. Serine/threonine kinase inhibition with staurosporine 
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increases sSema4D production while the tyrosine phosphatase inhibitor vanadate has no 
effect, suggesting that Sema4D release may be regulated by phosphorylation [98]. This 
supports “sheddase” mechanisms as shedding enzymes often have structural requirements 
[103], and post-translational modifications can alter protein conformation, inferring 
differential sheddase susceptibility. Similarly, protein-protein interactions regulate 
Sema4D shedding tendency as calmodulin binds to a polybasic region of the Sema4D 
intracellular domain and this binding inhibits ectodomain shedding [104].  
 
In addition to regulating physiologic responses, Sema4D ectodomain shedding is 
implicated in cancer and numerous diseases. Sema4D is highly expressed in carcinoma 
cell lines and tumors and is thought to promote tumor angiogenesis by MT1-MMP-
mediated Sema4D shedding and endothelial cell migration through PlxnB1 [102, 105]. 
Furthermore, elevated serum sSema4D levels are correlated with autoantibody 
production, atrial fibrillation, heart failure, and postmenopausal osteoporosis in women 
[99, 106-108].  
 
Soluble ectodomain production may be a general phenomenon of the Sema4 class, 
as large scale proteomic studies have detected Sema4B and Sema4C as substrates of 
BACE proteases [109].  Interestingly, the protease responsible may not be conserved 
among the Sema4 members suggesting that the while the shedding mechanisms vary 





Vertebrate class 5 Semas, Sema5A and Sema5B, play roles in the nervous system 
and cardiovascular system. Sema5 members are structurally characterized by seven 
thrombospondin (TSP) type-1 repeats in the extracellular domain, which are thought to 
enhance ligand binding and Sema5A inhibitory potency [110]. Sema5A has a relatively 
broad expression pattern, being expressed in the adult brain, heart, kidney, muscle, and 
liver as well as during embryonic development [111]. Sema5A has bifunctional roles in 
the nervous system, attracting or repulsing axons via differential proteoglycan 
interactions through the TSP repeats, as well as functions in the vasculature and immune 
systems [30, 31, 112]. Sema5A acts as an inhibitory cue for retinal ganglion cell axons 
while it is a permissive cue for dorsal root ganglion cell axons and endothelial cells [31, 
110, 113-115]. Sema5A positively regulates endothelial cell proliferation through PlxnB3 
binding and Met tyrosine kinase activity and Akt phosphorylation [31]. There is also 
evidence that Sema5A plays a role in the immune response, as increased Sema5A 
expression in a human breast cancer cell line enhances proinflammatory genes including 
TNF-α and IL-8 [116]. 
 
An endogenous soluble Sema5A fragment was first discovered in the media of the 
pancreatic tumor cell line T3M4, which expresses high levels of endogenous Sema5A 
[109]. HeLa cells stably-expressing full-length Sema5A also release the soluble fragment 
[112]. Little is known of the cleavage site or mechanisms regulating sSema5A 
production, although ADAM17 has been shown to contribute to sSema5A production 
[112].  
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While the function of naturally released soluble Sema5A is not known, functional 
assays using recombinant Sema5A ectodomain (Sema5A-ECD) in culture and in vivo 
systems suggest that sSema5A plays roles in the vasculature and immune systems [109, 
112]. Sema5A-ECD stimulation in cell culture increases proliferation of endothelial cells 
as well as increases expression of the pro-angiogenic factors IL-8 and VEGF [109]. 
sSema5A may also play roles in the immune system as stimulating cultured T cell or 
natural killer (NK) cells with Sema5A-ECD results in an increase in proliferation and the 
production of cytokines as well as promotes T cell differentiation [112]. Implanting 
Sema5A-ECD-expressing tumor cells in the pancreas of mice shows an increase in 
angiogenesis, suggesting a role of sSema5A in disease [31]. Interestingly, tumor cell 
metastasis may be mediated by autocrine signaling as Sema5A-ECD-expressing Panc1 
tumor cells show increased invasiveness [117]. Furthermore, serum sSema5A levels are 
elevated in patients with Rheumatoid Arthritis (RA), suggesting that sSema5A could be a 
biomarker for RA and may contribute to RA pathogenesis [112].  
 
Investigating the signaling mechanisms of Sema5A-ECD shows that recombinant 
sSema5A is mediated through PlxnA1 or PlxnB3 receptors in various systems. 
Knockdown of PlxnA1 or PlxnB3 in NK cells resulted in a significant decrease in 
Sema5A-ECD induced cytokine production [112]. PlxnB3 also mediates Sema5A-ECD-
induced endothelial cell proliferation through Met tyrosine kinase and Akt activation [31, 
114]. Future work is needed to investigate if the signaling mechanisms and function of 
the naturally released sSema5A is similar to that of the recombinant Sema5A ectodomain 
as well as further address the mechanisms of Sema5A shedding. 
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1.5.3. Sema5B 
Similar to Sema5A, the homologous vertebrate family member Sema5B is critical 
for nervous system and cardiovascular development [118-121]. However, unlike the 
broad tissue expression pattern of Sema5A, Sema5B is highly expressed in the 
developing brain and spinal cord with lower expression in the embryonic heart and 
kidney [69, 111]. Within the brain, Sema5B is expressed in the cortex, hippocampus and 
olfactory bulbs, where it acts as an inhibitory guidance cue for cortical axons and 
mediates synapse elimination in hippocampal neurons [118, 119]. Similarly, Sema5B acts 
as a repellent cue for sensory neurons, collapsing growth cones and inhibiting DRG axon 
growth in culture [120, 122]. Sema5B is also expressed in endothelial cells, with 
expression levels being regulated by the transcription factor FoxP1, where it inhibits 
endothelial cell proliferation and migration [121]. 
 
Sema5B was first hypothesized to be proteolytically processed in 2009 with the 
observation of smaller Sema5B protein fragments being expressed in the neonatal brain 
as well as primary hippocampal cultures [119]. Later, the ectodomain of Sema5B was 
found to be released from Sema5B-expressing HEK cells [122]. Characterization of 
sSema5B identified it as a biologically active molecule, inducing collapse of cultured 
DRG cell axons and eliminating synaptic connections in hippocampal neuron cultures 
[119, 122]. 
 
The molecular mechanisms regulating sSema5B production remain to be 
elucidated, however, the putative Sema5B cleavage site was identified as a three amino 
 34 
acid sequence in the ectodomain of Sema5B proximal to the transmembrane domain 
[122]. ADAM17 can induce cleavage of the Sema5B ectodomain, although other 
metalloproteases may also regulate sSema5B production as ADAM17 knockdown did not 
significantly decrease sSema5B production [122]. While cleavage produces a more 
potent repulsive protein for DRG axons, it is not necessary for Sema5B functioning as the 
non-cleavable deletion mutant is still able to induce axon repulsion [122].  
 
1.5.4. Sema7A 
Sema7A is a glycosylphosphatidylinositol (GPI) -anchored glycoprotein that has 
critical roles in the immune system [32, 123-125]. Sema7A is expressed in activated T 
cells, NK cells and B cells and is expressed on erythrocytes where it bears the JMH blood 
group antigen [126-128]. Sema7A activates chemotaxis in monocytes and induces 
monocyte pro-inflammatory cytokine production through the 11 integrin receptor [32, 
124]. Sema7A is also expressed in the postnatal and adult brain and acts as a permissive 
cue for olfactory bulb axon outgrowth by signaling through integrins, focal adhesion 
kinase (FAK) and MAPK [53, 123]. Similarly, Sema7A stimulates angiogenesis in mouse 
corneas and promotes corneal nerve regeneration [54, 129]. 
 
Sema7A was first hypothesized to be shed from immune cells in 2002, as it is 
highly expressed in monocytes while also activating monocytes, suggesting autocrine 
signaling [124]. Later, Sema7A ectodomain shedding in monocytes was confirmed and 
ADAM17 was identified as the protease responsible [130]. A naturally released sSema7A 
was detected to be shed in activated platelets using mass spectrometry while biochemical 
 35 
methods verified Sema7A shedding with ADAM17 as the predominant metalloprotease 
in Sema7A cleavage [130, 131].  
 
Direct functional analysis of sSema7A is still necessary in normal physiological 
responses, however most studies use a recombinant soluble Sema7A to investigate the 
roles and mechanisms [53, 125]. However, sSema7A is implicated in chemotherapy-
induced blood disorders. Thrombocytopenia is a blood disease characterized by low 
platelet count and chemotherapy patients have increased sSema7A plasma levels, being 
released by peripheral blood mononuclear cells (PBMCs), including T cells, B cells, NK 
cells and monocytes [125]. RA patients also have an increase in sSema7A plasma levels, 
leading to an increase in pro-inflammatory cytokine production in PBMCs, which may 
contribute to RA-mediated inflammation [130]. Treating a RA mouse model with 
Sema7A blocking antibodies, decreases pro-inflammatory cytokines and joint swelling, 
lending Sema7A as a possible RA drug target [130].  
 
1.5.5. Proteases Involved in Sema Ectodomain Shedding 
For most sSemas, a protease has been identified that is capable of or contributes 
to ectodomain release (Table 1.3). The zinc-dependent metalloprotease ADAM17 
contributes to the cleavage of Sema4D, Sema5A, Sema5B, and Sema7A while the matrix 
metalloprotease MT1-MMP is necessary to cleave Sema4D in carcinoma cell lines and 
tumors [90, 102, 112, 122, 130, 131]. The aspartyl proteases ACE1 and ACE2 can 
cleave Sema4C and Sema4B, respectively [109, 132], although the biological activity of 
these soluble ectodomain remains unknown. 
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Table 1.3. Summary of the proteases known to shed Sema ectodomains. This table 
lists the known sSemas, what cell type(s) they are released from and the known proteases 
that are capable of producing sSemas.  
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While there are many reasons for receptor cleavage, the function of Sema 
shedding remains elusive. Sema4D ectodomain release increases when dimerization 
occurs as well as receptor post-translational modification [97, 98], which may point to 
Sema shedding as one cellular mechanism of inhibiting receptor signaling by investing 
minimal cellular energy. Further fine-tuning of Sema activity could be achieved by 
differential expression of proteases. Additionally, shedding could allow paracrine or 
systemic signaling thus diversifying the roles of membrane-bound Semas. Investigating 
the circumstances of which Semas are cleaved will shed light onto the functional 
significance of sSemas and represents an important aspect of future research. 
 
1.6. CRMPs 
1.6.1. The CRMP family  
CRMPs are critical downstream mediators of Sema-Plxn signaling. There are five 
vertebrate isoforms, CRMP1-5, of which CRMP1-4 share 75% identity [133]. CRMPs 
are uniquely expressed in the nervous system [133-135]. However, the different family 
members are expressed in discreet tissues and at specific times during development [134, 
135]. CRMP2 is the most widely expressed CRMP, being present throughout the 
vertebrate cortex, hippocampus, cerebellum, retina and spinal cord as well as in the adult 
brain [135-137]. CRMP1 and CRMP4 are also expressed in the developing cortex and 
hippocampus and the ventral spinal cord [135]. CRMP3 is not expressed in the cortex, yet 
is expressed in the granule cell layer of the cerebellum throughout development and 
adulthood [135]. CRMP1-4 are also expressed in the peripheral nervous system, in the 
developing and adult dorsal root ganglia cells and CRMP1, CRMP2, and CRMP4 are 
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expressed in sympathetic ganglia [135]. In the adult, CRMP1, CRMP2 and CRMP5 are 
expressed in the post-mitotic neurons of the olfactory system [136]. 
 
At the subcellular level, CRMPs are expressed throughout neuronal cell bodies, 
dendrites and axons [136, 138]. CRMPs are most highly expressing during axonal 
outgrowth with CRMP2 expressed in growth cone lamellipodia [134]. Interestingly, 
CRMP2 is expressed during neuronal differentiation and is upregulated in response to 
neural induction cues such as noggin [134, 139]. Likewise, BMP4, a neural induction 
inhibitor and epidermalization signal suppresses CRMP2 expression, suggesting that 
CRMP2 plays roles in neuron differentiation and axonal outgrowth [139]. 
 
1.6.2. CRMPs are critical for axonal outgrowth and guidance 
As CRMPs are highly expressed during neuronal differentiation and axon 
outgrowth, early studies hypothesized that CRMPs play critical roles in neuronal 
migration and axonal guidance. Indeed, CRMP2 was first identified by two separate 
research groups in 1995: one studying the genes involved in Sema3A-mediated growth 
cone collapse [137] and the other studying genes upregulated during neuron 
differentiation [134]. Furthermore, mutations in the invertebrate C. elegans CRMP 
homologue unc-33 cause neuronal guidance abnormalities, including premature or 
ectopic axon termination and branching in motor and sensory neurons [7, 140-142]. The 
vertebrate isoform CRMP2 is highly expressed in distal axons during axon outgrowth in 
culture and overexpression of CRMP2 leads to an increase in the number of axons [143]. 
CRMP2-mediated axon formation and elongation has also been demonstrated in the 
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immortal neuronal cell line NIE-115 and in DRG explants [144]. Interestingly, this 
function may be isoform specific, as CRMP1 and CRMP5 overexpression in NIE-115 
cells does not increase neurite elongation [144]. 
 
CRMP1-deficient mice have defects in cortical migration and disorganization of 
dendrites [145]. Similarly, in vivo CRMP2 knockdown during embryonic development 
using in utero electroporation results in impaired radial migration of cortical neurons 
[146]. The CRMP2-silenced neurons are able to leave the ventricular zone, yet become 
stalled in the intermediate zone and do not migrate into the cortical plate [146]. 
Furthermore, the dendritic field is in an immature state, with a multipolar morphology 
instead of adapting the typical bipolar morphology of migrating pyramidal neurons [146, 
147]. Sema3A
-/-
 mice also exhibit abnormal pyramidal dendrite morphology [25], 
suggesting CRMP2 may be functioning downstream of Sema3A to mediate cortical 
development. Indeed, CRMP2 was first identified as a mediator of Sema3A signaling 
[137]. Sema3A signaling can be recapitulated in a COS7 collapse assay, as PlxnA1- and 
NP1-expressing COS7 cells collapse after 60 minutes of Sema3A stimulation [148]. 
When CRMP isoforms are co-transfected, Sema3A-mediated collapse occurs after only 
10 minutes, suggesting that CRMPs accelerate Sema3A functions [148]. 
 
1.6.3. CRMPs are regulated by phosphorylation 
CRMP2 is downstream of Sema3A signaling, as function-blocking antibodies to 
CRMP2 cause an absence in Sema3A-induced growth cone collapse [137]. Several amino 
acids have been identified that regulate CRMP affinity for microtubules. Activated Cdk5 
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phosphorylates CRMP2 in vitro and in vivo at Ser522 [67]. This initial phosphorylation 
event recruits another serine/threonine kinase, GSK3β, which phosphorylates CRMP2 at 
three residues, Thr509, Thr514, and Ser518 [26, 67]. These phosphorylation events cause 
a decrease in CRMP2 microtubule affinity, which may play a role in Sema-induced 
growth cone collapse (Figure 1.6) [26]. Indeed, CRMP2 phosphorylation is critical for its 
function in DRG explants as non-phosphorylatable mutants render DGRs insensitive to 
Sema3A [67].  
 
Interestingly, CRMPs can also be phosphorylated at S555, however this 
phosphorylation event is not mediated by Sema3A [149, 150]. Instead, this occurs 
downstream of the collapsing cues, LPA and EphrinA5 and mediated through Rho-
ROCK [149]. Suggesting that CRMPs are important mediators of cellular collapse and 
multiple pathways converge to activate CRMPs. Yet, not much is known about these 
phosphorylation events in vivo. Cdk5-dependent phosphorylation at S522 is necessary for 
proper dendritic patterning, as mouse knock-in of S522A mutant results in an increase in 
the number of basal dendrites of cortical pyramidal cells as well as impaired dendrite 
morphology and extension [147]. Interestingly, this mutant phenotype is exaggerated 
with a CRMP1
-/-
 background, giving evidence that CRMP isoforms work together. 
 
1.6.4. CRMPs regulate microtubule dynamics 
Functionally, CRMPs are heterotetramer microtubule associated proteins that 
regulate the cytoskeleton [148, 151]. CRMP1-4 interact with tubulin dimers and this 
interaction is mediated by the C-terminus of CRMPs [27]. Furthermore, CRMP2  
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Figure 1.6. Proposed Model of Sema6A-PlxnA2 Microtubule Regulation. A. In the 
absence of Sema6A, the PlxnA2 homodimer is in an auto-inhibitory “head-on” 
conformation. Although Fyn can still bind to PlxnA2, it has lower kinase activity and no 
downstream signaling occurs. Unphosphorylated CRMP2 binds and stabilizes 
microtubules. B. Upon Sema6A binding to PlxnA2, Fyn is activated and phosphorylates 
CDK5, which in turn phosphorylates CRMP2. This initial phosphorylation event recruits 
GSK3β, which further phosphorylates CRMP2, lowering CRMP2 microtubule affinity. 
This leads to microtubule destabilization and contributes to growth cone collapse. 
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promotes an increase of tubulin assembly into microtubules in vitro [27]. Cellular assays 
also indicate that CRMP2 co-localizes with microtubules in fibroblasts and promotes 
axon formation in NIE-115 cells and cultured hippocampal neurons [27]. CRMP2 also 
associates with the mitotic spindle in dividing HeLa cells as well as microtubules in N2A 
cells and cultured chick retinal ganglion cells [26, 152, 153]. 
 
 CRMP2 phosphorylation status regulates its affinity for microtubules and thus is 
a critical mechanism of CRMP2-mediated microtubule dynamics. A phospho-mimic 
CRMP2 mutant, T514D has a lower affinity for tubulin and T514D, S518D, or S522D 
mutants are no longer associated with the mitotic spindle in HeLa cells [26, 67]. In 
contrast alanine mutants localize to the spindle similarly to WT CRMP2 [26]. 
Functionally, aspartate mutants are not able to induce the CRMP2-mediated axon 
elongation and branching in culture hippocampal neurons nor can they induce Sema3A-
mediated DRG growth cone collapse [26, 67]. 
 
In conclusion, CRMPs are critical in mediating Sema signaling throughout 
nervous system development. Of the five isoforms, CRMP2 has the widest expression 
pattern and has been the most characterized, although the high homology between 
CRMP1-4 suggests conserved mechanisms. CRMP2 phosphorylation regulates its 
affinity for microtubules and tubulin dimers, thus influencing cytoskeletal dynamics and 
playing a critical role in Sema-mediated growth cone collapse and cortical cell migration. 
Future work is needed to elucidate the roles and mechanisms of CRMP2 outside of 
cortical development. 
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1.7. Zebrafish as a Model Organism 
This dissertation work used zebrafish as a model organism to study functionally-
critical molecular mechanisms of vertebrate eye development. Zebrafish are a strong 
model to study development due to external fertilization and transparency of the 
embryos, the short generation time of 2 – 3 months, and the high fecundity [154]. 
Embryonic development is rapid, completing at 72 hours [155]. Furthermore, there is 
high genetic similarity between zebrafish and humans. Approximately 70 percent of 
human genes have a zebrafish orthologue [156]. Many of these genes are involved in 
conserved processes such as proliferation, differentiation, and migration. Our genes of 
interest, including Sema6A, PlxnA1/A2, Fyn, and CRMP2 are expressed in the zebrafish 
and are genetically similar to their human orthologues (Table 1.4). 
 
Visual system development is a highly conserved process across vertebrates [5]. 
Retinal cellular differentiation and lamination occurs in a highly organized and 
stereotypical manner [157]. There are six neuronal cell types in the vertebrate retina, 
including retinal ganglion cells, amacrine cells, bipolar cells, horizontal cells, and 
photoreceptors (rods and cones), as well as one type of glial cell, known as Müller cells. 
Lamination of the retina occurs similar to cortical lamination, in which differentiation 
and migration occurs in an inside-to-outside fashion. The zebrafish inner retina 
differentiates first, with retinal ganglion cells at 26 hours post fertilization (hpf), while 
the photoreceptors and Müller glia differentiate last around 72 hpf [157]. Retinal 
ganglion cell axons form the optic nerve to innervate the optic tectum. In zebrafish, the 
pathfinding of retinal ganglion cell axons begins at 34-36 hpf, when retinal ganglion cell  
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Table 1.4. Percent Identity of Human Sema6A-PlxnA Signaling Protein to Model 
Organisms. This table displays a comparison of Sema6A, PlxnA1, PlxnA2, Fyn, and 
CRMP2 sequences across multiple species, including mammals, vertebrates, and 
invertebrates. If a model organism does not have the given protein, the closest homolog is 
written. Sequence information was acquired from NCBI and Uniprot and aligned using 
MUSCLE Sequence Alignment (EMBL-EBI). Human protein reference numbers are as 
follows: Sema6A: NP_065847.1; PlxnA1: NP_115618; PlxnA2: EAW93457.1; Fyn: 
NP_002028.1; CRMP2: NP_001377.1. 
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axons leave the retina. The axons cross the optic chiasm at 36-40 hpf, reach the tectum at 
46-48 hpf and innervate the tectum cells at 70-72 hpf, completing the visual system 
circuitry [158]. 
 
The rapid development of the zebrafish visual system makes zebrafish an optimal 
model for studying the vertebrate visual system. Retinal ganglion cell axons can be used 
as a model for axonal pathfinding. The transgenic zebrafish line, isl2b:GFP, expresses 
green fluorescent protein (GFP) in retinal ganglion cell bodies and processes that allows 
for visualization of the optic nerve and tectum innervation. Zebrafish are highly visual 
animals and the eye and tectum are relatively large [157]. This allows for robust 
morphological screens. Hematoxylin and Eosin staining (H & E), for example, visualizes 
all retinal cell types and retinal lamination. Additionally, in situ hybridization techniques 
allow for a qualitative analysis of transcript expression patterns.  
 
In addition to modeling visual system development and functioning, the zebrafish 
visual system is an excellent in vivo tool to study vertebrate Sema6A-PlxnA2 signaling 
mechanisms. There is high homology between the human and zebrafish proteins that are 
involved in Sema6A-PlxnA2 signaling (Table 1.4). Decreasing Sema6A or PlxnA2 give 
characteristic and reproducible visual system phenotypes, including impaired early eye 
field cohesion and smaller eye size [2, 68] (Figure 1.4). Therefore, we can use the 
zebrafish visual system as a tool to investigate the mechanisms of Sema6A-PlxnA2 
signaling. Rescue experiments can answer questions about the functionally relevant 
phosphorylation sites. By injecting morpholinos to decrease endogenous proteins, such as 
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PlxnA2 and CRMP2, and simultaneously co-injecting various non-phosphorylatable 
mRNA mutant constructs, we can determine which phosphorylation events are necessary 
for vertebrate eye development.  
 
In summary, the zebrafish visual system is a model system to 1) better understand 
and functionally characterize Sema6A-PlxnA2 signaling molecules in the vertebrate 
visual system and 2) elucidate in vivo mechanisms, such as phosphorylation events, of 
Sema6A-PlxnA2 signaling. 
 
1.8. Questions Remaining 
Semas function in numerous cell types during embryonic development of the 
nervous system, cardiovasculature, and immune systems. While many of the cellular 
players have been identified, a better understanding of the functionally significant in vivo 
molecular mechanisms of Sema signaling is required. Much work has characterized 
Sema-mediated roles in the context of cortical and hippocampal development. Yet, less is 
known about Sema signaling functions in other tissues such as the visual system. This 
dissertation aimed to fill this gap by investigating Sema6A-PlxnA signaling mechanisms 
using the zebrafish visual system. 
 
The complexity of Sema-Plxn signaling results in numerous downstream 
pathways being activated to govern cytoskeletal dynamics and adhesion as well as non-
canonical roles such as proliferation and transcriptional regulation. Investigating the 
receptor proximal mechanisms can begin to elucidate the activation steps required to 
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initiate various signaling cascades. The tyrosine kinase Fyn constitutively binds to 
PlxnA1 and PlxnA2 and can induce PlxnA phosphorylation [25].  Yet, the functional 
consequences of PlxnA phosphorylation are not understood. Herein, we report that Fyn 
induces PlxnA1 and PlxnA2 phosphorylation at two tyrosine residues and that this 
phosphorylation is critical for zebrafish eye size. Future work will elucidate the cellular 
and molecular functions of Fyn-mediated PlxnA phosphorylation in Sema6A signaling. 
 
Traditionally, Semas have been classified into either secreted or membrane-bound 
classes. Yet, many of the transmembrane and membrane-anchored Sema classes have 
been shown to undergo ectodomain cleavage to produce functional soluble ectodomains. 
However, a functional soluble ectodomain of the Sema6 class has not been characterized 
in the nervous system. We have previously identified Sema6A peptides in human and rat 
embryonic cerebrospinal fluid [159]. In this dissertation, we report that Sema6A does 
indeed produce a soluble form which is naturally released in addition to being regulated 
by the serine/threonine kinase PKC. Importantly, we show that sSema6A is functional, as 
it plays a role in maintaining cohesion of zebrafish early eye explants. Future work will 
further characterize the regulation and roles of Sema6A ectodomain cleavage. 
  
While CRMP functions have been well established in cell culture systems, less is 
known about the in vivo roles. The relatively few in vivo studies have investigated 
CRMP2 function in cortical lamination [146, 147]. Less is known about the roles of 
CRMP2 in non-cortical laminated brain regions, such as the retina. However, CRMP2 is 
known to be expressed and associated with microtubules in chick retinal ganglion cells 
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[137, 153]. Herein, we report that CRMP2 has a novel in vivo role in visual system 
development, mediating lamination and axonal migration in a similar manner to its 
function in cortical lamination. Future work will determine if Cdk5- and GSK3β- 
mediated CRMP2 phosphorylation is critical for CRMP2 in vivo functions during visual 
system development. 
 
Together, this dissertation describes critical and novel Sema6A-PlxnA signaling 
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CHAPTER 2: FYN-DEPENDENT PHOSPHORYLATION OF PLEXINA1 AND 




Plexins (Plxns) are semaphorin (Sema) receptors that play important signaling 
roles, particularly in the developing nervous system and vasculature. Sema-Plxn signaling 
regulates cellular processes such as cytoskeletal dynamics, proliferation, and 
differentiation. However, the receptor-proximal signaling mechanisms driving Sema-Plxn 
signal transduction are only partially understood. Plxn tyrosine phosphorylation is 
thought to play an important role in these signaling events as receptor and non-receptor 
tyrosine kinases have been shown to interact with Plxn receptors. The Src-family kinase 
Fyn can induce the tyrosine phosphorylation of PlxnA1 and PlxnA2. However, the Fyn-
dependent phosphorylation sites on these receptors have not been identified. Here, using 
mass spectrometry-based approaches, we have identified highly-conserved, Fyn-induced 
PlxnA tyrosine phosphorylation sites. Mutation of these sites to phenylalanine results in 
significantly decreased Fyn-dependent PlxnA tyrosine phosphorylation. Furthermore, in 
contrast to wildtype human PLXNA2 mRNA, mRNA harboring these point mutations 
cannot rescue eye developmental defects when co-injected with a plxnA2 morpholino in 
zebrafish embryos. Together these data suggest that Fyn-dependent phosphorylation at 




Plexins (Plxns) are semaphorin (Sema) receptors that are highly expressed during 
development where sema-plxn signaling plays important roles in nervous system, cardiac, 
vasculature and bone development [1, 2]. At the cellular level, Sema-Plxn signaling 
regulates cytoskeletal dynamics, integrin-mediated adhesion, proliferation, 
differentiation, transcription, and programmed cell death [3-7]. With a wide array of 
functions, the signaling outcome of Semas depends on a variety of factors, including 
receptor subtype and the effector proteins associated with the cytosolic regions of both 
Plxns and transmembrane Semas [2, 8]. The intracellular signaling milieu in which Plxns 
and Semas act is highly dynamic and determined by differential protein expression driven 
by changing cell types and developmental timing [9-11].  
 
In mammals, there are nine Plxns classified into four subfamilies: PlxnA1-A4, 
B1-3, C1, and D1 [12]. PlxnA family members, receptors for Sema3 and Sema6 classes, 
are the most highly expressed Plxns throughout nervous system development, with 
PlxnA2 being the most highly expressed PlxnA in the cortical plate [12-16]. Furthermore, 
PlxnA2 and the close family member PlxnA1 are also expressed in non-cortical regions 
of the nervous system, including the retina [14, 17]. We have previously shown the 
importance for Sema6-PlxnA signaling in early vertebrate eye development, as 
decreasing PlxnA2 or Sema6A in the zebrafish results in reduced retinal precursor cell 
proliferation, loss of eye field cohesion, and impaired retinal lamination [7, 17]. 
Together, these results show that Sema6-PlxnA signaling initiates a variety of functional 
outcomes depending on cellular and organismal context. 
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Although the nature of Sema-Plxn binding has been well characterized [18, 19], 
the receptor proximal events that initiate specific functional outcomes of Sema-Plxn 
signaling are only partially understood. Plxn phosphorylation by tyrosine kinases is 
thought to be one way by which Plxns mediate intracellular signaling in response to Sema 
binding [20]. Receptor-type and cytoplasmic tyrosine kinases are known to associate with 
Plxn family members [16, 21-23]. In fact, there is evidence through large-scale proteomic 
screens that the intracellular domain of all nine Plxn family members can be tyrosine 
phosphorylated at least to some degree [24]. However, currently only PlxnB, based on 
mutagenesis studies, has been shown to be phosphorylated at specific sites by a specific 
kinase (ErbB2) [25] and to our knowledge no kinases have been identified to 
phosphorylate specific PlxnA tyrosine residues. Nonetheless, PlxnA receptors have been 
shown to be tyrosine phosphorylated when overexpressed in standard human cell lines 
[12] and the Src family tyrosine kinase (SFK) Fyn was later discovered to constitutively 
associate with and phosphorylate the intracellular region of PlxnA1 and PlxnA2 [21]. 
Furthermore, the cytosolic tyrosine kinase Fes has been shown to bind and phosphorylate 
PlxnA1 [22], and the receptor tyrosine kinase (RTK) VEGFR2 has been shown to 
associate with PlxnA1 [16, 23]. 
 
In spite of these known associations between tyrosine kinases and PlxnA 
receptors, no tyrosine phosphorylation sites have been identified to be regulated by 
specific tyrosine kinases. As Fyn has been implicated in PlxnA phosphorylation and is 
critical to Sema-induced dendritic maturation in cultured cortical neurons [21, 26], we 
focused our study on Fyn-dependent PLXNA phosphorylation. To begin to elucidate the 
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signaling role of tyrosine phosphorylation sites on Plxns, we set out to ascertain Fyn-
dependent phosphorylation sites of PLXNA2 and PLXNA1. Using mass spectrometry 
and biochemical approaches, we have identified two novel Fyn-induced PLXNA 
phosphorylation sites that are conserved across vertebrates and invertebrates. Site-
specific mutants of PLXNA2 and PLXNA1 verified that these tyrosine residues are the 
major sites of Fyn-dependent phosphorylation. Using zebrafish as a model organism, we 
investigated the in vivo functional significance of these sites and found that Fyn-
dependent PlxnA2 phosphorylation is critical for zebrafish eye size. We end with a 
discussion on the possible signaling roles of these phosphorylation events at the 




2.3.1. Fyn Induces PLXNA2 and PLXNA1 Tyrosine Phosphorylation 
To recapitulate the Fyn-dependent PlxnA2 and PlxnA1 phosphorylation found 
by Sasaki et al. 2002, we first transfected HEK293 cells with expression plasmids 
encoding Flag-tagged PLXNA2 and either Fyn wildtype (WT) or a kinase dead (KD) 
point mutant of Fyn. PLXNA2 showed prominent tyrosine phosphorylation when Fyn 
WT was co-expressed and this phosphorylation was absent when Fyn KD was co-
expressed (Figure 2.1A). Similarly, Flag-tagged PLXNA1 tyrosine phosphorylation was 
present when Fyn WT was co-expressed and absent when Fyn KD was co-expressed 
(Figure 2.1B). These results are consistent with the findings of others (Sasaki et al., 2002)  
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Figure 2.1. Fyn Induces PLXNA2 and PLXNA1 Phosphorylation. A-B. HEK293 
cells were transfected with expression plasmids encoding PLXNA2-Flag (A), PLXNA1-
Flag (B), Fyn wildtype (WT) or Fyn kinase dead (KD) as indicated. Cell extracts were 
subjected to immunoprecipitation with α-Flag resin. Immune complexes and whole cell 
extracts were subjected to SDS-PAGE and immunoblotting with the indicated antibodies. 
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and demonstrate tyrosine phosphorylation events on PlxnA2 and PlxnA1 that are induced 
by Fyn kinase activity. To understand the molecular mechanisms of how PlxnA tyrosine 
phosphorylation might regulate PlxnA receptors, we next sought out to identify the 
tyrosine residues on PLXNA2 and PLXNA1 that are phosphorylated in a Fyn-dependent 
manner. 
 
2.3.2. Bioinformatics Reveals Conserved Tyrosine Phosphorylation Sites on 
PLXNA2 and PLXNA1 
As an initial approach to identify potential Fyn-dependent tyrosine 
phosphorylation sites we asked if PlxnA family members were known to be tyrosine 
phosphorylated at specific sites as determined by large-scale phosphoproteomic analyses. 
PhosphoSitePlus [24] is an online database that curates post-translational modification 
information, including phosphorylation, from both large-scale and site-specific studies. 
PhosphoSitePlus listed eight intracellular tyrosine residues found to be phosphorylated on 
PLXNA2 in large-scale proteomic screens. Seven out of these eight residues were found 
phosphorylated two or fewer times. However, Y1605 has been found phosphorylated in 
20 independent proteomic screens (Figure 2.2A). This site is conserved across vertebrates 
and invertebrates as well as within PLXNA1 (Figure 2.2B). Indeed, PhosphoSitePlus 
shows nine intracellular tyrosine residues to be phosphorylated on PLXNA1, with eight 
of these sites only being found to be phosphorylated once (Figure 2.2A). However, 
Y1608 in PLXNA1 is homologous to PLXNA2 Y1605 and has been found to be 




Figure 2.2. Bioinformatic Analysis Identifies a Conserved Tyrosine Phosphorylation 
Site in PlxnA2 and PlxnA1. A. PhosphoSitePlus curation shows 20 large-scale mass 
spectrometry records of human PLXNA2 Y1605 being phosphorylated (top) and 58 
records of phosphorylation at the homologous site Y1608 in human PLXNA1 (bottom). 
Plxns are single-pass type I transmembrane proteins and the N-terminal extracellular and 
the C-terminal intracellular domain structures are displayed. PSI: plexin, semaphorin, 
integrin domain; IPT: Ig-like, plexin, transcription factors domain; TM: transmembrane; 
GAP C1/2: split Ras-GTPase-activating protein domains; RBD: Rho family GTPase-
binding domain. B. A sequence alignment highlights the conservation of PlxnA2 Y1605 
across vertebrates and invertebrates as well as among PlxnA1 family members. 
Accession numbers are as follows: human PLXNA2: NP_079455.3, mouse PlxnA2: 
NP_032908.2, rat PlxnA2: NP_001099458.2, chicken PlxnA2: XP_015154528.1, 
zebrafish PlxnA2: BAD35133.1, human PLXNA1: NP_115618.3, mouse PlxnA1: 
NP_032907.1, rat PlxnA1: XP_002729444.2, chicken PlxnA1: XP_414370.4, zebrafish 
PlxnA1a: XP_003201265.4, zebrafish PlxnA1b: NP_001103480.1, fruit fly PlxnA: 
NP_524637.2, and roundworm PlxnA: BAB85224.1. 
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conserved role for this phosphorylation event in PlxnA signaling. Importantly, the kinase 
that phosphorylates this site has not been identified and we hypothesized that Fyn could 
be the tyrosine kinase responsible for phosphorylating PlxnA2 and PlxnA1 on Y1605 and 
Y1608, respectively.  
 
2.3.3. Targeted Mass Spectrometry Finds Y1605 as a Fyn-Dependent 
Phosphorylation Site on PLXNA2 
To determine if Fyn phosphorylates PLXNA2 at Y1605 we made use of 
synthetic, stable isotope-containing peptides harboring phosphorylated and 
unphosphorylated Y1605 as references to determine the expected elution time of the 
native PLXNA2 peptides as well as their MS2 spectral patterns. HEK293 cells were 
transfected with expression plasmids encoding PLXNA2 WT-Flag alone or with either 
Fyn WT or Fyn KD. PLXNA2 was then immunopurified from extracts of each group. A 
portion of each immunoprecipitation was used for immunoblotting to confirm PLXNA2 
expression and to confirm Fyn-induced PLXNA2 tyrosine phosphorylation (Figure 
2.3A). The majority of each immunoprecipitation was subjected to SDS-PAGE and 
coomassie staining (Figure 2.3B). From these gels, the control and PLXNA2 bands 
running at approximately 200 kDa were excised and subjected to in-gel tryptic digestion. 
Extracted peptides were supplemented with unphosphorylated and phosphorylated 





proline. A targeted approach was used to trigger MS/MS scans on the m/z values of the 
doubly-charged precursor ions for the native tryptic peptides of PLXNA2 containing 
unphosphorylated and phosphorylated Y1605. Using the synthetic stable isotope- 
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Figure 2.3. Targeted Mass Spectrometry Reveals Y1605 as a Fyn-Induced 
Phosphorylation Site on PLXNA2. HEK293 cells were transfected with expression 
plasmids encoding PLXNA2-Flag, Fyn wildtype (WT) or Fyn kinase dead (KD) as 
indicated. Whole cell extracts were subjected to immunoprecipitation with α-Flag resin. 
A. Whole cell extracts and a small fraction of the immune complexes were subjected to 
SDS-PAGE and immunoblotting with the indicated antibodies. B. The majority of the 
immune complexes for each sample was subjected to SDS-PAGE and protein bands were 
visualized by coomassie staining. The regions of the gel where PLXNA2 bands run were 
excised and digested with trypsin and the tryptic peptides were prepared for mass 
spectrometry. Unphosphorylated and phosphorylated Y1605-containing synthetic 




N-labeled proline (P*) were added to the native 
extracted peptides. A targeted approach was used to subject the appropriate m/z values of 
the doubly-charged tryptic peptides containing either the unphosphorylated or 
phosphorylated Y1605 to Collision-Induced Dissociation in a linear ion trap-orbitrap 
mass spectrometer. C-D. The unphosphorylated native PLXNA2 peptide containing 
Y1605 was found across treatment groups, but the phosphorylated native peptide was 
only found in the PLXNA2 + Fyn WT group. Shown are the MS/MS spectra of the 
phosphorylated Y1605 synthetic peptide (C) and the Y1605 phosphorylated native 
peptide (D). 
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containing peptides as a reference allowed us to readily detect the phosphorylated and 
unphosphorylated Y1605-containing PLXNA2 tryptic peptides (the MS2 spectral pattern 
of the phosphorylated synthetic peptide is shown in Figure 2.3C). The unphosphorylated 
peptide was found across treatment groups. However, the phosphorylated Y1605 
PLXNA2 peptide was only detected in cells expressing both PLXNA2 and Fyn WT 
(Figure 2.3D). This supports the hypothesis that active Fyn can induce phosphorylation of 
PLXNA2 at Y1605 in cells. 
 
2.3.4. A SILAC Mass Spectrometry Approach Identifies Y1677 as a Novel Fyn-
Dependent Phosphorylation Site on PLXNA2 
To ascertain if additional Fyn-dependent PLXNA2 phosphorylation sites could 
be identified, we used Stable Isotope Labeling of Amino Acids in Cell Culture (SILAC), 
a proteomics approach that utilizes cells grown in media containing heavy-labeled amino 
acids [27]. The advantage of a quantitative labeling method such as SILAC is that it 
allows different treatment types to be combined and handled equally in the preparation of 
peptides for LC-MS/MS. HEK293 cells expressing PLXNA2 WT-Flag and Fyn WT were 
grown in DMEM containing no heavy labeled amino acids (Light condition, Figure 





N- labeled arginine and lysine (Heavy condition), resulting in 
newly synthesized proteins incorporating heavy labels. PLXNA2 was 
immunoprecipitated using α-Flag resin and both PLXNA2 groups were combined and 




Figure 2.4. Y1677 is a Novel Fyn-Dependent PLXNA2 Phosphorylation Site. A. 
Diagram showing the SILAC design to identify PLXNA2 phosphorylation sites 
dependent on Fyn kinase activity. B. Coomassie-stained gel of proteins 
immunoprecipitated from SILAC cell extracts. The region of the gel corresponding to 
approximately 200 kDa was cut out from experimental and control lanes, subjected to in-
gel tryptic digestion and run on a linear ion trap-orbitrap mass spectrometer. C-D. MS1 
mass spectra highlighting the isotopic envelopes of the tryptic peptides containing 
unphosphorylated PLXNA2 Y1677 (C) and phosphorylated PLXNA2 Y1677 (D). The 
blue dashed line (bottom) indicates the expected value of the phosphorylated PLXNA2 
peptide, which was not present (m/z = 601.282). The black dashed line in both spectra 
represents the mean heavy:light fold change (mean = 2.87 +/- 0.48 fold change; n = 71, 
errors bars indicate s.d.) of all other fully tryptic PLXNA2 peptides identified. E. 
Multiple sequence alignment showing the position of Y1677 across several model 
organisms for both PlxnA2 as well as PlxnA1. 
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PLXNA2 band as well as the untransfected control band were cut and prepared for mass 
spectrometry analysis. 
 
Following a SEQUEST search and an automated calculation of the heavy:light 
ratio [28] of PLXNA2 peptides, we determined the distribution of all PLXNA2 fully 
tryptic peptides identified which covered amino acid sequences for which we did not find 
a phosphorylation event. As the relative abundance of these peptides was not likely 
altered by the treatment, they would define the relative amount of PLXNA2 
immunoprecipitated from the two conditions. The average heavy:light ratio for the 71 
peptide pairs we identified was 2.9 with a standard deviation of 0.5. This indicated that in 
this experiment the amount of PLXNA2 immunoprecipitated from the heavy state with 
Fyn KD expressed was nearly three times the amount immunoprecipitated from the light 
state with Fyn WT expressed. Only one phosphotyrosine-containing peptide was 
identified in our analysis and, importantly, it was found only in the light state. 
Surprisingly, we did not identify phosphotyrosyl-1605 in the SILAC analysis. The 
identified phosphopeptide contained tyrosine phosphorylation at Y1677. The 
stoichiometry of phosphorylation at Y1677 can be inferred by the decrease in the 
unphosphorylated form of this peptide relative to the average SILAC ratio. The SILAC 
ratio of the unphosphorylated form is approximately 15% less when Fyn WT is co-
expressed compared to the mean SILAC ratio of PLXNA2 peptides suggesting 15% 
phosphorylation at that site (Figure 2.4C).  As the precursor ion for the phosphopeptide 
was not observable in the heavy state, a signal-to-noise (S/N) calculation was used to 
approximate its minimum fold increase. While the total amount of the phosphopeptide 
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might in fact be zero, the S/N calculation describes the lowest possible observable signal 
and serves as a baseline for the minimum fold increase. The lowest possible signal is a 
peptide ion in the full MS1 mass spectrum with an observable isotopic envelope as 
compared to surrounding noise peaks which do not have observable isotopic envelopes 
and therefore are considered noise from the solvent alone. In this case the signal of the 
observed light phosphopeptide was 9.4 times the noise. Given that less light PLXNA2 
was immunoprecipitated compared to heavy PLXNA2, the total fold increase of this 
phosphopeptide induced by Fyn WT was even greater. 
 
Interestingly, a multiple species alignment indicates that Y1677 is conserved 
between PlxnA2 and PlxnA1 across species, including vertebrates and invertebrates 
(Figure 2.4E). Indeed, this tyrosine residue is in a highly conserved region of the 
cytoplasmic domain across all Plxn family members [20], which may point to an 
evolutionarily important function.  
 
2.3.5. Y1605 and Y1677 are the Major Fyn-dependent Sites of PLXNA2 Tyrosine 
Phosphorylation 
To determine if Y1605 and Y1677 were the major sites of Fyn-dependent 
PLXNA2 tyrosine phosphorylation we made single and double tyrosine-to-phenylalanine 
substitutions in PLXNA2 at these sites (Y1605F, Y1677F, and Y1605F/Y1677F (Y2F)). 
Co-transfection of expression plasmids encoding PLXNA2 Y2F-Flag and Fyn WT 
showed a significant decrease in Fyn-dependent PLXNA2 tyrosine phosphorylation 
(Figure 2.5A, quantified in Figure 2.5C). However, some Fyn-dependent tyrosine 
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phosphorylation remained on the Y2F mutant suggesting the presence of at least one 
additional Fyn-dependent tyrosine phosphorylation site on PLXNA2. To determine the 
predominant Fyn-induced PLXNA2 phosphorylation site, the single point mutants were 
co-expressed in HEK293 cells with Fyn WT. We found that Fyn-induced tyrosine 
phosphorylation was reduced for both Y1605F and Y1677F mutants (Figure 2.5B, 
quantified in Figure 2.5C). Interestingly, each PLXNA2 mutant appeared to decrease in 
tyrosine phosphorylation signal equally, suggesting Fyn shows roughly equal preference 
for phosphorylating Y1605 and Y1677. 
 
2.3.6. Fyn-Dependent Phosphorylation Sites are Conserved Between PLXNA1 and 
PLXNA2 
To ascertain if Fyn phosphorylates PLXNA1 at sites homologous to those 
identified on PLXNA2, we co-transfected HEK293 cells with expression plasmids 
encoding Fyn WT and either PLXNA1 WT-Flag or PLXNA1 Y2F-Flag. The Y2F allele 
of PLXNA1 has tyrosine-to-phenylalanine substitutions at Y1608 and Y1679, the sites 
homologous to Y1605 and Y1677 in PLXNA2. As hypothesized, PLXNA1 tyrosine 
phosphorylation decreased significantly when both Y1608 and Y1679 were unable to be 
phosphorylated (Figure 2.6A, quantified in Figure 2.6B). In fact, it appears that the 
combination of Y1608 and Y1679 constitute almost all of the Fyn-dependent tyrosine 
phosphorylation on PLXNA1 (Figure 2.6A). 
 




Figure 2.5. Y1605 and Y1677 are the Major Sites of Fyn-Induced PLXNA2 Tyrosine 
Phosphorylation. A-B. HEK293 cells were co-transfected with Fyn WT and Flag-tagged 
expression constructs for either PLXNA2 WT or the PLXNA2 tyrosine-to-phenylalanine 
mutants Y2F (Y1605F/Y1677F), Y1605F, or Y1677F. PLXNA2 was immunopurified by 
α-Flag resin and subjected to SDS-PAGE and immunoblotting with the indicated 
antibodies. C. The relative decrease in overall tyrosine phosphorylation normalized to 
PLXNA2 WT + Fyn WT was quantified for each sample type. Histograms show the 




Figure 2.6. Y1608 and Y1679 are the Major Fyn-Induced Sites of PLXNA1 Tyrosine 
Phosphorylation. A. HEK293 cells were co-transfected with Fyn WT or Fyn KD and 
Flag-tagged expression constructs for either PLXNA1 WT or the PLXNA1 tyrosine-to-
phenylalanine Y2F mutant (Y1608F/Y1679F). PLXNA1 was immunopurified by α-Flag 
resin and subjected to SDS-PAGE and immunoblotting with the indicated antibodies. B. 
The relative decrease in overall tyrosine phosphorylation normalized to PLXNA1 WT + 
Fyn WT was quantified for each sample type. Histograms show the average of three 
independent experiments. *Students T-Test, p < 0.05. 
 77 
To investigate the functional importance of in vivo PlxnA2 phosphorylation, we 
turned to the zebrafish model as we have previously characterized the function of PlxnA2 
in zebrafish eye development [7, 17]. PlxnA2 is expressed in the retina and is critical to 
zebrafish eye development, as decreasing endogenous PlxnA2 using a morpholino anti-
sense oligonucleotide (MO) targeted to plxnA2 results in decreased proliferation of retinal 
precursor cells (RPCs), loss of RPC cohesion within migrating optic vesicles, impaired 
retinal lamination, and decreased eye size [7, 17]. Importantly, these phenotypes are 
rescued by co-injecting the plxnA2 MO with human PLXNA2-WT mRNA at the one-cell 
stage of development, supporting the evolutionary conservation of PlxnA2 among 
vertebrates [7, 17]. The plxnA2 MO construct used has been previously validated to 
address knock-down specificity and any potential off-target effect [7, 17]. If PlxnA 
phosphorylation is critical to Sema6A signaling and vertebrate eye development, we 
hypothesized that the plxnA2 morphant phenotypes would not be rescued upon co-
injection of plxnA2 MO with human PLXNA2 Y2F mRNA. Indeed, while co-injecting 
plxnA2 MO with PLXNA2 WT mRNA rescued the small eye phenotype at 48 hours post 
fertilization (hpf), co-injection of PLXNA2 Y2F mRNA did not (Figure 2.7A-D). To 
control for any variations in overall embryo size we normalized eye diameter to head 
length (quantified in Figure 2.7G). Furthermore, overexpression of human PLXNA2 WT 
or Y2F mRNA resulted in no obvious phenotype, nor was eye size significantly different 
than uninjected controls (UIC) (Figure 2.7E-F; quantified in 2.7G). As it was formally 
possible that PLXNA2 Y2F did not rescue the plxnA2 MO phenotype due to improper 
subcellular localization, we conducted immunofluorescence on HEK293, COS7, and 
NIE-115 cells expressing PLXNA2 WT and Y2F (Figure 2.7H-O). HEK293 and COS7  
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Figure 2.7. Fyn-dependent PlxnA2 tyrosine phosphorylation is essential for 
zebrafish eye development. A-F. Brightfield images of zebrafish embryos at 48 hours 
post fertilization (hpf). PlxnA2 morphants showed a reduction in eye size (A, B, G) 
compared to uninjected control (eye diameter relative to head length (Control 0.513 μm 
+/-0.003 μm, n=40 N=4; PlxnA2 MO 0.439 μm +/-0.009 μm, n=40 N=4, 
****P<0.0001)). Co-injection of 2 ng plxna2 MO with 200 pg full-length human 
PLXNA2 WT mRNA rescued the small eye phenotype (C, D, G), however, full-length 
human PLXNA2 Y2F mRNA was unable to rescue eye size when co-injected with 2 ng 
plxna2 MO (Control 0.513 μm +/-0.003 μm, n=40 N=4; WT rescue 0.488 μm +/-0.008 
μm, n=34 N=4, n.s; Y2F rescue 0.437 μm +/-0.007 μm, n= 40 N=4, ****P<0.0001). No 
observed difference in eye size was seen with overexpression of 200 pg WT or Y2F full-
length human mRNA (E, F, G) (Control 0.513 μm +/-0.003 μm, n=40 N=4; 200 pg WT 
0.493 μm +/-0.005 μm, n=30 N=3, n.s; 200 pg Y2F 0.502 μm +/-0.005 μm, n=30 N=3, 
n.s). One-way ANOVA, multiple comparisons test. Error bars indicate s.e.m. UIC: 
uninjected control, MO:  morpholino, hpf: hours post fertilization. (H-K) PLXNA2 WT 
and Y2F show similar subcellular localization in both HEK293 and COS7 cells. Green is 
PLXNA2 and blue is DAPI. 
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cells were relevant given they have been used to investigate PlxnA2 signaling in 
biochemical and cell-based assays [12, 15, 18, 19]. COS7 cells are heterogeneous and we 
focused here on cells with extended processes as Sema-PlxnA signaling is known to 
localize to neuronal processes and to regulate axon and dendrite guidance [12, 29-31]. 
NIE-115 is a heterogeneous cell line that is responsive to semaphorins, as Sema3A 
stimulation results in neurite retraction [32]. We show immunofluorescence of PLXNA2 
WT and Y2F expressed in NIE-115 cells displaying long processes (Figure 2.7L,M) as 
well as numerous short processes (Figure 2.7N,O). In all cases PLXNA2 WT and Y2F 
appeared to have similar subcellular expression patterns (Figure 2.7H-O), suggesting that 
the Y2F mutation did not affect protein localization. Together, these results suggest that 
the Fyn-dependent PlxnA phosphorylation sites identified in this study have important, 
conserved in vivo functions. 
 
2.4. Discussion 
Here we show that Fyn induces the phosphorylation of two conserved sites on 
PLXNA1 and PLXNA2. Mechanistically, PlxnA tyrosine phosphorylation by SFKs 
could, via structural alterations, modulate the GAP activity of the receptors as the 
conserved sites of tyrosine phosphorylation are in or near the split GAP domain of the 
PlxnA receptors [33]. Additionally, PlxnA tyrosine phosphorylation could be involved in 
recruiting effectors of signal transduction. Tyrosine phosphorylation can regulate protein-
protein interactions by providing docking sites for SH2 or PTB domain-containing 
proteins. Precedence for these signaling mechanisms have been established in Sema-Plxn 
signaling with Sema4D-induced tyrosine phosphorylation of PlxnB1 leading to the 
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recruitment of the p85 subunit of PI3K and subsequent Akt activation. Stimulation of this 
signaling axis in endothelial cells was shown to promote endothelial migration [34]. 
While PI3K is not predicted to bind to PLXNA1 and PLXNA2, a Scansite [35] analysis 
of the intracellular domains predicts a possible function for one of the two sites we have 
identified here. Scansite suggests that PLXNA2 Y1605 phosphorylation could provide a 
binding site for the SH2 domain of the adaptor molecule Crk, or its relative CrkL, which 
preferentially bind to phosphorylated YXXP motifs [36]. The Rap1-GEF C3G binds to 
the SH3 domain of Crk and CrkL, and is involved in many cellular processes including 
cell-cell interactions, integrin-mediated adhesion, and differentiation [37]. Thus, Crk and 
CrkL binding to phosphorylated PlxnA2 could mediate some of the individual roles of 
Sema signaling. In spite of the fact that SFKs themselves harbor the name-sake SH2 
domain, they do not appear to use their SH2 domains to bind to PlxnA receptors as Fyn 
has been reported to be constitutively bound to PlxnA2 independent of Fyn’s kinase 
activity, and by extension, the tyrosine phosphorylation state of PlxnA2 [21]. Future 
work will work to identify the proteins that bind to PLXNA proteins at the Fyn-induced 
phosphorylation sites.  
 
Although the mechanisms downstream of these phosphorylation sites are 
unknown, the identification of Fyn-dependent PlxnA phosphorylation sites has been 
anticipated for some time [20]. Here, we have identified the two predominant sites and 
have found them to be functionally relevant to PlxnA signaling, setting the stage for 
future steps in delineating the role of tyrosine phosphorylation in PlxnA signaling 
pathways. 
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2.5. Materials and Methods 
 
2.5.1. Bioinformatics and Multiple Sequence Alignments 
Previously reported human PLXNA2 and PLXNA1 tyrosine phosphorylation 
from large-scale proteomic screens was collected from PhosphoSitePlus [24] (Cell 
Signaling Technology, Danvers, MA, USA). The conservation of PlxnA2 Y1605 and 
Y1677 was determined by aligning PlxnA2 and PlxnA1 for vertebrates and invertebrates: 
human (PLXNA2: NP_079455.3; PLXNA1: NP_115618.3), mouse (PlxnA2: 
NP_032908.2; PlxnA1: NP_032907.1), rat (PlxnA2: NP_001099458.2; PlxnA1: 
XP_002729444.2), chicken (PlxnA2: XP_015154528.1; PlxnA1: XP_414370.4), 
zebrafish (PlxnA2: BAD35133.1; PlxnA1a: XP_003201265.4; PlxnA1b: 
NP_001103480.1), fruit fly (PlxnA: NP_524637.2), and roundworm (PlxnA: 
BAB85224.1). Alignments were done using MUSCLE [38] in Geneious version 10.1 
(Biomatters, Auckland, New Zealand). 
 
2.5.2. Plasmids, Cell Culture, and Transfections 
The human PLXNA2 construct (Origene Technologies, Rockville, MD, USA) 
harbored human PLXNA2 (NP_079455) containing a C-terminal Myc and Flag tag in 
pCMV6-Entry. The cloning sites were SgfI and MluI. BioBasic (Markham, Ontario, 
Canada) produced the single and double point mutant PLXNA2 constructs: Y1605F, 
Y1677F, and Y1605F/Y1677F. BioBasic also synthesized human PLXNA1-WT and 
PLXNA1-Y1608F/Y1679F (Y2F) containing a C-terminal Myc and Flag tag and cloned 
them into the vector pUC57. BioBasic cloned PLXNA1-WT into pCMV6-Entry vector 
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using SgfI and MluI. To develop a pCMV6-PLXNA1-Y2F construct, we used MluI and 
BssHII (New England Biolabs, Ipswich, MA, USA) to subclone a portion of PLXNA1 
containing Y1608F/Y1679F from pUC57-PLXNA1-Y2F into pCMV6-Entry-PLXNA1-
WT. Human Fyn-WT (plasmid #16032) and kinase dead mutant L299M Fyn (plasmid 
#16033) constructs were purchased from Addgene (Cambridge, MA, USA), which were 
originally cloned into pRK5 and deposited by Dr. Filippo Giancotti [39]. HEK293 cells 
were maintained in DMEM with L-glutamine, 4.5 g/L glucose and sodium pyruvate 
(MediaTech/Corning Life Sciences, Tewksbury, MA, USA) supplemented with 5% Fetal 
Bovine Serum (Hyclone, Logan, UT, USA), 5% Cosmic Calf Serum (Hyclone), 50 
units/mL penicillin and 50 µg/mL streptomycin (Invitrogen, Carlsbad, CA, USA) at 37 
C and 5.0% CO2. Calcium phosphate-based transfections were conducted on cells grown 
to 75% of confluence. Following a 6-hour incubation, the cells were washed with warm 
PBS and incubated for an additional 18-20 hours in full medium prior to lysis. 
 
2.5.3. Cell Lysis, Immunoprecipitation, and Western Blotting 
After transfection, cells were placed on ice, washed with cold PBS, and lysed in 
lysis buffer (25 mM Tris pH 7.4, 137 mM NaCl, 10% glycerol, 1% Igepal) containing 
protease inhibitors (5 g/mL Pepstatin, 10 g/mL Leupeptin, 1 mM PMSF) and 
phosphatase inhibitors (1 mM NaVO3, 25 mM NaF, 10 mM Na2H2P2O7). Cell extracts 
were prepared for SDS-PAGE, immunoblotting and immunoprecipitation as previously 
described [40]. A Bradford Assay [41] was performed to determine protein concentration 
and extracts were normalized with lysis buffer. Depending on the experiment, between 20 
and 30 μg of total protein extract was used for immunoblotting. Depending on the 
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experiment, between 750 and 1,000 μg total protein was used for immunoprecipitations 
and was incubated overnight at 4 C with 10 μl of a 50% slurry of -Flag M2 affinity 
resin (Sigma-Aldrich Corp., St. Louis, MO, USA) pre-washed with lysis buffer. Immune 
complexes were washed three times with lysis buffer, drained, and then denatured in 
protein sample buffer at 95 C for 5 minutes prior to SDS-PAGE separation. The 
following primary antibodies and dilutions were used: α-Fyn (rabbit mAb, 1:2000, Cell 
Signaling Technology), α-Flag M2 (mouse mAb, 1:2000, Sigma-Aldrich Corp.), α-
phosphotyrosine 4G10 (mouse mAb; 1:1000, EMD Millipore, Billerica, MA, USA), and 
α-Src pY416 (rabbit mAb, 1:5000, Cell Signaling Technology). The following secondary 
antibodies were used: α-rabbit-HRP (goat IgG, 1:15,000, EMD Millipore), α-mouse-HRP 
(goat IgG, 1:5,000, EMD Millipore), or for immunoprecipitation samples α-mouse-HRP 
Light Chain Specific (goat IgG, 1:10,000, Jackson ImmunoResearch Laboratories, West 
Grove, PA, USA). Immunoblotting was performed as described previously [40]. 
 
2.5.4. Enhanced Chemiluminescence, Densitometry Analysis, and Statistics 
Proteins from Western Blotting were detected using enhanced 
chemiluminescence (ThermoFisher Scientific, Waltham, MA, USA) and film was 
developed using a Medical Film Processor SRX-101A (Konica Minolta Medical & 
Graphic, Tokyo, Japan). The raw film scans were converted to grayscale and inverted in 
Adobe Photoshop for densitometry analysis using the mean histogram tool. The 
background (“untransfected control” group) signal was subtracted from all bands and the 
tyrosine phosphorylated PLXNA2 or A1 (as measured by α-phosphotyrosine 4G10) 
levels were made relative to PLXNA2 or A1 + Fyn WT in each experiment by setting this 
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value as 100%. Total PLXNA2 or A1 protein levels were made relative in a similar 
fashion using α-Flag M2 lanes. Relative α-phosphotyrosine 4G10 levels were then 
divided by the relative α-Flag M2 levels to calculate the PLXNA2 or A1 tyrosine 
phosphorylation per sample type. To account for relative Fyn activity, α-phosphotyrosine 
(4G10) or α-Src pY416 levels for Fyn (as a proxy for kinase activity) were made relative 
with the levels in the co-transfected Fyn with PLXNA1 or PLXNA2 WT set as 100% in 
each experiment. The relative PLXNA2 or A1 tyrosine phosphorylation levels were then 
divided by the relative levels of phosphotyrosyl-Fyn to calculate the final relative 
tyrosine phosphorylation levels of PLXNA2 or A1.  These values were then Log2 
transformed and a Student’s T-Test pair-wise comparison was performed on the data 
from three independent experiments using JMP Pro 12 Statistical Software (SAS 
Institute, Cary, NC, USA). 
 
2.5.5. Sample Preparation for Mass Spectrometry and Mass Spectrometry Data 
Analysis 
HEK293 cells either untransfected or expressing PLXNA2-WT-Flag and either 
Fyn WT or Fyn KD were lysed and extracts were subjected to immunoprecipitation with 
-Flag M2 affinity resin as described above. Samples were loaded onto 10% SDS-PAGE 
gels and proteins were visualized using coomassie stain (0.1% coomassie brilliant blue R-
250, 20% glacial acetic acid, 40% methanol). The gel region containing the visible 
PLXNA2-Flag band and corresponding to approximately 200 kDa was cut out, diced, and 
prepared for tryptic digestion as previously described [42] with the reduction and 
alkylation steps being omitted.  Proteins were subjected to in-gel digestion with 6 ng/μL 
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sequencing-grade modified trypsin (Promega, Madison, WI, USA) in 50 mM ammonium 
bicarbonate at 37 C for 6-9 hours. The tryptic peptides were resuspended in Solvent A 
(2.5% acetonitrile, 0.15% formic acid) and separated via HPLC prior to MS/MS analysis 
on a linear ion trap-orbitrap (LTQ-Orbitrap) mass spectrometer controlled with Thermo 
Xcalibur 2.1 software. Peptides were loaded onto 15 cm x 100 µm columns packed with 
5 µm C18 packing material (Bruker Daltonics, Billerica, MA, USA, pore size = 200 Å) 
over 15 minutes in Solvent A and eluted using a 0–50% gradient of Solvent B (99.85% 
acetonitrile, 0.15% formic acid) over 38 minutes and electrosprayed (2.1 kV) into the 
mass spectrometer. This gradient was followed by 3 minutes of a 50-100% gradient of 
Solvent B. This was followed by 4 minutes at 100% Solvent B before a 10-minute 
equilibration in 100% Solvent A. The precursor scan (scan range = 360–1700 m/z, 
resolution = 3.0x10
4
, scan speed = 0.3 Hz) was followed by four collision-induced 
dissociation (CID) tandem mass spectra. CID spectra were acquired for the top two ions 
in the precursor scan (isolation window = ±2.0 m/z, collision energy = 35 eV), followed 
by two targeted scans. The targeted scans targeted the average mass (+/- 1.6 m/z) of the 
doubly-charged tryptic peptide ions harboring: (i) the unphosphorylated PLXNA2 Y1605 
peptide (791.859 m/z, QTSSYNIPASASISR); and (ii) the phosphorylated (pY, 
underlined) PLXNA2 Y1605 peptide (831.842 m/z, QTSSpYNIPASASISR). Dynamic 
exclusion of precursor ions for MS/MS was enabled with a repeat count of 2, repeat 
duration of 30 seconds, and exclusion duration of 120 seconds. Theoretical m/z values 
were determined using the Fragment Ion Calculator from the Proteomics Toolkit 
(Institute for Systems Biology, Seattle, WA, USA). Synthetic tryptic peptides (Cell 
Signaling Technology) harboring unphosphorylated and phosphorylated Y1605 were 
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added prior to the LC-MS/MS runs. The synthetic peptides were distinguishable from the 




N-proline residue increasing the mass by 6.0138 
Da. Both manual examination using Thermo Xcalibur’s Qual Browser as well as 
SEQUEST searches were used to interrogate tandem mass spectra. SEQUEST searches 
queried the forward and reversed concatenated human 2011 Uniprot proteome. The 
search parameters required tryptic peptides, permitted a precursor m/z tolerance of +/- 20 
ppm and allowed amino acid modifications of serine, threonine, and tyrosine (+79.9663 
Da for phosphorylation), cysteine (+71.0371 Da for acrylamidation), and methionine 
(+15.9949 Da for oxidation). SEQUEST peptide identifications were required to be 
within a false discovery cutoff of 1%. 
 
For the Stable-Isotope Labeling of Amino Acids in Cell Culture (SILAC) 









labeld lysine (“heavy condition”) as previously described [43]. These cells were 
transfected as described above with expression plasmids encoding PLXNA2 WT-Flag 
and Fyn KD. HEK293 cells grown in DMEM containing no heavy-labeled amino acids 
(“light condition”) were transfected with expression plasmids encoding PLXNA2 WT-
Flag and Fyn WT. Following lysis, PLXNA2-Flag was immunoprecipitated from each 
cell state using α-Flag resin. Immune complexes from the two states were combined and 
subjected to SDS-PAGE. The coomassie-stained PLXNA2 band and the corresponding 
control derived from untransfected cells were cut and prepared for mass spectrometry 
analysis as detailed above. Peptides were subjected to LC-MS/MS in a linear ion trap-
orbitrap run as previously described [44]. SEQUEST search parameters allowed a 
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precursor ion mass tolerance of 30 ppm, required peptides to be tryptic and allowed for 
the same amino acid modifications as described above with the addition of arginine 
(+10.008 for the heavy label) and lysine (+8.014 for the heavy label). Following an 
automated calculation of the heavy:light ratio [28], the average heavy:light fold change 
was calculated from unphosphorylated peptides that were fully tryptic and contained no 
internal arginines or lysines. 
 
2.5.6. Immunofluorescence in Cell Culture 
HEK293 cells were transfected in 6 cm dishes at 75% of confluence with 0.25 
µg of either PLXNA2-WT-Flag or PLXNA2-Y2F-Flag using calcium phosphate 
precipitation as previously described [45]. COS7 cells were seeded onto glass coverslips 
in 6-well plates and transfected at 20% of confluence using polyethylenimine [46] and 
incubated at 37 ᴼC and 5.0% CO2 for 48 hours. NIE-115 cells were seeded onto poly-L-
lysine treated coverslips and transfected at 90% of confluence with Lipofectamine 2000 
(ThermoFisher Scientific). Both COS7 and NIE-115 cells were transfected with 2 µg of 
either PLXNA2-WT-Flag or PLXNA2-Y2F-Flag and incubated at 37 ᴼC and 5.0% CO2 for 
48 hours. HEK293, NIE-115, and COS7 cells were then processed for 
immunofluorescence as previously described [45]. The primary antibody was incubated 
at room temperature for 1 hour in a humidified chamber: α-Flag M2 (mouse mAb, 
1:5000, Sigma-Aldrich) in 1.5% BSA in PBS. The secondary antibody was incubated for 
45 minutes at 4 ᴼC in a humidified chamber: α-mouse Alexa Fluor 488 (1:10,000, 
Molecular Probes/Invitrogen). Coverslips were mounted onto microscope slides using 
VectaShield Hardset mounting media with DAPI (Vector Laboratories, Burlingame, CA, 
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USA). Cells were imaged at 40X magnification using a Nikon Eclipse Ti inverted 
confocal microscope (Nikon Instruments, Melville, NY, USA). Raw image files were 
converted to TIFs using ImageJ version 1.48a (National Institutes of Health, USA) and 
color processing was done in Adobe Photoshop CS6 (San Jose, CA, USA). 
 
2.6.7. Zebrafish husbandry, Morpholino and mRNA Rescue Experiments 
Zebrafish embryos were developmentally staged as previously described [47]. 
The zebrafish used in this study (isl2b:GFP transgenic line) were generously provided by 
Dr. Chien (University of Utah, USA). All procedures were approved by the University of 
Vermont Institutional Animal Care and Use Committee (IACUC). For morpholino 
injections, 2 ng of a splice-blocking morpholino (MO) (Gene Tools, Philomath, OR, 
USA) targeting plxnA2 and/or 200 pg of full-length human PLXNA2 or PLXNA2 Y2F 
mRNA was injected at the one-cell stage as previously described [7]. The plxnA2 MO 
sequence was as follows: AAAAGCGATGTCTTTCTCACCTTCC, which targeted the 
exon 2-intron 2 boundary. The plxnA2 MO knock-down efficiency has been previously 
validated using RT-PCR, and off-target effects and MO specificity have been addressed 
by rescue of morphant phenotypes with full length human PLXNA2 mRNA and co-
injection of plxnA2 and p53 MOs [7, 17]. A second non-overlapping MO construct 
reproduced the same phenotypes [17]. Capped and tailed full-length mRNA was 
generated from the pCMV6-Entry-PLXNA2-WT and -Y2F plasmids by linearizing the 
plasmids using PmeI (New England Biolabs), T7 RNA polymerase (mMESSAGE 
mMACHINE kit, Ambion, Austin, TX, USA), and the ThermoFisher PolyA Tailing Kit. 
These constructs were injected or co-injected with MO into zebrafish embryos at the one-
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cell stage [47]. Zebrafish embryos were incubated at 28.5 ᴼC for 2 days until the 48 hours 
post fertilization (hpf) stage [47]. Measurements and brightfield images taken at 6.3X 
magnification were obtained using SPOT imaging software version 5.2 (Sterling Heights, 
MI, USA). To account for any variations in overall embryo size, eye size was calculated 
as eye diameter normalized to head size, which was defined as the distance from the 
anterior tip of the head to the posterior otic placode [7]. Figures were compiled using 
Adobe Photoshop CS6, where image brightness was optimized. Graphs and statistical 
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CHAPTER 3: PKC INDUCES RELEASE OF A FUNCTIONAL ECTODOMAIN 
OF THE GUIDANCE CUE SEMAPHORIN6A 
 
3.1. Abstract 
Semaphorins (Semas) are a family of secreted and transmembrane proteins that 
play critical roles in development. Of the four vertebrate transmembrane or membrane-
bound Sema classes, all but the Sema6 class has been shown to be capable of producing 
functional soluble ectodomains. Herein, we show that the soluble ectodomain of 
Sema6A, sSema6A, exhibits natural and PKC-induced release from cells. We also show 
sSema6A release correlates with PKC induced Sema6A phosphorylation. Finally, this 
soluble variant is functional as it promotes the cohesion of zebrafish early eye field 
explants. This report of the first soluble ectodomain of the Sema6 class that is functional 
in the nervous system suggests that in addition to its canonical contact-mediated 
functions, Sema6A may have regulated, long-range, forward-signaling capacity. 
 
3.2. Introduction 
Semaphorins (Semas) are a family of secreted and transmembrane proteins that 
play crucial roles in the developing nervous system. Although Semas are best 
characterized as repulsive axonal guidance cues [1, 2], it is now appreciated that Semas 
also play diverse developmental and homeostatic roles in numerous tissue types including 
endothelial cells, bone cells, and cells of the cardiovascular and immune systems [3-5]. 
Semas also participate in pathogenic states such as metastatic cancers and 
neurodegenerative diseases [4, 6, 7]. Semas bind primarily to plexin (Plxn) receptors [8, 
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9] and regulate many cellular processes including cytoskeletal dynamics, integrin-
dependent adhesion, proliferation, differentiation, and transcription [3, 10-13]. There are 
20 vertebrate Semas identifiable by their conserved extracellular, Plxn-binding sema 
domain encompassing ~500 amino acids near the N-terminus [14, 15] followed by a 
cysteine-rich plexin–semaphorin–integrin (PSI) domain of ~50 amino acids. Vertebrate 
Semas can be both transmembrane and secreted and have been grouped into five classes 
(Sema3-7). Membrane-bound Semas (Semas4-7) act locally and regulate cells via cell-
cell contact while secreted Semas (Sema3) can act over longer distances and typically 
require neuropilins as Plxn co-receptors [16].  
 
While membrane-bound Semas canonically govern contact-mediated cellular 
events, it is appreciated that regulated processing of Semas at the plasma membrane 
results in soluble Sema (sSema) ectodomains that can function similarly to their 
traditional membrane-bound counterparts [17-21]. These sSemas, notably sSema4D and 
sSema7A, were first identified to be functional in the mammalian immune system [17, 
18, 22]. However, sSema5B has been shown to be produced and functional in the nervous 
system, acting as a neuronal and axonal guidance cue [19]. Currently, at least one 
member of each vertebrate membrane-bound or transmembrane Sema class has been 
shown to produce a functional soluble variant except for the Sema6 class. However, in 
proteomics analyses we and others found evidence for additional sSemas, including 
possible variants of Sema6A and Sema6D, that were produced in vivo and released into 
mammalian embryonic cerebrospinal fluid (CSF) or plasma [23-25]. 
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We have been studying the molecular mechanisms and developmental function of 
Sema6A-PlxnA signaling. Previously, we reported that Sema6A is highly expressed in 
retinal precursor cells in the early eye field and is critical in maintaining early eye field 
cohesion [11, 26, 27]. Given that our proteomics analyses identified Sema6A in CSF 
[23], we were prompted to ask if Sema6A might generate a naturally-released 
ectodomain. This would have important implications as Sema6A could then signal at a 
distance and could act as a cue that would be effectively separated from, or even 
antagonistic to, its known reverse signaling roles [28-30].  
 
Herein, we show that the Sema6A ectodomain can be naturally released and that 
Protein Kinase C (PKC) activity enhances its release. Further, consistent with the 
regulatory roles of kinases driving the release of other sSemas [22], we find that 
sSema6A release correlates with PKC-induced Sema6A phosphorylation at intracellular 
serines. Finally, we show that sSema6A is functional as it promotes the cohesion of early 
zebrafish eye fields in cultured explants, a phenotype known to be induced by Sema6A-
FC [26]. To our knowledge, these data constitute the first characterization of a natural 
and regulated release of an ectodomain for the Sema6 class that is functional in the 
nervous system. These results suggest that Sema6A may be acting at a distance in 
addition to its canonical contact-mediated effects. As Sema6 class members can also 
reverse signal, ectodomain release may also be a novel mechanism to regulate uni-





3.3.1. Semaphorin ectodomains are present in embryonic cerebrospinal fluid and 
sSema6A is produced by cultured cells 
We have previously shown, by proteomic analysis, that there are numerous 
signaling molecules present in human and rat embryonic cerebrospinal fluid (CSF) during 
critical stages of development [23]. Of these, Sema proteins from several Sema classes 
were identified, including Sema4 and Sema6 [23]. We performed a SEQUEST analysis 
of the raw data from this study using the original parameters to identify the location of 
the peptides on the Sema proteins (Figure 3.1A-B). Proteins that were identified by two 
or more unique peptides were retained and of these, Sema6A, Sema6D, Sema4B, and 
Sema5A were detected in rat and/or human embryonic CSF. Mapping the peptides to the 
protein location showed that only peptides corresponding to the ectodomain of the Sema 
proteins were identified. While protein secretion through exosomes is a possibility, many 
vertebrate transmembrane and membrane-bound Sema proteins have been identified to be 
proteolytically processed to release a functional ectodomain [17-19, 21, 22, 31]. Of the 
Sema proteins detected, Sema4B and Sema5A can be cleaved by BACE2 and ADAM17, 
respectively, to produce soluble ectodomains [20, 31, 32]. We have been investigating the 
roles of Sema6A in eye development and have shown it to be critical for early eye field 
cohesion and retinal precursor cell proliferation [11, 26]. Although the Sema6 class has 
not yet been shown to have soluble, released ectodomains, we asked the question if a 
soluble form of Sema6A can be naturally-released from Sema6A-expressing cells. To 
begin to address this, we first transfected HEK293 cells with an expression construct 
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encoding full-length human Sema6A. Following a recovery in full media, cells were 
rinsed and incubated with OPTI-MEM reduced media for 18-24 hours and the 
conditioned media was collected. Cell lysate and conditioned media samples were 
denatured and subjected to SDS-PAGE and immunoblotted with an extracellular-targeted 
α-Sema6A (Figure 3.1C). Compared to the full-length protein found in whole cell 
extracts, a smaller protein was detected by the antibody in the conditioned media of 
Sema6A-expressing cells. We also found that the soluble Sema6A can be produced in the 
neuronal cell line N2A (Figure 3.1D).  
 
3.3.2. Mass spectrometry analysis identifies a soluble Sema6A ectodomain 
To determine the identity of the Sema6A fragment contained in the conditioned 
media of Sema6A-expressing cells, we transfected HEK293 cells with an expression 
plasmid that encoded for human Myc-Sema6A, with the Myc tag located at the N-
terminus, following the signal sequence [28]. After overnight recovery in full media, cells 
were incubated in OPTI-MEM reduced serum and the conditioned media was collected 
after 18-24 hours. Sema6A protein expression was verified in whole cell extracts via 
immunoblotting (Figure 3.2A, left). Sema6A was immunoprecipitated using α-Myc from 
cell lysates and the conditioned media. A minor portion of the immune complexes was 
subjected to SDS-PAGE and immunoblotted with α-Myc to confirm immunoprecipitation 
efficiency of full-length and soluble Sema6A (Figure 3.2A, right).  Interestingly, the 
banding pattern of the soluble Sema6A variant, sSema6A, suggests that it could contain 
post-translational modifications such as glycosylation. The major portion of each immune 
complex was run on SDS-PAGE and coomassie stained (Figure 3.2B). Although not  
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Figure 3.1. Semaphorin ectodomain peptides identified in Zappaterra et al. in 
human and rat embryonic cerebrospinal fluid. A. Schematic illustrating the 
semaphorin (Sema) proteins that we previously identified in human and rat embryonic 
cerebrospinal fluid (eCSF). Asterisks indicate positions of peptides discovered in rat CSF 
while triangles indicate positions of peptides discovered in human CSF. Of note, all 
peptides identified were in the ectodomains. B. Table summarizing the number of 
peptides identified in each sample. If a semaphorin protein is not listed, it was not 
identified. C-D. HEK293 cells (C) and N2A cells (D) cells overexpressing an expression 
construct encoding human Sema6A were incubated in OPTI-MEM reduced serum media 
overnight. The conditioned media was collected and cells were lysed. Samples were run 
on SDS-PAGE and immunoblotted with ⍺-Sema6A. A smaller protein of approximately 
95 kDa was detected in the conditioned media (arrowhead) of cells expressing full-length 
(FL) Sema6A (arrow).  
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detectable by coomassie staining, the region of the gel corresponding to the molecular 
weight of the soluble Sema6A product, 85-110 kDa, was excised, digested with trypsin, 
and tryptic peptides were analyzed using LC-MS/MS. Mapping the peptide coverage of 
the soluble Sema6A fragment, we found only peptides of the ectodomain (Figure 3.2C, 
Supplemental Table 3.1) consistent with the sSema6A variant encompassing the 
ectodomain alone. As Semas are known glycoproteins and glycosylation can hinder 
peptide detection, we conducted glycosylation prediction analyses using three separate 
prediction software programs for both O- and N-linked glycosylation (Supplemental 
Table 3.2). The ectodomain residues that were predicted to be glycosylated in at least two 
prediction programs were mapped to the Sema6A protein (Figure 3.2C, labeled as “O” 
and “N”). In an attempt to determine the C-terminus of sSema6A, the last tryptic peptide 
detected was LTFEQDIER at amino acid positions 551-559. A SEQUEST analysis with 
no enzyme specified identified the peptide GNTDGLGDCHN at amino acid positions 
560-570 (Supplemental Figure 3.1). With the discovery of the possible C terminus of 
sSema6A, we hypothesize that the ectodomain is released by proteolytic cleavage after 
asparagine 570, approximately 80 amino acids distal to the transmembrane domain.  
 
As we purified the full length and ectodomain Myc-Sema6A proteins via 
immunoprecipitation, we also conducted mass spectrometry analysis to determine 
binding partners of full-length cell-bound Sema6A and the sSema6A ectodomain released 
into the media. We identified 373 proteins interacting with full-length Sema6A 
(Supplemental Figure 3.3). Of these, tubulin and cadherin binding proteins were enriched 
as analyzed by GO Molecular Functions and Cellular Components using Metascape  
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Figure 3.2. Mass spectrometry analysis reveals the Sema6A ectodomain as the 
soluble Sema6A product. HEK cells were transfected with an expression plasmid 
encoding Myc-SEMA6A. Immunoprecipitation with α-Myc was used to purify the full-
length cell-bound Sema6A, and the soluble Sema6A contained in the media. A. Whole 
cell extracts and a small portion of the immune complexes were subjected to SDS-PAGE 
and western blotting to verify SEMA6A expression and a successful 
immunoprecipitation. Arrows indicate the full length protein and arrowheads indicate the 
smaller soluble Sema6A form. The multiple bands of Sema6A may indicate post-
translational modifications such as glycosylation. B. The major portion of the immune 
complexes was subjected to coomassie staining. Each sample lane was excised according 
to molecular weight, digested with trypsin, and prepared for tandem mass spectrometry. 
C. The tryptic peptides from bands corresponding to a molecular weight of the soluble 
Sema6A variant, approximately 85-110 kDa, were analyzed and mapped onto human 
Sema6A. Gray bars indicate the location and spectral count of the tryptic peptides 
identified. The starred bar indicates the non-tryptic peptide detected which is predicted to 
be the cleavage site that produces sSema6A. As peptide coverage is negatively affected 
by glycosylation, we also mapped potential glycosylation sites. The letters “O” and “N” 
indicate predicted O- or N-linked glycosylation sites, respectively, that were identified 
from at least two independent glycosylation prediction programs. 
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enrichment analyses (Supplemental Figure 3.2). For the sSema6A ectodomain binding 
partners, 24 proteins were identified (Supplemental Table 3.4). Of these, proteins 
involved in binding kinases and inhibiting enzymes were enriched (Supplemental Figure 
3.3). 
 
3.3.3. Naturally-released sSema6A can be regulated by PKC 
To verify that sSema6A production does not occur simply due to over-expression 
or cell death, we determined if sSema6A can be produced in a regulated manner. To 
examine this, we first conducted a time course analysis of sSema6A release into the 
media. After 24 hours, transfected HEK cells were incubated with OPTI-MEM reduced 
media for various amounts of time, from 0 minutes to 18 hours (Figure 3.3A-B). We were 
able to detect sSema6A in as little as 2 hours and, although variable, consistently detected 
sSema6A at 6 hours, and observed a plateau at 18 hours. As proteases and kinases are 
known to regulate the release of ectodomains [33-35], we asked whether the activation of 
PKC through phorbol 12-myristate 13-acetate (PMA) stimulation could enhance 
sSema6A production. Indeed, a 30 minute PMA stimulation (100 nM) at the end of the 6 
hour conditioned media incubation of Sema6A-expressing cells caused a significant 
increase of sSema6A (Figure 3.3C-D). To verify that PMA-induced sSema6A release is 
occurring through PKC activation, we pre-treated cells with the specific PKC inhibitor 
Bisindolylmaleimide 1 (BIM1, 5 µM, 30 minutes) before stimulating cells with PMA. 
PKC inhibition using BIM1 resulted in a significant decrease of sSema6A and brings 
sSema6A levels back to baseline (Figure 3.3E-F).  Lastly, to determine if PKC-induced 
sSema6A production is occurring through the Mek/Erk pathway, a well-known  
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Figure 3.3. Naturally released sSema6A can be regulated by PKC. 
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Figure 3.3. Naturally released sSema6A can be regulated by PKC. HEK293 cells 
were transfected with an expression construct encoding human Myc-Sema6A. Following 
overnight growth, HEK293 cells were incubated in OPTI-MEM reduced-serum media for 
the indicated amount of time or 6 hours if not indicated. The conditioned media was then 
collected and the cells were lysed. Proteins were concentrated from the conditioned 
media using TCA precipitation. Protein samples were subjected to SDS-PAGE and 
immunoblotting with the indicated antibodies. A. The time course of detectable sSema6A 
production, which was normalized to 18 hours, quantified in B. As sSema6A was 
consistently detected at 6 hours, this time point was selected for subsequent 
pharmacological experiments. C. Sema6A-expressing cells were treated with the PKC 
activator PMA (100 nM, 30 minutes) or DMSO vehicle alone during the last 30 minutes 
of the 6-hour conditioned media incubation. The Log2 fold change in sSema6A 
production with PMA treatment was normalized to the Sema6A untreated group and 
quantified in D (p < 0.0001). E. PMA-induced sSema6A production is due to PKC 
activation. Sema6A-expressing cells were pre-treated with the selective PKC inhibitor 
BIM1 (5 µM) for 30 minutes prior to PMA stimulation. Log2 fold change sSema6A 
levels were normalized and quantified in F (+PMA/-BIM1 compared to +PMA/+BIM1 p 
< 0.018; -PMA/+BIM1 compared to +PMA/-BIM1 p < 0.039).  G. PMA/PKC-induced 
sSema6A production is independent of the Mek/Erk pathway. Sema6A-expressing cells 
were pre-treated with the Mek inhibitor U0126 (10 µM) for 30 minutes prior to PMA 
stimulation.  Log2 fold change sSema6A levels were normalized and quantified in H (p < 
0.012). 
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downstream target of PKC, we pre-treated cells with the specific Mek inhibitor U0126 
(10 µM, 30 minutes) before stimulating cells with PMA (Figure 3.3G-H). Although the  
Mek inhibitor blocked PMA-induced Erk activation, we observed no significant decrease 
in sSema6A release in Mek-inhibited cells, suggesting that PKC-induced sSema6A 
production occurs through a Mek/Erk-independent mechanism. 
 
3.3.4. PKC-induced phosphorylation of Sema6A  
To begin to address how PKC can be inducing Sema6A ectodomain release, we 
hypothesized that a conformational change, possibly due to phosphorylation, could be 
occurring which allows Sema6A to be more susceptible to ectodomain processing. We 
asked if Sema6A phosphorylation can be induced by PKC activation. Indeed, we detected 
basal Sema6A phosphorylation using a phospho-motif-specific antibody, α-RXXpS/T, 
which recognizes the phosphorylated minimal target motif of PKC as well as several 
AGC family kinases. This phospho-signal can be inhibited when PKC is blocked with 
BIM1 (Figure 3.4A). This phosphorylation increases when PKC is activated with PMA 
and this increase can be blocked by pre-treatment with BIM1 (Figure 3.4A, quantified in 
3.4B). While we cannot rule out indirect PKC-dependent phosphorylation, the major 
kinase targeting RXXS/T sites downstream of PKC is RSK, and RSK is dependent on 
Mek-Erk signaling [36, 37]. Bioinformatics show that the Sema6A intracellular domain 
contains multiple AGC kinase/PKC phosphorylation target motifs (Figure 3.4C). To 
identify phosphorylated RXXpS motifs, we subjected Myc-Sema6A immunoprecipitation 
samples to mass spectrometry analysis. We identified three phosphorylation sites: S952, 
S988, and S1005 within PKC-preferred RXXS motifs (Supplemental Figures 3.4-6). 
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While future validation is required, bioinformatics and mass spectrometry data suggest 
that these sites could be phosphorylated by PKC which may be one mechanism of 
regulating sSema6A production.  
 
3.3.5. Naturally released sSema6A promotes cellular cohesion of early eye fields 
To determine if spontaneously released sSema6A was functional, we collected 
conditioned media from Sema6A-expressing and untransfected HEK cells. Sema6A-
PlxnA2 signaling is known to be required for proper eye vesicle integrity, as decreasing 
levels of either Sema6A or PlxnA2 in zebrafish embryos results in ectopic cells and loss 
of eye field cohesion [11, 26]. We have previously developed a cohesion-based assay to 
test the function of secreted forms of Semas in zebrafish eye explants (Figure 3.5A) [26]. 
Sema6A-FC is known to promote cellular cohesion of early eye fields as stimulating 
whole eye explants at 18 hours post fertilization (hpf) with Sema6A-FC results in less 
ectopic cells [26].  We used this assay to determine if sSema6A can regulate cells of the 
early eye field. We used eye explants from rx3:GFP zebrafish, which drives GFP 
expression in retinal precursor cells, enabling observation of the integrity of the early eye 
field. Consistent with published findings, stimulating 18 hpf eye explants with sSema6A-
containing conditioned media for 6 hours resulted in increased eye field cohesion, 
compared to conditioned media from untransfected control cells, as sSema6A resulted in 
a significant decrease in the number of GFP-positive ectopic cells (Figure 3.5B-E, 
quantified in 3.5F). The presence of sSema6A in the Sema6A conditioned media was 
verified via Western Blotting (Figure 3.5G). 
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Figure 3.4. PKC-induced phosphorylation of Sema6A. A-B. HEK293 cells expressing 
Myc-Sema6A were stimulated with PMA or DMSO vehicle control, with or without pre-
treatment of BIM1. Sema6A was purified via immunoprecipitation with α-Myc and 
immune complexes were subjected to SDS-PAGE and immunoblotting with a PKC/AGC 
kinase phospho-motif specific antibody, α-RXXpS/T. A. Untreated cells show baseline 
RXXpS/T Sema6A phosphorylation while PMA stimulation increases this 
phosphorylation. BIM1 abolishes the baseline and PMA-induced phosphorylation, as 
quantified in B. Phosphorylation levels and total protein levels were normalized to 
Sema6A +PMA/+BIM1 and the Log2 fold change was calculated using the fraction 
phosphorylated/total Sema6A (-PMA/-BIM1 compared to –PMA/+BIM1 p < 0.0087; 
+PMA/-BIM1 compared to +PMA/+BIM1 p < 0.0042). Dashed line indicates cropping 
together due to a tear in the gel. See Figure 3E for whole cell extract Myc-Sema6A 
expression levels and RXXpS/T protein levels. C. Bioinformatics indicate four RXXS 
sites predicted (ScanSite) and/or observed to be phosphorylated in large-scale proteomic 
studies (PhosphoSitePlus). Mass spectrometry analysis of Sema6A identified three of 
these sites to be phosphorylated (Supplementary Figures 3.4-3.6). 
 108 
 
Figure 3.5. Naturally released sSema6A promotes cellular cohesion of early eye 
fields. A. Eyes were dissected from 18 hpf embryos of rx3:GFP transgenic zebrafish, 
which have GFP-positive retinal precursor cells. Individual eye explants were cultured in 
individual wells of a 96-well plate containing conditioned media from either 
untransfected or Sema6A-expressing cells for 6 hours. B-E. After incubations in 
conditioned media, brightfield (B, C) and fluorescent (D, E) images of the eye explants 
were taken and eye field cohesion was assessed by counting the number of GFP-positive 
ectopic cells, quantified in F, n=26 embryos incubated in control media and n=23 
embryos incubated in sSema6A media, p = 0.009. Scale bar represents 75 µm. G. Cell 
extracts and conditioned media of untransfected or Sema6A-expressing cells were 
subjected to SDS-PAGE and immunoblotted with α-Sema6A to verify protein expression 
and the presence of sSema6A in the conditioned media. 
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3.4. Discussion 
We report here that the transmembrane Sema6A can be naturally released from 
the cell as a soluble ectodomain fragment and that this sSema6A functions in maintaining 
the integrity of the early eye field in explant studies. We show that sSema6A can be 
produced in common cell lines, including a neuronal cell line, and that this release is a 
regulated process that can be induced by PKC activation. This increase in sSema6A 
levels is correlated with an increase in full-length Sema6A phosphorylation at 
intracellular PKC phosphorylation motifs, suggesting this could be one mechanism 
regulating Sema6A’s susceptibility to ectodomain processing. Similarly, there is evidence 
that Sema4D ectodomain shedding may be regulated by phosphorylation [22] and future 
work will investigate if Sema6A phosphorylation is necessary for ectodomain release.  
 
To our knowledge, Sema6A is the first Sema6 class capable of being converted 
naturally by cells into a soluble ectodomain that is functional in the nervous system. With 
the addition of this report, it is now clear that ectodomain release is common to each of 
the vertebrate and membrane-bound Sema classes (Figure 3.6). The transmembrane 
Sema4D and the GPI-linked Sema7A have soluble, released forms that are involved in 
monocyte and B cell migration and stimulating monocyte cytokine production, 
respectively [17, 18, 21, 22, 38]. Additionally, sSema5B is released by ADAM-17 and 
functions as a repulsive guidance cue in dorsal root ganglion explants [19]. Furthermore, 
the Sema6D ectodomain is released from cells expressing full-length Sema6D, with 
possible functional roles in cardiac development [39]. While the protease responsible for 
cleaving Sema6A remains unknown, mass spectrometry analysis suggests cleavage 
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occurs between amino acids 570 and 571. The proteases involved in producing all of the 
known sSemas have not yet been identified. However, membrane-type 1 MMP has been 
shown to cleave Sema4D while ADAM-17 is sufficient to cleave Sema5B and Sema7A 
[19, 38, 40]. Interestingly, substrate O-glycosylation can influence ADAM-mediated 
ectodomain processing [41] and our bioinformatics analyses show that Sema6A may be 
heavily glycosylated near the predicted cleavage sequence.   
 
The signaling mechanisms of sSema6A have yet to be determined. Semas act as 
homodimers that bind to Plxn receptors and the secreted Sema3 class requires neuropilin 
co-receptors. Thus, the nature of how sSema6A binds to its receptor and whether or not it 
is different from transmembrane Sema6A remains to be deciphered. The roles of 
recombinant Sema6A ectodomain proteins have previously been studied and suggest that 
it acts as a repulsive cue, blocking endothelial cell migration and regulating apoptosis in 
lung cancer cells [42, 43]. We hypothesize that the soluble form is a way to propagate the 
effects of Sema6A over greater distances. Sema6A cleavage could also allow for 
autocrine signaling or to down-regulate surface expression. Additionally, sSema6A may 
be regulating the direction of signaling. As a transmembrane Sema, Sema6A exhibits 
reverse signaling resulting in collapse of Sema6A-expressing cells, possibly through 
interactions with Mena and Ena/VASP-like protein (EVL) [28, 44]. The discovery of a 
naturally released Sema6A that is functional in nervous system development suggests 
that Sema6A can have both contact-mediated and long-range effects and sSema6A may 
be one process by which cells control the activation of forward-only signaling, or control 
reverse signaling in a dominant-negative fashion. This report opens the field to  
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Figure 3.6. Schematic depicting the structural domains of Semas and indicating 
Semas whose ectodomains can be naturally released from cells. There are 2 
invertebrate classes and 5 vertebrate classes of Semas (*class 5 Semas are found in 
vertebrates and invertebrates). ‡Although Semas can have broad expression patterns and 
diverse functions, this figure focuses on those systems in which the functional role of the 
indicated Sema class has been highly characterized. The major domains of each Sema 
class are shown. The specific Sema family members known to produce a soluble 
ectodomain are labeled. ^Sema4B and Sema4C have been shown to be substrates of 
BACE proteases, although a naturally-released ectodomain has not yet been characterized 
[32, 45]. †Some viral Semas do not have an Ig-like domain. The schematic was inspired 
in part by a previous review [46]. 
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investigate the nature of sSema6A binding and the mechanisms of sSema6A processing 
and signaling. 
 
3.5. Materials and Methods 
3.5.1. Plasmids and Molecular Cloning 
The untagged human Sema6A cDNA (Genbank reference BC032619.1 and 
IMAGE reference 5578066) in pCMV-Sport6 was acquired from Open 
Biosystems/Thermo Scientific (Huntsville, AL, USA). The post-signal sequence, N-
terminally tagged human Myc-Sema6A in pCAGGS vector was published previously 
[28] and generously provided by Kevin J. Mitchell at Trinity College (Dublin, Ireland) 
and Alain Chédotal, Céline Heitz and Yvrick Yager from the Institut de la Vision, 
INSERM (Paris, France). 
 
3.5.2. Cell Culture and Transfections 
HEK293 cells were maintained in DMEM with sodium pyruvate, L-glutamine, 
and 4.5 g/L glucose (MediaTech/Corning Life Sciences, Tewksbury, MA, USA). This 
media was supplemented with 5% Fetal Bovine Serum (Hyclone, Logan, UT, USA), 5% 
Cosmic Calf Serum (Hyclone), 50 units/mL penicillin and 50 g/mL streptomycin (Pen 
Strep, Invitrogen, Carlsbad, CA, USA). Cells were cultured to 75% of confluence at 37 
C and 5% CO2 and were then transfected with 5-7.5 g Sema6A expression plasmids 
using calcium phosphate precipitation.  
 
3.5.3. Conditioned Media, Pharmacological Treatments, and Western Blotting 
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Following transfection, cells were incubated at 37 C and 5% CO2 for 6 hours and 
then washed with warm PBS and incubated overnight in full medium. The cells were then 
washed again with warm PBS and incubated for the indicated amount of time in OPTI-
MEM (ThermoFisher Scientific, Waltham, MA, USA) supplemented with Pen Strep. For 
pharmacological studies, cells were incubated in OPTI-MEM for 6 hours, with or without 
stimulation with 100 nM PMA (Biomol, Enzo Life Sciences, Plymouth Meeting, PA, 
USA) for the final 30 minutes. Pre-treatment of 5 µM BIM1 (EMD/Millipore Sigma, 
Burlington, MA, USA) or 10 µM U0126 (Biomol) occurred for 30 minutes immediately 
prior to PMA stimulation. The conditioned media was collected and clarified by 
centrifugation at 4,000 rpm for 5 minutes.  
 
Cells lysis was as previously described [47] in lysis buffer (25 mM Tris pH 7.4, 
137 mM NaCl, 10% glycerol, 1% Igepal) containing protease inhibitors (5 g/mL 
Pepstatin, 10 g/mL Leupeptin, 1 mM PMSF) and phosphatase inhibitors (1 mM NaVO3, 
25 mM NaF, 10 mM Na2H2P2O7). For immunoblotting, 20-30 g total protein extract 
was denatured in protein sample buffer (125 mM Tris pH 6.8, 7.5% glycerol, 2% sodium 
dodecyl sulfate (SDS), 5% -mercaptoethanol, and bromophenol blue at 0.02%) at 95 C 
for 5 minutes and subjected to SDS-PAGE as previously described [47]. Proteins were 
precipitated from the conditioned media using 15% trichloroacetic acid (TCA) as 
previously described [48] before resuspension in sample buffer. The primary antibodies, 
-Sema6A (rabbit pAb, 1:1000, Novus Biologicals, Littleton, CO, USA) or α-Myc 
(rabbit mAb, 1:1000, Cell Signaling Technology, Beverly, MA, USA), were diluted in 10 
mL of 1.5% BSA in TBST containing 0.0005% sodium azide and incubated with the 
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membranes overnight, rocking at 4 C. The secondary antibody was -rabbit (goat IgG, 
1:15,000, EMD Millipore, Billerica, MA, USA). Protein bands were detected using 
enhanced chemiluminescence (ThermoFisher Scientific) and film, which was developed 
using a Medical Film Processor SRX-101A (Konica Minolta Medical & Graphic, Tokyo, 
Japan). The raw film scans were converted to grayscale and brightness was optimized in 
Adobe Photoshop CS2 (San Jose, CA, USA). Densitometry analysis was conducted on 
the raw film scans using the mean histogram tool in Photoshop. The sSema6A levels 
were normalized to the untreated sSema6A α-Myc band and the Log2 fold change was 
calculated. For Sema6A phosphorylation experiments, densitometry analysis was 
conducted as previously described [49] by first subtracting the background film signal 
then normalizing the phosphorylated Sema6A (α-RXXpS/T) and total Sema6A (α-Myc) 
to the +PMA/+BIM1 group. The Log2 fold change was calculated using the fraction of 
normalized phosphorylated Sema6A over the normalized total Sema6A levels. A 
student’s T-test comparison was performed on the data from 2-3 independent 
experiments using GraphPad Prism 7 (La Jolla, CA, USA). 
 
3.5.4. Mass Spectrometry 
To identify the tryptic peptides of the Sema proteins detected in human and rat 
embryonic cerebrospinal fluid previously published [23], the original raw mass 
spectrometry results were subjected to a SEQUEST search using the forward and reverse 
concatenated International Protein Index (IPI) human and rat databases. The same filter 
parameters were used as in the previous study except proteins were retained if two or 
more unique peptides were identified, as opposed to three or more.  
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The conditioned media of HEK293 cells either untransfected or expressing Myc-
Sema6A was collected and cells were lysed. Sema6A protein from extracts and 
conditioned media was purified by immunoprecipitation with 7.5 µL α-Myc resin 
(BioLegend, San Diego, CA, USA) supplemented with 1 µg α-Myc (Cell Signaling) and 
2.5 µL each of Protein A and G beads, rocking at 4 ᴼC overnight. Immune complexes 
were washed three times with lysis buffer, drained completely, and denatured in sample 
buffer. Boiled samples were loaded onto a 10% SDS-PAGE gel. After running, gels were 
stained with coomassie (0.1% coomassie brilliant blue R-250, 20% glacial acetic acid, 
40% methanol). The entire gel lanes were excised and prepared for mass spectrometry as 
previously described [50]. Briefly, gel regions were diced and proteins were reduced and 
alkylated prior to being subjected to in-gel digestion with 6 ng/ul trypsin (Promega, 
Madison, WI, USA) in 50 mM ammonium bicarbonate at 37 ᴼC for 9-12 hours. The 
tryptic peptides were resuspended in 2.5% acetonitrile, 0.15% formic acid and separated 
via HPLC prior to MS/MS analysis on a Q Exactive Plus mass spectrometer controlled 
with Thermo Xcalibur 4.0 software (ThermoFisher Scientific). Peptides were eluted and 
analyzed as previously described [51]. A SEQUEST search of the mass spectrometry data 
was performed using the forward and reverse concatenated 2011 Uniprot Human Protein 
database requiring tryptic peptides and permitting phosphorylation of serine, threonine 
and tyrosine (+79.9663 Da), oxidation of methionine (+15.9949 Da), and acrylamidation 
and carbamidomethylation of cysteine (+71.0371 and +57.0215, respectively). XCorr 
filters for peptide identification were set at 1.8, 2.0, 2.2, 2.4, and 2.6 for +1, +2, +3, +4, 
and +5 charged peptides, respectively. Proteins were filtered by excluding those proteins 
 116 
that were not identified by three or more unique peptides. Proteins were considered to be 
binding partners after subtracting non-specific proteins found in untransfected control 
groups.  
The peptide coverage of the soluble Sema6A product detected in the conditioned 
media was determined by analyzing the peptides corresponding to the molecular weight 
85-110 kDa. A SEQUEST search was performed as described above and Sema6A was 
identified with a false discovery rate (FDR) of 0.00%. To identify additional Sema6A 
peptides, the XCorr filters were relaxed to 0.8, 1.1, 1.4, 1.7, and 2.0 for +1, +2, +3, +4, 
and +5 charged peptides, respectively. This did not increase the FDR and those additional 
peptides that emerged were manually validated. To identify the putative C-
terminus/cleavage site of sSema6A, a similar SEQUEST search using the forward and 
reverse human Sema6A Uniprot sequence was performed but without requiring tryptic 
peptides (no enzyme search). 
 
3.5.5. Bioinformatics methods 
To predict O- and N-linked glycosylation sites on the ectodomain of human 
Sema6A, the following glycosylation prediction software programs were used: NetOGlyc 
4.0 [52], GlycoEP [53], YinOYang 1.2 [54] for O-glycosylation sites and ExPASy 
ScanProsite [55], GlycoEP [53], and NetNGlyc 1.0 [56] for N-glycosylation sites. If a 
site was predicted to be glycosylated in two or more prediction programs, it was 
considered likely to be glycosylated. 
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Metascape [57] (http://metascape.org) was used to determine the Gene Ontology 
(GO) classifications and enrichment scores of the Sema6A-FL and sSema6A binding 
partners. Of the 373 binding partners identified for Sema6A-FL, those proteins identified 
by the top quartile of peptides (9+ peptides, n = 101 proteins) were used in the analyses. 
All of the 24 binding partners of sSema6A were used in the analyses. Proteins were 
classified based on GO Molecular Functions and GO Cellular Components and an 
enrichment analysis was conducted using the human genome as background with a 
minimum enrichment of 1.5 and a p value less than 0.01. 
 
PKC phosphorylation motifs, RXXpS, on Sema6A were identified by using 
ScanSite 4.0 [58] (MIT, Cambridge, MA, USA). PhosphoSite Plus [59] (Cell Signaling 
Technology) was used to identify phospho-serine residues in RXXS motifs that were 
previously found by large-scale proteomics studies.  
 
3.5.6. Zebrafish Husbandry and Eye Explant Experiments 
Zebrafish embryos were developmentally-staged as previously described [60]. 
The rx3:GFP transgenic zebrafish line, which expresses GFP in retinal precursor cells, 
was generously provided by Dr. Joachim Wittbrodt at the University of Heidelberg, 
Germany. All procedures were approved by the University of Vermont Institutional 
Animal Care and Use Committee (IACUC). Zebrafish embryos were collected at the one-
cell stage and incubated at 25 C for approximately 24 hours until the 18 somite stage 
was reached [60]. At 18 somites, whole eyes were dissected from GFP-positive embryos 
as previously described [26] using a Nikon SMZ800 brightfield dissecting microscope 
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with an add-on GFP fluorescent lamp and filter set (NightSea, Hatfield, PA, USA). 
Dissected eyes were transferred to individual wells of a 96-well plate containing 100 L 
of either untransfected control conditioned media or Sema6A conditioned media and 
incubated at 28 C and 5.0% CO2 for 6 hours. After conditioned media treatment, eye 
explants were imaged at 40X magnification using SPOT imaging software version 5.2 
(Sterling Heights, MI, USA) on an Olympus inverted epifluorescent microscope. Figures 
were generated using Adobe Photoshop CS6, where image brightness was normalized 
and optimized. Quantification of eye explants was performed in Image J version 1.48a 
(National Institutes of Health, USA) by counting the number of ectopic GFP-positive 
precursor cells that had dissociated from the eye field following 6 hours of conditioned 
media incubation. Images were blinded prior to quantification and the average number of 





1. Luo Y, Raible D & Raper JA (1993) Collapsin: a protein in brain that induces the 
collapse and paralysis of neuronal growth cones. Cell 75, 217-227. 
2. Kolodkin AL (1996) Semaphorins: mediators of repulsive growth cone guidance. 
Trends Cell Biol 6, 15-22. 
3. Jongbloets BC & Pasterkamp RJ (2014) Semaphorin signalling during 
development. Development 141, 3292-3297, doi: 10.1242/dev.105544. 
4. Kruger RP, Aurandt J & Guan KL (2005) Semaphorins command cells to move. 
Nat Rev Mol Cell Biol 6, 789-800, doi: 10.1038/nrm1740. 
5. Treps L, Le Guelte A & Gavard J (2013) Emerging roles of Semaphorins in the 
regulation of epithelial and endothelial junctions. Tissue Barriers 1, e23272, doi: 
10.4161/tisb.23272. 
6. Worzfeld T & Offermanns S (2014) Semaphorins and plexins as therapeutic targets. 
Nat Rev Drug Discov 13, 603-621, doi: 10.1038/nrd4337. 
7. Pasterkamp RJ & Giger RJ (2009) Semaphorin function in neural plasticity and 
disease. Curr Opin Neurobiol 19, 263-274, doi: 10.1016/j.conb.2009.06.001. 
8. Tamagnone L, Artigiani S, Chen H, He Z, Ming GI, Song H, Chedotal A, Winberg 
ML, Goodman CS, Poo M, et al. (1999) Plexins are a large family of receptors for 
transmembrane, secreted, and GPI-anchored semaphorins in vertebrates. Cell 99, 
71-80. 
9. Winberg ML, Noordermeer JN, Tamagnone L, Comoglio PM, Spriggs MK, 
Tessier-Lavigne M & Goodman CS (1998) Plexin A is a neuronal semaphorin 
receptor that controls axon guidance. Cell 95, 903-916. 
10. Pasterkamp RJ, Peschon JJ, Spriggs MK & Kolodkin AL (2003) Semaphorin 7A 
promotes axon outgrowth through integrins and MAPKs. Nature 424, 398-405, doi: 
10.1038/nature01790. 
11. Emerson SE, St Clair RM, Waldron AL, Bruno SR, Duong A, Driscoll HE, Ballif 
BA, McFarlane S & Ebert AM (2017) Identification of target genes downstream of 
semaphorin6A/PlexinA2 signaling in zebrafish. Dev Dyn 246, 539-549, doi: 
10.1002/dvdy.24512. 
12. Bernard F, Moreau-Fauvarque C, Heitz-Marchaland C, Zagar Y, Dumas L, Fouquet 
S, Lee X, Shao Z, Mi S & Chedotal A (2012) Role of transmembrane semaphorin 
Sema6A in oligodendrocyte differentiation and myelination. Glia 60, 1590-1604, 
doi: 10.1002/glia.22378. 
13. Kerjan G, Dolan J, Haumaitre C, Schneider-Maunoury S, Fujisawa H, Mitchell KJ 
& Chedotal A (2005) The transmembrane semaphorin Sema6A controls cerebellar 
granule cell migration. Nat Neurosci 8, 1516-1524, doi: 10.1038/nn1555. 
14. Kolodkin AL, Matthes DJ & Goodman CS (1993) The semaphorin genes encode a 
family of transmembrane and secreted growth cone guidance molecules. Cell 75, 
1389-1399. 
15. Gherardi E, Love CA, Esnouf RM & Jones EY (2004) The sema domain. Curr 
Opin Struct Biol 14, 669-678, doi: 10.1016/j.sbi.2004.10.010. 
 120 
16. Kolodkin AL, Levengood DV, Rowe EG, Tai YT, Giger RJ & Ginty DD (1997) 
Neuropilin is a semaphorin III receptor. Cell 90, 753-762. 
17. Wang X, Kumanogoh A, Watanabe C, Shi W, Yoshida K & Kikutani H (2001) 
Functional soluble CD100/Sema4D released from activated lymphocytes: possible 
role in normal and pathologic immune responses. Blood 97, 3498-3504. 
18. Delaire S, Billard C, Tordjman R, Chedotal A, Elhabazi A, Bensussan A & 
Boumsell L (2001) Biological activity of soluble CD100. II. Soluble CD100, 
similarly to H-SemaIII, inhibits immune cell migration. J Immunol 166, 4348-4354. 
19. Browne K, Wang W, Liu RQ, Piva M & O'Connor TP (2012) Transmembrane 
semaphorin5B is proteolytically processed into a repulsive neural guidance cue. J 
Neurochem 123, 135-146, doi: 10.1111/j.1471-4159.2012.07885.x. 
20. Sadanandam A, Sidhu SS, Wullschleger S, Singh S, Varney ML, Yang CS, Ashour 
AE, Batra SK & Singh RK (2012) Secreted semaphorin 5A suppressed pancreatic 
tumour burden but increased metastasis and endothelial cell proliferation. Br J 
Cancer 107, 501-507, doi: 10.1038/bjc.2012.298. 
21. Holmes S, Downs AM, Fosberry A, Hayes PD, Michalovich D, Murdoch P, Moores 
K, Fox J, Deen K, Pettman G, et al. (2002) Sema7A is a potent monocyte 
stimulator. Scand J Immunol 56, 270-275. 
22. Elhabazi A, Delaire S, Bensussan A, Boumsell L & Bismuth G (2001) Biological 
activity of soluble CD100. I. The extracellular region of CD100 is released from the 
surface of T lymphocytes by regulated proteolysis. J Immunol 166, 4341-4347. 
23. Zappaterra MD, Lisgo SN, Lindsay S, Gygi SP, Walsh CA & Ballif BA (2007) A 
comparative proteomic analysis of human and rat embryonic cerebrospinal fluid. J 
Proteome Res 6, 3537-3548, doi: 10.1021/pr070247w. 
24. Terpos E, Ntanasis-Stathopoulos I, Christoulas D, Bagratuni T, Bakogeorgos M, 
Gavriatopoulou M, Eleutherakis-Papaiakovou E, Kanellias N, Kastritis E & 
Dimopoulos MA (2018) Semaphorin 4D correlates with increased bone resorption, 
hypercalcemia, and disease stage in newly diagnosed patients with multiple 
myeloma. Blood Cancer J 8, 42, doi: 10.1038/s41408-018-0075-6. 
25. Lu Q, Dong N, Wang Q, Yi W, Wang Y, Zhang S, Gu H, Zhao X, Tang X, Jin B, et 
al. (2013) Increased levels of plasma soluble Sema4D in patients with heart failure. 
PLoS One 8, e64265, doi: 10.1371/journal.pone.0064265. 
26. Ebert AM, Childs SJ, Hehr CL, Cechmanek PB & McFarlane S (2014) Sema6a and 
Plxna2 mediate spatially regulated repulsion within the developing eye to promote 
eye vesicle cohesion. Development 141, 2473-2482, doi: 10.1242/dev.103499. 
27. Ebert AM, Lamont RE, Childs SJ & McFarlane S (2012) Neuronal expression of 
class 6 semaphorins in zebrafish. Gene Expr Patterns 12, 117-122, doi: 
10.1016/j.gep.2012.01.007. 
28. Perez-Branguli F, Zagar Y, Shanley DK, Graef IA, Chedotal A & Mitchell KJ 
(2016) Reverse Signaling by Semaphorin-6A Regulates Cellular Aggregation and 
Neuronal Morphology. PLoS One 11, e0158686, doi: 
10.1371/journal.pone.0158686. 
29. Sun LO, Brady CM, Cahill H, Al-Khindi T, Sakuta H, Dhande OS, Noda M, 
Huberman AD, Nathans J & Kolodkin AL (2015) Functional assembly of accessory 
 121 
optic system circuitry critical for compensatory eye movements. Neuron 86, 971-
984, doi: 10.1016/j.neuron.2015.03.064. 
30. Andermatt I, Wilson NH, Bergmann T, Mauti O, Gesemann M, Sockanathan S & 
Stoeckli ET (2014) Semaphorin 6B acts as a receptor in post-crossing commissural 
axon guidance. Development 141, 3709-3720, doi: 10.1242/dev.112185. 
31. Gras C, Eiz-Vesper B, Jaimes Y, Immenschuh S, Jacobs R, Witte T, Blasczyk R & 
Figueiredo C (2014) Secreted semaphorin 5A activates immune effector cells and is 
a biomarker for rheumatoid arthritis. Arthritis Rheumatol 66, 1461-1471, doi: 
10.1002/art.38425. 
32. Stutzer I, Selevsek N, Esterhazy D, Schmidt A, Aebersold R & Stoffel M (2013) 
Systematic proteomic analysis identifies beta-site amyloid precursor protein 
cleaving enzyme 2 and 1 (BACE2 and BACE1) substrates in pancreatic beta-cells. J 
Biol Chem 288, 10536-10547, doi: 10.1074/jbc.M112.444703. 
33. Parra LM, Hartmann M, Schubach S, Li Y, Herrlich P & Herrlich A (2015) Distinct 
Intracellular Domain Substrate Modifications Selectively Regulate Ectodomain 
Cleavage of NRG1 or CD44. Mol Cell Biol 35, 3381-3395, doi: 
10.1128/MCB.00500-15. 
34. Xu P & Derynck R (2010) Direct activation of TACE-mediated ectodomain 
shedding by p38 MAP kinase regulates EGF receptor-dependent cell proliferation. 
Mol Cell 37, 551-566, doi: 10.1016/j.molcel.2010.01.034. 
35. Thorp E, Vaisar T, Subramanian M, Mautner L, Blobel C & Tabas I (2011) 
Shedding of the Mer tyrosine kinase receptor is mediated by ADAM17 protein 
through a pathway involving reactive oxygen species, protein kinase Cdelta, and 
p38 mitogen-activated protein kinase (MAPK). J Biol Chem 286, 33335-33344, doi: 
10.1074/jbc.M111.263020. 
36. Ballif BA, Roux PP, Gerber SA, MacKeigan JP, Blenis J & Gygi SP (2005) 
Quantitative phosphorylation profiling of the ERK/p90 ribosomal S6 kinase-
signaling cassette and its targets, the tuberous sclerosis tumor suppressors. Proc 
Natl Acad Sci U S A 102, 667-672, doi: 10.1073/pnas.0409143102. 
37. Hauge C & Frodin M (2006) RSK and MSK in MAP kinase signalling. J Cell Sci 
119, 3021-3023, doi: 10.1242/jcs.02950. 
38. Xie J & Wang H (2017) Semaphorin 7A as a potential immune regulator and 
promising therapeutic target in rheumatoid arthritis. Arthritis Res Ther 19, 10, doi: 
10.1186/s13075-016-1217-5. 
39. Toyofuku T, Zhang H, Kumanogoh A, Takegahara N, Suto F, Kamei J, Aoki K, 
Yabuki M, Hori M, Fujisawa H, et al. (2004) Dual roles of Sema6D in cardiac 
morphogenesis through region-specific association of its receptor, Plexin-A1, with 
off-track and vascular endothelial growth factor receptor type 2. Genes Dev 18, 
435-447, doi: 10.1101/gad.1167304. 
40. Basile JR, Holmbeck K, Bugge TH & Gutkind JS (2007) MT1-MMP controls 
tumor-induced angiogenesis through the release of semaphorin 4D. J Biol Chem 
282, 6899-6905, doi: 10.1074/jbc.M609570200. 
41. Goth CK, Halim A, Khetarpal SA, Rader DJ, Clausen H & Schjoldager KT (2015) 
A systematic study of modulation of ADAM-mediated ectodomain shedding by 
 122 
site-specific O-glycosylation. Proc Natl Acad Sci U S A 112, 14623-14628, doi: 
10.1073/pnas.1511175112. 
42. Dhanabal M, Wu F, Alvarez E, McQueeney KD, Jeffers M, MacDougall J, Boldog 
FL, Hackett C, Shenoy S, Khramtsov N, et al. (2005) Recombinant semaphorin 6A-
1 ectodomain inhibits in vivo growth factor and tumor cell line-induced 
angiogenesis. Cancer Biol Ther 4, 659-668. 
43. Shen CY, Chang YC, Chen LH, Lin WC, Lee YH, Yeh ST, Chen HK, Fang W, Hsu 
CP, Lee JM, et al. (2018) The extracellular SEMA domain attenuates intracellular 
apoptotic signaling of semaphorin 6A in lung cancer cells. Oncogenesis 7, 95, doi: 
10.1038/s41389-018-0105-z. 
44. Klostermann A, Lutz B, Gertler F & Behl C (2000) The orthologous human and 
murine semaphorin 6A-1 proteins (SEMA6A-1/Sema6A-1) bind to the 
enabled/vasodilator-stimulated phosphoprotein-like protein (EVL) via a novel 
carboxyl-terminal zyxin-like domain. J Biol Chem 275, 39647-39653, doi: 
10.1074/jbc.M006316200. 
45. Hemming ML, Elias JE, Gygi SP & Selkoe DJ (2009) Identification of beta-
secretase (BACE1) substrates using quantitative proteomics. PLoS One 4, e8477, 
doi: 10.1371/journal.pone.0008477. 
46. Messina A & Giacobini P (2013) Semaphorin signaling in the development and 
function of the gonadotropin hormone-releasing hormone system. Front Endocrinol 
(Lausanne) 4, 133, doi: 10.3389/fendo.2013.00133. 
47. Weir ME, Mann JE, Corwin T, Fulton ZW, Hao JM, Maniscalco JF, Kenney MC, 
Roman Roque KM, Chapdelaine EF, Stelzl U, et al. (2016) Novel 
autophosphorylation sites of Src family kinases regulate kinase activity and SH2 
domain-binding capacity. FEBS Lett 590, 1042-1052, doi: 10.1002/1873-
3468.12144. 
48. Ballif BA, Arnaud L, Arthur WT, Guris D, Imamoto A & Cooper JA (2004) 
Activation of a Dab1/CrkL/C3G/Rap1 pathway in Reelin-stimulated neurons. Curr 
Biol 14, 606-610, doi: 10.1016/j.cub.2004.03.038. 
49. St Clair RM, Emerson SE, D'Elia KP, Weir ME, Schmoker AM, Ebert AM & Ballif 
BA (2018) Fyn-dependent phosphorylation of PlexinA1 and PlexinA2 at conserved 
tyrosines is essential for zebrafish eye development. Febs J 285, 72-86, doi: 
10.1111/febs.14313. 
50. Cheerathodi M, Vincent JJ & Ballif BA (2015) Quantitative comparison of CrkL-
SH3 binding proteins from embryonic murine brain and liver: Implications for 
developmental signaling and the quantification of protein species variants in 
bottom-up proteomics. J Proteomics 125, 104-111, doi: 
10.1016/j.jprot.2015.04.033. 
51. Sheehe JL, Bonev AD, Schmoker AM, Ballif BA, Nelson MT, Moon TM & 
Dostmann WR (2018) Oxidation of cysteine 117 stimulates constitutive activation 
of the type Ialpha cGMP-dependent protein kinase. J Biol Chem 293, 16791-16802, 
doi: 10.1074/jbc.RA118.004363. 
52. Steentoft C, Vakhrushev SY, Joshi HJ, Kong Y, Vester-Christensen MB, 
Schjoldager KT, Lavrsen K, Dabelsteen S, Pedersen NB, Marcos-Silva L, et al. 
 123 
(2013) Precision mapping of the human O-GalNAc glycoproteome through 
SimpleCell technology. Embo J 32, 1478-1488, doi: 10.1038/emboj.2013.79. 
53. Chauhan JS, Rao A & Raghava GP (2013) In silico platform for prediction of N-, 
O- and C-glycosites in eukaryotic protein sequences. PLoS One 8, e67008, doi: 
10.1371/journal.pone.0067008. 
54. Gupta R & Brunak S (2002) Prediction of glycosylation across the human proteome 
and the correlation to protein function. Pac Symp Biocomput, 310-322. 
55. de Castro E, Sigrist CJ, Gattiker A, Bulliard V, Langendijk-Genevaux PS, Gasteiger 
E, Bairoch A & Hulo N (2006) ScanProsite: detection of PROSITE signature 
matches and ProRule-associated functional and structural residues in proteins. 
Nucleic Acids Res 34, W362-365, doi: 10.1093/nar/gkl124. 
56. Gupta R, Jung, E., Brunak, S. (2004) Prediction of N-glycosylation sites in human 
proteins. http://wwwcbsdtudk/services/NetNGlyc/. 
57. Tripathi S, Pohl MO, Zhou Y, Rodriguez-Frandsen A, Wang G, Stein DA, Moulton 
HM, DeJesus P, Che J, Mulder LC, et al. (2015) Meta- and Orthogonal Integration 
of Influenza "OMICs" Data Defines a Role for UBR4 in Virus Budding. Cell Host 
Microbe 18, 723-735, doi: 10.1016/j.chom.2015.11.002. 
58. Obenauer JC, Cantley LC & Yaffe MB (2003) Scansite 2.0: Proteome-wide 
prediction of cell signaling interactions using short sequence motifs. Nucleic Acids 
Res 31, 3635-3641. 
59. Hornbeck PV, Zhang B, Murray B, Kornhauser JM, Latham V & Skrzypek E 
(2015) PhosphoSitePlus, 2014: mutations, PTMs and recalibrations. Nucleic Acids 
Res 43, D512-520, doi: 10.1093/nar/gku1267. 
60. Kimmel CB, Ballard WW, Kimmel SR, Ullmann B & Schilling TF (1995) Stages 
of embryonic development of the zebrafish. Dev Dyn 203, 253-310, doi: 
10.1002/aja.1002030302. 
 124 
3.7. Supplemental Tables and Figures 
 
 
Supplemental Table 3.1. Tryptic peptides detected for Sema6A in the conditioned 
media of Sema6A-expressing cells. This table shows the location, sequence, charge, and 
SEQUEST cross-correlation value (XCorr), a peptide confidence score, of the 17 unique 
and 41 total tryptic peptides found in the 85-110 kDa range of the conditioned media 
sample. **The non-tryptic peptide at amino acid positions 560-570 is shown that was 
identified using SEQUEST analysis with no enzyme specified. Residue modifications are 
shown as follows: # acrylamidation of cysteine, * oxidization of methionine, ^ 




Supplemental Table 3.2. Predicted O- and N-linked glycosylation sites on 
extracellular Sema6A. A. Three O-linked glycosylation prediction software programs 
(NetOGlyc, GlycoEP, and YinOYang) predicted the serines and threonines to be 
glycosylated. B. Three N-linked glycosylation prediction software programs (ExPASy 
ProSite, GlycoEP, and NetNGlyc) predicted the asparigines to be glycosylated. Those 
sites that were predicted to be glycosylated in at least two of the prediction software 
programs were considered likely to be glycosylated and indicated in the Final Sites 





Supplemental Table 3.3. Sema6A binding partners. HEK293 cells were transfected 
with expression constructs encoding full-length Myc-Sema6A. After 48 hours, cells were 
lysed and Sema6A was immunoprecipitated using α-Myc. Immune complexes were run 
on a SDS-PAGE gel and subjected to commassie staining. The entire lane was cut and 
proteins were digested with trypsin and prepared for mass spectrometry. After subtracting 
non-specific binding partners from mock-transfected cells, 373 proteins were detected to 
interact with Sema6A. Proteins are sorted by spectral count, the number of peptides that 
were detected for each protein. 
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Supplemental Table 3.4. The Binding Partners of the Soluble Sema6A Ectodomain. 
The conditioned media of HEK293 cells expressing full-length Myc-Sema6A was 
collected and soluble Sema6A was immunoprecipitated using α-Myc. Immune complexes 
were run on a SDS-PAGE gel and subjected to commassie staining. The entire lane was 
cut and proteins were digested with trypsin and prepared for mass spectrometry. After 
subtracting non-specific binding partners from collected media of mock-transfected cells, 
25 proteins were detected to interact with sSema6A. Proteins are sorted by spectral count, 




Supplemental Figure 3.1. Amino acid sequence GNTDGLGDCHN is a potential C 
terminus of the soluble Sema6A ectodomain. Conditioned media from Myc-Sema6A-
transfected HEK293 cells was collected and the soluble Sema6A ectodomain was 
purified by immunoprecipitation with ⍺-Myc. Immune complexes were subjected to 
SDS-PAGE and coomassie staining. The region of the gel corresponding to the molecular 
weight of sSema6A, 85-110 kDa, was excised, digested with trypsin and prepared for 
mass spectrometry. A SEQUEST search with no enzyme specified enabled the detection 
of a peptide indicating the potential C-terminus. The spectra (A) and predicted and 
observed b/y ion masses (B) of one representative peptide identified (3 total peptides 




Supplemental Figure 3.2. Gene Ontology Annotation and Enrichment Analysis of 
Sema6A-FL binding partners. HEK293 cells expressing Myc-Sema6A-FL were lysed 
and FL Sema6A was purified by immunoprecipitation with ⍺-Myc. Immune complexes 
were subjected to SDS-PAGE and coomassie staining. The entire lane was excised, 
digested with trypsin and prepared for mass spectrometry. A SEQUEST search identified 
peptides and proteins. Non-specific binding partners were removed by subtracting those 
proteins present in the untransfected control immunoprecipitation group. Of the 373 
binding proteins with three or more peptides identified, the top 25% were subjected to 
GO annotation analysis and enrichment analysis relative to the entire human genome via 
Metascape Software. A-B are analyses using GO Molecular Functions. B-C are analyses 
using GO Cellular Components. 
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Supplemental Figure 3.3. Gene Ontology Annotation and Enrichment Analysis of 
sSema6A-binding partners. sSema6A was purified via ⍺-Myc immunoprecipitation 
from the conditioned media of HEK293 cells expressing Sema6A-FL. Immune 
complexes were subjected to SDS-PAGE and coomassie staining. The entire lane was 
excised, digested with trypsin and prepared for mass spectrometry. A SEQUEST search 
identified peptides and proteins. Non-specific binding partners were removed by 
subtracting those proteins present in the untransfected control immunoprecipitation 
group. The 24 binding proteins identified by three or more peptides were subjected to GO 
annotation analysis and enrichment analysis relative to the entire human genome via 
Metascape Software. A-B are analyses using GO Molecular Functions. B-C are analyses 
using GO Cellular Components. 
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Supplemental Figure 3.4. CID MS/MS spectra of peptides with phosphorylated and 
unphosphorylated RXXpS site S952 found on the intracellular domain of Sema6A.  
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Supplemental Figure 3.5. CID MS/MS spectra of peptides with phosphorylated and 
unphosphorylated RXXpS site S988 found on the intracellular domain of Sema6A.  
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Supplemental Figure 3.6. CID MS/MS spectra of peptides with phosphorylated and 
unphosphorylated RXXpS site S1005 found on the intracellular domain of Sema6A.  
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Supplemental Figures 3.4-3.6. CID MS/MS spectra of peptides with phosphorylated 
and unphosphorylated RXXpS sites found on the intracellular domain of Sema6A. 
HEK293 cells expressing Myc-Sema6A were lysed and Sema6A was purified via 
immunoprecipitation with α-Myc. Immune complexes were subjected to SDS-PAGE and 
coomassie staining. The band corresponding to full-length Sema6A was excised, diced, 
digested with trypsin, and analyzed via LC-MS/MS. A SEQUEST analysis and manual 
verification of the spectra found three sites to be phosphorylated within the PKC/AGC 
kinase-preferred motif RXXS: S952 (Supplemental Figure 4), S988 (Supplemental Figure 
5), and S1005 (Supplemental Figure 6). The spectra of the phosphorylated peptides (A) 
are presented with their corresponding unphosphorylated peptides (B). A bracket (on 




CHAPTER 4: THE PLXNA DOWNSTREAM EFFECTOR PHOSPHOPROTEIN 
CRMP2 IS ESSENTIAL FOR ZEBRAFISH EYE DEVELOPMENT 
 
4.1. Abstract 
Plexins (Plxns) are a family of semaphorin (Sema) receptors that play essential 
roles in the developing nervous system and cardiovasculature as well as the activation of 
the immune response. We have previously shown that the transmembrane Sema6A and 
its PlxnA2 receptor are critical in vertebrate eye development, as morpholino-based 
knockdowns of Sema6A and PlxnA2 in zebrafish result in decreased early eye field 
cohesion, smaller eye size, and impaired retinal lamination. Yet, the molecular 
mechanisms downstream of Sema6A-PlxnA signaling are only partially understood. 
Collapsin response mediator proteins (CRMPs) are a family of microtubule-associated 
proteins that are regulated by phosphorylation initiated by Sema-Plxn signaling. Here, we 
show a novel role for Crmp2 in the development of the zebrafish visual system. Using in 
situ hybridization, we show that crmp2 mRNA is expressed in the retinal ganglion cell 
layer of the retina. Knockdown of Crmp2 results in smaller eye size, impaired optic tract 
formation, and disrupted retinal lamination. The effects of CRMPs may be mediated by 
phosphorylation on the C-terminal tail, which in turn is hypothesized to regulate 
microtubule dynamics. To test the role of CRMP2 phosphorylation, we made phospho-
mimetic and non-phosphorylatable mutants. Using the zebrafish, we show preliminary 
data characterizing the in vivo role Crmp2 phosphorylation plays in vertebrate visual 
system development. Future work will test the functional significance of Crmp2 
phosphorylation in visual system development using crmp2
-/-
 CRISPR/Cas9 zebrafish. 
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4.2. Introduction 
 Semaphorins (Semas) are extracellular cues that play critical roles in the 
development of numerous tissues, including the nervous system and cardiovascular [1]. 
Semas are a large family of secreted and membrane-bound ligands that typically signal 
through Plexin (Plxn) receptors to mediate cellular and axonal migration [1-3]. Sema-
Plxn signaling is mediated through small GTPases and kinases that ultimately regulate 
integrin-dependent adhesion and cytoskeletal dynamics to cause growth cone collapse 
[4]. The microtubule associated protein CRMP2 (collapsin response mediator protein 2) 
is a necessary downstream effector protein of the canonical secreted Sema, Sema3A [5, 
6]. CRMP2 is a phosphoprotein that binds to tubulin and microtubules to promote 
polymerization and stabilization in vitro and in cell culture systems [7, 8]. When 
phosphorylated, CRMP2 has a lower affinity for microtubules and is thought to 
destabilize microtubules leading to growth cone collapse [8, 9]. The serine/threonine 
kinases Cdk5 and GSK3β are activated downstream of Sema3A signaling and 
subsequently phosphorylate CRMP2 [8-10]. Cdk5 phosphorylates CRMP2 at S522, 
which primes CRMP2 to be processively phosphorylated by GSK3β at T509, T514 and 
S518. These phosphorylation steps are critical for Sema3A-mediated collapse, as alanine 
mutations rendering CRMP2 unable to be phosphorylated results in dorsal root ganglion 
cells resistant to Sema3A-induced growth cone collapse [9]. 
 
 CRMP2 is expressed in the vertebrate brain, spinal cord and retina throughout 
nervous system development [5, 11, 12]. In the brain, CRMP2 is expressed in the cortex, 
hippocampus and cerebellum and in vivo studies have investigated CRMP2 function in 
 137 
cortical lamination and pyramidal cell migration [11-14]. Little is known of the in vivo 
functions of CRMP2 in non-cortical laminated regions such as the retina. CRMP2 is 
expressed in the retinal ganglion cell (RGC) layer [5, 15] and has been shown to co-
localize with microtubules in dissociated chick RGCs [16]. CRMP2 is a known 
downstream mediator of Sema3A [5, 6], which utilizes the PlxnA receptors PlxnA1-4 in 
complex with neuropilin co-receptors [17]. Similarly, the transmembrane Sema6A can 
signal through PlxnA2 and PlxnA4 [17, 18]. We have previously shown that Sema6A and 
PlxnA2 to be critical for vertebrate eye development, as anti-sense oligonucleotide-based 
knockdown of Sema6A or PlxnA2 in the zebrafish results in decreased early eye field 
cohesion, impaired retina lamination and smaller eye size [19, 20]. Therefore, we 
hypothesized that CRMP2 may play an important mediator of Sema6A-PlxnA2 signaling 
during zebrafish eye development. We show that crmp2 is expressed in the zebrafish 
retina throughout embryonic development, in similar cell layers as PlxnA2. Using an 
anti-sense oligonucleotide targeting crmp2, we herein report a novel role for Crmp2 in 
the developing zebrafish retina. We show that knockdown of Crmp2 expression results in 
smaller eye size, disrupted retinal lamination, and impaired optic tract formation. As 
phosphorylation is critical for CRMP2 functions in vitro, cell culture systems and in 
mouse cortical development [8, 9, 14], we hypothesize that CRMP2 phosphorylation 
downstream of Sema6A signaling is critical in these described novel roles. Using site-
directed mutagenesis, we mutated the Cdk5- and GSK3β- dependent residues to alanine, 
rendering them unable to be phosphorylated at these four sites (CRMP2 4A: T509A, 
T514A, S518A, S522A). Future work will investigate the function of Crmp2 
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4.3.1. Sema6A signaling molecules are expressed in the developing zebrafish retina 
 CRMP2 is expressed in the chick and zebrafish retinal ganglion cell layer and its 
expression pattern partially overlaps with PlxnA4 in the zebrafish brain and spinal cord 
[5, 15]. To recapitulate these findings and to compare the expression pattern to Sema6A 
and PlxnA2 in the retina, we performed in situ hybridization to crmp2 (Figure 4.1).  At 
48 hours post fertilization (hpf), Crmp2 is expressed in the RGC layer which is 
maintained at 72 hpf, where it is also expressed in the inner nuclear layer (INL) which 
includes bipolar cell bodies (Figure 4.1C, F). We have previously reported the retina 
expression patterns of Sema6A and PlxnA2 [21, 22]. At 48 and 72 hpf, Sema6A is 
expressed in the RGC layer (Figure 4.1A, D). PlxnA2 is expressed primarily in the INL 
in addition to lower expression in the RGC layer (Figure 4.1B, E). Comparing the 
expression patterns indicates the PlxnA2 and Crmp2 have overlapping expression and 
Sema6A is expressed in adjacent cells. This suggests that Crmp2 may be downstream of 
PlxnA2 and involved in Sema6A-mediated functions in eye development. 
 
 To further determine the expression pattern of crmp2 throughout zebrafish 
embryonic development, in situ hybridization was conducted at the 18 somite (18 hpf), 
24 hpf, 36 hpf, 48 hpf, 60 hpf and 72 hpf stages (Figure 4.2). Crmp2 mRNA expression 
was observed in the brain and spinal cord throughout nervous system development.  
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Figure 4.1. Sema6A signaling molecules are expressed during zebrafish visual 
system development. In situ hybridization using anti-sense probes targeting Sema6A (A, 
D), PlxnA2 (B, E), and Crmp2 (C, F) mRNA at 48 hours post fertilization (hpf) (A-C) 
and 72 hpf (D-F) representing mid-late embryonic development. Zebrafish were fixed 
and embedded for sectioning. The transverse sections illustrated are at or near the center 
of the eye, where the optic tract leaves the retina. While mRNA-specific staining occurs, 
all three transcripts are expressed in the developing retina, specifically in the retinal 
ganglion cell layer (RGC) and inner nuclear layer (INL). TeO: optic tectum; DT: dorsal 
thalamus. The Sema6A and PlxnA2 figures (A, D, E) are re-printed with permission from 
Gene Expression Patterns Journal (Elsevier Publishing) from Ebert et al. (2012) under 
license number 4532031503659 and from Emerson et al. (2017) under license number 
4532040354318, respectively.  
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Figure 4.2. CRMP2 is highly expressed in the cortex and retina throughout 
development. In situ hybridization using an anti-sense oligonucleotide crmp2 targeted 
probe shows crmp2 mRNA expression in zebrafish throughout embryonic development, 
at the 18 somite stage (A), 24 hpf (B), 36 hpf (C), 48 hpf (D), 60 hpf (E), and 72 hpf (F) 
stages. Lateral views (A-F) and dorsal views (A’-F’) of whole-mount in situs are shown. 
Crmp2 is highly expressed in the nervous system, including the forebrain (FBr), midbrain 
(MB), hindbrain (HB), ear (Ea) and Rohan Beard neurons (RBN). Transverse sections 
(C”-F”) of the retina show specific staining in the retinal ganglion cell layer (RGC) and 
inner nuclear layer (INL). 
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Specific staining was seen in the developing forebrain (FBr), ear (Ea) and Rohan Beard 
neurons (RBN), which are early sensory neurons of the spinal cord, at the 18 somite and  
24 hpf stages (Figure 4.2A-B’). Crmp2 expression becomes more discreet at 36 hpf 
(Figure 4.2C-C”), with visible staining in the neural retina by 48 hpf and remaining 
throughout retina development until 72 hpf (Figure 4.2D-F’). Transverse sections show 
that crmp2 retina expression is confined to the RGC and INL layers (Figure 4.2D”-F”). 
 
4.3.2. Crmp2 is necessary for zebrafish eye size 
 As Sema6A and PlxnA2 are necessary for zebrafish eye size [20], we first asked 
the question if Crmp2 has a similar role. As an initial assessment of Crmp2 function in 
the zebrafish visual system, we visualized gross morphological changes upon knockdown 
of endogenous Crmp2 expression. We injected increasing doses of a splice-blocking anti-
sense oligonucleotide (MO) targeting crmp2 at the one-cell stage of TL or AB zebrafish 
(Figure 4.3A, left). To verify crmp2 knockdown efficiency, RNA was isolated from 
uninjected (UIC) or MO embryos at 24 hpf and a cDNA library was made using RT-
PCR. Primers recognizing mature crmp2 mRNA were used for semi-quantitative analysis 
of knockdown efficiency (Figure 4.3A, right). Zebrafish were developmentally staged at 
72 hpf and eye size was measured, normalized to head size. Normalized eye size 
decreased in a dose-dependent manner (Figure 4.3B-C). To determine if this phenotype 
occurs due to a general developmental delay, UIC and crmp2 morphant embryos were 
developmentally staged at 5 days post fertilization (dpf) and normalized eye size was 
measured. At 5 dpf, crmp2 morphant embryos still have a significantly smaller eye size  
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Figure 4.3. Crmp2 is necessary for zebrafish eye size. A. Zebrafish were injected at the 
one-cell stage with varying amounts of crmp2 morpholino (MO). B. Endogenous 
knockdown occurs via blocking intron 1 splicing, thus removing exon 2 and encoding for 
a truncated protein. C. The efficiency of endogenous crmp2 knockdown was determined 
by detecting mature crmp2 mRNA levels using semi-quantitative RT-PCR. D. Eye size 
was measured at 72 hpf and quantified by normalizing eye size to head size in two 
independent experiments, quantified in E. Brightfield images are of representative 
embryos from each group. The black circle overlay shows the relative eye size of an 
uninjected control (UIC) embryo. UIC = 63 n, 2 ng MO = 40 n, 4 ng MO = 54 n, 6 ng 
MO = 56 n. ***p = 0.0003. ****p < 0.0001. 
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(Figure 4.4A-B) suggesting that the observed decreased eye size is not due to a 
developmental delay. 
 
4.3.3. Crmp2 is necessary for retina lamination 
As Crmp2 is necessary for proper cortical lamination [13, 14], and we observed 
smaller eye size in crmp2 morphants, we hypothesized that Crmp2 may play a role in 
non-cortical lamination, such as in the retina. Increasing doses of crmp2 MO were 
injected at the one-cell stage. Embryos were developmentally staged at 72 hpf, fixed, 
embedded and sectioned transversely through the retina. The cells of the retina were 
visualized using hemotoxylin and eosin (H & E) staining, which showed retinal 
lamination defects in a dose-dependent manner as well as a decrease in retina area at 
higher doses of MO (Figure 4.5A-C). The retinal abnormalities in crmp2 morphants 
appeared to be due to a lack of the inner and outer plexiform layers as evident in the H & 
E staining. Quantifying the number of retina layers using the plexiform layers as 
boundaries showed that higher doses of crmp2 MO results in less retina layers due to 
weakened or absent inner and outer plexiform layers (Figure 4.5B). Morpholinos have 
been shown to have off-target effects by activating p53-mediated apoptosis [23]. To 
ensure that the crmp2 MO does not non-specifically activate p53, the highest dose of 
crmp2 MO was co-injected with a p53-targeted MO. Although more variable, co-
injecting the p53 MO does not fully rescue the crmp2 MO-induced defect in retina layers, 
suggesting that the non-specific p53 activation plays little role in eye size (Figure 4.5B). 




Figure 4.4. Impaired retinal development by decreasing crmp2 expression is not due 
to a developmental delay. Zebrafish were injected with 8 ng crmp2 morpholino (MO) at 
the one-cell stage. A. Brightfield images of representative embryos at 5 days post 
fertilization (dpf). B. Eye size was quantified and normalized to head size in two 
independent experiments. UIC = 34 n, MO = 30 n. p <0.0001. 
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To qualitatively investigate the specific retina cell layers, we repeated the 
experiment using Spectrum of Fates (Sofa1) transgenic zebrafish which have RFP+ 
retinal ganglion cells (RGCs), GFP+ amacrine and horizontal cells and CYP+ bipolar 
cells and photoreceptors [24]. At higher doses of MO, photoreceptors and horizontal cells 
were absent while the RGC layer appeared thinner (Figure 4.5D-E).  
 
4.3.4. Crmp2 is critical for optic tract development 
 With a thinner RGC layer of crmp2 morphant Sofa1 embryos, we asked whether 
or not the optic tract was impaired when Crmp2 is decreased. We repeated the 
experiment using isl2b:GFP zebrafish, which expresses GFP in RGC cell bodies and 
axons. At 72 hpf, the RGC layer and optic tract was impaired with increasing doses of 
crmp2 MO, as shown by confocal Z-stacks of a lateral view of the eye (Figure 4.6A). 
Qualitatively, crmp2 morphants appeared to have thinner GFP+ RGC layers, compared to 
UIC (Figure 4.6A). A small sample size rendered it difficult to quantify the thickness of 
the RGC layer. Crmp2 knockdown also resulted in a weakened optic tract, as visualized 
using isl2b:GFP zebrafish (Figure 4.6A-B). To account for fluorescent variability, the 
fluorescent optic tract intensity was normalized to the cranial ganglia intensity. 
 
4.3.5. Exogenous Crmp2 WT mRNA does not rescue the crmp2 morphant eye size 
phenotype 
 We next sought to investigate the in vivo mechanism of Crmp2 in zebrafish eye 
development. CRMPs are phosphoproteins regulated by the serine/threonine kinases 
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Figure 4.5. Crmp2 is necessary for proper retinal lamination.  Zebrafish were 
injected with an anti-sense oligonucleotide (MO) at the one-cell stage to knockdown 
endogenous Crmp2 expression. A. 72 hours post fertilization, 6 ng MO-injected zebrafish 
were fixed, embedded in resin, and sectioned transversely through the retina. 
Hemotoxylin and eosin (H & E) staining show retinal lamination defects in crmp2 
morphant zebrafish. B. The number of retina layers was quantified by using the eosin-
positive inner and outer plexiform layers (IPL, OPL) to demarcate the nuclear layers. 
UIC vs 4 ng, p < 0.0002; UIC vs. 8 ng, p < 0.0001; UIC vs 8 ng+p53 MO, p < 0.0001; 8 
ng vs 8 ng+p53 MO, p < 0.008. UIC = 12 n, 2 ng = 12 n, 4 ng = 13 n, 8 ng = 11, 8 
ng+p53 MO = 13 n. C. The retina area was measured from the transverse sections and 
normalized to the mean UIC area. UIC vs 8 ng, p < 0.04. UIC = 10 n, 2 ng = 12 n, 4 ng = 
12 n, 8 ng = 11, 8 ng+p53 MO = 11 n. D-E. Further analysis of individual retinal cell 
types was observed using the Spectrum of Fates (Sofa1) zebrafish transgenic line. D. A 
schematic representing an uninjected control Sofa1 zebrafish retina at 72 hpf. E. 
Increasing doses of crmp2 MO result in impaired retinal ganglion cells (Ath5 marker), 




Figure 4.6. Crmp2 is critical for the proper development of the optic tract. 
Transgenic isl2b:GFP zebrafish, which express GFP in retinal ganglion cell (RGC) 
bodies and axons, were injected with varying amounts of crmp2 morpholino (MO) at the 
one-cell stage to knockdown endogenous Crmp2 expression. A. At 72 hours post 
fertilization (hpf), zebrafish were anesthetized and the RGC layer and optic tract was 
visualized using confocal z-stack imaging. At 4-8 ng MO, the RGC layer appears 
qualitatively thinner and the optic tract (OT) is impaired as measured by the optic tract 
fluorescent intensity normalized to the cranial ganglia (CG) intensity, quantified in B. 
UIC = 2 n; 2 ng = 4 n; 6 ng = 2 n; 8 ng = 3 n; 8 ng+p53 MO =4 n. UIC vs 4 ng, p < 
0.009. UIC vs 8 ng, p < 0.02. 
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Cdk5 and GSK3, which are known to be activated downstream of Sema3A [8, 9]. Most 
CRMP phosphorylation studies have been conducted in cell culture or explant studies 
using Sema3A, while the S522 phosphorylation event has been studied in mouse cortical 
development [14]. To investigate whether or not Crmp2 phosphorylation is critical for 
Crmp2-mediated functions in zebrafish retina development, we mutated the four residues 
that are phosphorylated by Cdk5 and GSK3 to alanines using site-directed mutagenesis 
in the rat CRMP2 sequence: T509A, T514A, S518A and S522A (CRMP2 4A). 100 pg of 
rat CRMP2 WT or 4A constructs were co-injected into zebrafish embryos with 4 ng 
crmp2 MO at the one-cell stage. Normalized eye size was measured at 72 hpf and neither 
CRMP2 WT nor 4A rat mRNA constructs were able to rescue crmp2 MO-induced smaller 
eye size (Figure 4.7A). To ensure that the mRNA was not contributing to this phenotype, 
eye size was measured for 72 hpf embryos injected with WT or 4A alone and we observed 
no difference to UIC (Figure 4.7A).  
 
As a control, WT mRNA should be able to rescue endogenous RNA knockdowns 
[25]. Although rat CRMP2 is 90% identical to zebrafish, the small difference may have 
caused the rat CRMP2 mRNA to be unable to rescue. Therefore, zebrafish crmp2 WT 
DNA was amplified from embryonic cDNA using RT-PCR and cloned into TOPO II 
vector. mRNA was produced from this plasmid and co-injected with crmp2 MO at the 
one-cell stage. The zebrafish crmp2 WT mRNA was unable to rescue the crmp2 
morphant phenotype (Figure 4.7B-C). As we are unable to rescue the eye size phenotype 
with zebrafish crmp2 mRNA, we cannot at this time make any conclusions about the 
necessity of Crmp2 phosphorylation in eye development. Future work will address the  
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Figure 4.7. Overexpressing Crmp2 WT mRNA does not rescue the crmp2 morphant 
phenotype. One-cell-stage zebrafish embryos were co-injected with 4-6 ng crmp2 MO 
and 100 pg MO-resistant Crmp2 mRNA. Eye size phenotype was observed and 
quantified at 72 hours post fertilization (hpf). A. Co-injecting rat, Rattus norvegicus, 
Crmp2 wildtype (WT) mRNA constructs (90% identity to zebrafish) results in no rescue 
of crmp2 morphant eye size. Similarly, co-injecting a phospho-null Crmp2 mutant (4A) 
results in no rescue, although no mechanistic inferences can be made due to WT not 
rescuing. Eye size was normalized to head size in two independent experiments. UIC = 
60 n, MO = 33 n, MO + WT = 12, MO + 4A = 15, WT alone = 30, 4A alone = 28. p < 
0.0001. B. Co-injecting zebrafish, Danio rerio, crmp2 WT mRNA construct results in no 
rescue of crmp2 morphant eye size. Quantification of eye size was conducted in one 
independent experiment, UIC = 23 n, MO = 26 n, Rescue = 18, p < 0.0001. C. Brightfield 
images of representative embryos at 72 hpf. 
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 Here we show that Crmp2 is expressed in the RGC layer during zebrafish 
embryonic development. A comparison with Sema6A and PlxnA2 retina expression 
indicates that Crmp2 is expressed in similar cell layers to PlxnA2 in the developing 
zebrafish retina and in adjacent cell layers to Sema6A expression. This supports previous 
findings as Crmp2 has previously been shown to be expressed in the RGC layer of chick 
and zebrafish [5, 15]. Interestingly, Sema6A has been shown to be expressed in the 
mouse IPL [26, 27] in contrast to our findings of RGC expression. We show that Sema6A 
is most highly expressed in the RGC layer while PlxnA2 and Crmp2 are expressed in the 
RGC and INL. The PlxnA2- and Crmp2-expressing INL cells could be repelled from 
ectopically innervating the RGC layer through Sema6A signaling. Furthermore, CRMP2 
plays critical roles in initiating axon formation in hippocampal neurons and dendritic 
patterning in cortical neurons [13, 14, 28, 29]. Early Crmp2 RGC expression could 
initiate axon outgrowth while late Crmp2 expression could function to properly guide 
RGC processes. Indeed, we also report that Crmp2 functions in proper optic tract 
development. However, a weaker optic tract may be due to a corresponding thinning in 
the RGC layer. Increasing our sample size and performing RGC cell counts would allow 
us to distinguish if the weak optic tract is due to a decrease in RGC number or due to the 
impaired guidance of RGC axons. Furthermore, observing the process formation and 
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guidance of dissociated UIC or crmp2 morphant RGCs in culture would give better 
insight into the cellular effects of Crmp2 on RGC cellular migration. 
 
 We also show that knockdown of Crmp2 in the zebrafish results in smaller eye 
size and impaired retina lamination. The lamination defects are phenotypically similar to 
PlxnA2 morphants [19], suggesting that Crmp2 could be mediating PlxnA2 signaling. 
While Sema-CRMP2 studies have used the canonical secreted Sema3A, both Sema3A 
and Sema6A share PlxnA2 as a receptor. Therefore it is likely that the downstream 
mechanisms of Sema3A and Sema6A are conserved and CRMP2 could be an important 
mediator of Sema6A signaling. CRMP2 mediates the lamination and dendritic 
morphology of cortical neurons [13, 14]. As crmp2 morphants have impaired lamination, 
particularly in the inner and outer plexiform layers in which dendritic fields reside, our 
work gives evidence that Crmp2 has a similar function in the retina. Transgenic lines, 
such as the Zebrabow which enables individual cells and their processes to be 
distinguished [30], or immunofluorescent studies using synaptic markers would allow the 
observation of dendrite morphology in the retina. 
 
 Interestingly, the p53 MO control rescued the crmp2-MO induced decrease in 
retina area. While it is possible that the crmp2 MO has off-target effects, it is unlikely as 
co-injecting the p53 MO did not rescue the retina lamination phenotype. In combination 
with the eye size phenotype, this could point to Crmp2 having functions in proliferation 
or apoptosis. Future experiments will investigate if the small eye size phenotype is due to 
a decrease in proliferation or an increase in apoptosis.  
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Initial analysis of the molecular mechanisms governing in vivo Crmp2 function 
showed that MO-based experiments cannot determine the role of Crmp2 phosphorylation 
in our system. This could be due to a number of reasons. First, this could be due to 
technical or experimental reasons. The expression levels of endogenous and exogenous 
mRNA may be crucial in governing Crmp2-mediated phenotypes. Optimizing the amount 
of injected MO and mRNA may enable WT RNA to rescue. Furthermore, Crmp2 may be 
tightly spatiotemporally regulated and perhaps driving Crmp2 expression in a tissue-
specific manner, for example under the isl2b promoter, may overcome this obstacle. 
Similarly, photo-MOs could be used to precisely control temporal and spatial gene 
expression [31]. Lastly, CRMPs form heterotetramers which may introduce a biological 
challenge to using MOs. The crmp2 MO splices out exon 2, yet this is predicted to 
produce a truncated protein as exon 3 is still in frame (Figure 4.3A) and RT-PCR analysis 
could verify this. If so, the observed phenotypes could be due to a dominant negative 
instead of a knockdown. It is possible that exogenous zebrafish crmp2 WT RNA is 
therefore unable to rescue the functional consequences of the dominant negative protein. 
These potential problems could be addressed by using the CRISPR/Cas9 system to 
produce crmp2
-/-
 zebrafish to avoid the technical challenges introduced by MO use in our 
system. Future work will use crmp2
-/-
 to study the mechanisms of Crmp2 phosphorylation 
in zebrafish visual system development. 
 
4.5. Materials and Methods 
 
4.5.1. Zebrafish husbandry 
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 Zebrafish embryos were raised at 28.5 ᴼC and developmentally staged as 
previously described [32]. Embryos were raised in E3 solution (5 mM NaCl, 0.17 mM 
KCl, 0.50 mM CaCl2, 8.42 mM MgCl2) with 0.0001% methylene blue. For fluorescent 
analyses, pigmentation was blocked by addition of 0.003% phenylthiourea (PTU) at 24 
hours post fertilization (hpf). The following zebrafish lines were used in this study: 
isl2b:GFP, Sofa1, TL (Tüpfel long fin) and AB. The isl2b:GFP and Sofa1 lines were 
generously provided by Chi-Bin Chien (University of Utah, Salt Lake City, Utah, USA) 
and William Harris (University of Cambridge, Cambridge, UK) respectively. The TL and 
AB lines were purchased from the Zebrafish International Resource Center (ZIRC, 
Eugene, OR, USA). All procedures were approved by the University of Vermont 
Institutional Animal Care and Use Committee (IACUC), protocol number 15-031. 
 
4.5.2. In situ hybridization 
 Zebrafish embryos were developmentally staged at 48 or 72 hpf, fixed in 4% 
paraformaldehyde overnight at 4 ᴼC and stored at -20 ᴼC in 100% methanol until use. 
Whole-mount in situ hybridization was performed using digoxigenin-labeled antisense 
RNA probes as previously described [33]. The CRMP2 (accession #: NM_001020517) 
antisense probe was generated from the Crmp2 zebrafish plasmid pCMVSport6-crmp2 
(IMAGE clone 7062180). The Sema6A and PlxnA2 antisense probes are published and 
previously described [21, 22]. For whole-mount in situ visualization, embryos were 
embedded in 4% methyl cellulose and imaged using a Nikon SMZ800 dissecting light 
microscope at 6x magnification. Embryos were embedded in resin using the JB4 
Embedding Kit (Polysciences, Warrington, PA, USA) and sectioned on a Leica RM2265 
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microtome at 20 µm. Sections were imaged on an Olympus iX71 microscope at 20x 
magnification. Figures were compiled using Adobe Photoshop CS6, where image 
brightness was optimized. 
 
4.5.3. CRMP2 morpholino 
 Endogenous CRMP2 was knocked down using antisense morpholino (MO) 
oligomers (Gene Tools, Philomath, OR, USA) targeting the intron 1-exon 2 boundary. 
Knockdown efficiency was verified by semi-quantitative RT-PCR using the following 
forward and reverse primers: TAGATGTCGGCACAGAACGA and 
TCCTCCATTCGCTTCTGAAT. 
 
4.5.4. mRNA rescue experiments 
 Rat (Rattus norvegicus) CRMP2 RNA was amplified from the pcDNA3.1-
CRMP2 construct generously provided by Alyson Fournier (McGill University, 
Montreal, QC, CA). The CRMP2 4A construct was generated using site-directed 
mutagenesis to create serine to alanine or threonine to alanine point mutations at the 
following residues: T509, T514, S518 and S522. DNA was linearized using Stu1 (New 
England Biolabs, Ipswich, MA, USA) followed by in vitro RNA production using T7 
polymerase with the mMessage mMachine T7 kit (Invitrogen, Carlsbad, CA, USA). 
 
 Zebrafish (Danio rerio) CRMP2 WT RNA was made by amplifying CRMP2 
from 48 hpf cDNA from the forward primer ATGTCTGGCTATCAGGGCAAG and the 
reverse primer TTAGCCCAGGCTGGTGATG using Q5 high-fidelity DNA polymerase 
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(New England Biolabs). The zebrafish CRMP2 PCR product was cloned into pCR-Blunt 
II Topo using the Zero Blunt Topo PCR cloning kit (Invitrogen). DNA was linearized 
using BamH1 (New England Biolabs) followed by in vitro RNA production using the 
mMessage mMachine T7 kit. 
 
 RNA was stored in single-use aliquots at -80 C until immediately before use. 
100 pg RNA was injected or co-injected with Crmp2 MO at the one-cell stage. RNA was 
injected directly into the cell, while the MO was injected into the yolk. 
 
4.5.5. Eye size, retinal lamination, and optic tract quantification 
 Zebrafish were developmentally staged at 72 hpf [32], when embryonic 
development is complete. To measure eye size, zebrafish were first imaged using a Nikon 
SMZ800 dissecting light microscope at 6x magnification. Eye diameter was measured 
using SPOT software version 5.2 (Sterling Heights, MI, USA). To account for embryo 
variability, eye diameter was normalized to head diameter as previously described: as 
measured by the length between the anterior tip of the head and the posterior otic placode 
[20, 34].  
 
 To measure retinal lamination, 72 hpf UIC or Crmp2 MO zebrafish were fixed 
in 4% paraformaldehyde overnight and dehydrated in 100% ethanol. Zebrafish were 
embedded in resin as described above and sectioned on a Leica RM2265 microtome at 8 
µm. Sections were stained with hematoxylin, rinsed and stained with eosin. Sections were 
imaged on an Olympus iX71 microscope at 20x magnification. Lamination was 
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quantified by counting the number of layers present as defined by the eosin-predominant 
inner and outer plexiform layers. Retina area was also measured using SPOT software, 
excluding the lens and retinal pigmented epithelial regions. Figures were compiled using 
Adobe Photoshop CS6, where image brightness was optimized. To further observe 
specific retina cell layers, the Sofa1 transgenic line was used for a Crmp2 morpholino 
dose response experiment. The Sofa1 line uses fluorescent markers to visualize the 
photoreceptor, horizontal, bipolar, amacrine and retinal ganglion cell layers [24]. 
 
 To visualize the optic tract, the isl2b:GFP transgenic line was used, which have 
GFP+ retinal ganglion cell bodies and processes. At 72 hpf, UIC or Crmp2 MO zebrafish 
were embedded in 4% methyl cellulose and lateral view Z-stack images were taken at 
20x magnification using a Nikon Eclipse Ti inverted confocal microscope (Nikon 
Instruments, Melville, NY, USA). Raw image files were compressed and converted to 
TIFs using ImageJ version 1.48a (National Institutes of Health, Bethesda, MA, USA) and 
color was optimized in Adobe Photoshop. The optic tract was quantified on raw images 
in Photoshop by measuring the intensity of the optic tract region. To account for 
fluorescent variability among individual zebrafish, the optic tract intensity value was 
normalized to the cranial ganglion intensity for each zebrafish. A one-way ANOVA and 
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CHAPTER 5: BROADER IMPACTS AND FUTURE DIRECTIONS 
 
5.1. Sema6A-PlxnA signaling in vertebrate eye development 
The reports described in this dissertation aimed to elucidate the functionally 
significant molecular mechanisms of Sema6A signaling in vertebrate eye development. 
While Sema6A is critical for the development of the nervous system and 
cardiovasculature, the mechanisms initiating signal transduction remain poorly 
understood. We show that the tyrosine kinase Fyn induces the phosphorylation of PlxnA1 
and PlxnA2 receptors at two specific tyrosine residues and that this phosphorylation 
event is critical for zebrafish eye development. Furthermore, some transmembrane and 
membrane-bound Semas can produce functional soluble ectodomains and we show here, 
for the first time, that the Sema6A ectodomain is naturally released from the cell surface. 
This soluble Sema6A, sSema6A, can be regulated through PKC activation and is 
biologically active in maintaining eye field cohesion in zebrafish early eye explants. 
Lastly, we show that the microtubule associated protein Crmp2, which is known to be 
downstream of Sema-Plxn signaling, is critical in zebrafish eye development by 
regulating retinal lamination, optic tract formation and overall eye size.  
 
5.1.1. Broader Impacts 
 In summary, we have identified and characterized novel mechanisms in 
Sema6A-PlxnA signaling that are critical in governing vertebrate visual system 
development. Semas and Plxns are highly conserved molecules that play roles in the 
development and homeostasis of numerous tissues including the nervous system, 
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cardiovasculature and immune system, in addition to bone and organ development [1, 2]. 
Thus, the functionally-significant mechanisms of Sema-Plxn signaling we have identified 
in the visual system may be relevant to other developmental contexts.  
 
 We have shown that Fyn-mediated PlxnA1 and PlxnA2 phosphorylation occurs 
at two critical tyrosines. Multiple Sema molecules can bind to PlxnA1 and PlxnA2 
including the Sema3, Sema5, and Sema6 classes (see Figure 1.2). Interestingly, Sema6A 
is not known to bind PlxnA1, while Sema6B and Sema6D can signal through the PlxnA1 
receptor [3]. Sema6B is expressed in the spinal cord in addition the adult brain, heart and 
lungs [4] while Sema6D-PlxnA1 signaling mediates heart development [5]. Sema5A and 
5B play roles in the nervous system, vasculature and immune system, with PlxnA1 as one 
of their receptors [5, 6]. Many Sema3 class members can interact with PlxnA1 and 
PlxnA2, which have important roles in the nervous and vasculature systems as well as 
mediating immune responses [7]. Thus, it is possible that PlxnA1/A2 phosphorylation 
may be a conserved mechanism that is crucial for transducing signals from numerous 
Sema classes in multiple systems.  
 
 An alignment of the human Plxn proteins indicates that the PlxnA2 Y1605 and 
Y1677 sites are conserved in the PlxnA family and in all eight Plxn molecules, 
respectively (Figure 5.1). The crystal structure of the PlxnA intracellular domain [8] may 
give insights into the potential reasons for this. The functionally-critical Plxn GAP 
domain is conserved in all Plxns and consists of two split GAP domains surrounding a 
Rho GTPase-binding domain (RBD) [8, 9]. The Y1677 site resides in the C-terminal split  
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Figure 5.1. The Fyn-mediated PlxnA2 phosphorylated tyrosine residues are 
conserved in the Plxn family. An alignment of the human Plxn proteins indicates that 
the PlxnA2 Y1605 site is conserved in the PlxnA class while the PlxnA2 Y1677 site is 
highly conserved in all Plxn proteins. The numbers correspond to the PlxnA2 protein. 
The sequence information was acquired from NCBI and aligned using MUSCLE 
Sequence Alignment (EMBL-EBI). The protein reference numbers are as follows: 
PlxnA1: NP_115618.3; PlxnA2: NP_079455.3; PlxnA3: NP_059984.3; PlxnA4: 
NP_065962.1; PlxnB1: XP_016962119.1; PlxnB2: NP_036533.2; PlxnB3: 
NP_005384.2; PlxnC1: NP_005752.1; PlxnD1: NP_055918.2. 
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GAP domain (C2) while the Y1605 site in is the C-terminal linker region between the 
RBD and C2 [8]. Indeed, Y1677 is in a highly conserved region (Figure 5.1) and 
phosphorylation of this residue may be critical in regulating Plxn GAP activity. Perhaps 
the PlxnA class-specific Y1605 is involved in recruiting specific effector proteins. 
Intriguingly, Fyn mediates the phosphorylation of both Y1605 and Y1677 at equal 
preference (see Figure 2.5B). This could suggest that Fyn plays a general role for all 
Plxns while also mediating PlxnA-specific signaling functions. 
 
 We have also shown that the transmembrane Sema6A produces a naturally-
released and PKC-induced soluble ectodomain that functions in early zebrafish eye 
development. This report suggests that ectodomain release is a phenomenon common to 
all vertebrate transmembrane and membrane-bound Sema classes. Future work will 
determine if this is common to the other three Sema6 class members. Indeed, a large-
scale protease screen for βACE1 substrates identified Sema6A and Sema6D although 
βACE1-mediated cleavage of Sema6A and Sema6D has not been validated [10]. As the 
Sema6 class members are closely related, this could point to a conserved mechanism and 
may suggest that cleavage in this region is common to the Sema6 proteins. As Sema6 
class members are expressed throughout the body in numerous tissues, this could have 
broad implications with Sema6 acting through cell-contact or paracrine and autocrine 
manners.  
 
 Through discovering a soluble functional form of Sema6A, we have also 
characterized a useful tool to study Sema6A-mediated signaling mechanisms. Most of the 
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molecular mechanisms have been elucidated by stimulating cells with the secreted 
Sema3A, while transmembrane and GPI-anchored Sema mechanisms have been 
addressed by using FC chimeric forms. This allows for the dimerization and secretion of 
Semas yet may have less biological relevance. With the addition of this report, studies 
can now be performed using concentrated and purified naturally-released sSema6A to 
investigate Sema6A-mediated mechanisms. For example, cell culture systems have 
shown that CRMP2 phosphorylation occurs upon Sema3A stimulation [11, 12]. 









 mice show no additive 
phenotypic effects [13]. Using sSema6A can be one way to determine if these proteins 
are also regulated by Sema6A binding. 
 
 Finally, we have shown that the microtubule associated protein Crmp2 has a 
novel role in governing zebrafish eye development. We report that Crmp2 functions in 
retinal lamination, optic tract formation and eye size. This study indicates that CRMP2 
has in vivo roles outside of the traditionally studied cortex and opens the field to 
investigate the molecular mechanisms governing CRMP2-mediated functions in the 
vertebrate visual system.  
 
In addition to having critical roles in development, Sema signaling molecules are 
also implicated in pathogenesis and thus there is clinical significance in determining the 
mechanisms of Sema-Plxn signal transduction. Sema signaling is crucial for axonal 
guidance and may play a role in axonal guidance deficits such as congenital synkinesis 
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and congenital cranial dysinnervation disorders [14]. Many Sema molecules are 
implicated in neurodegeneration disorders, cancers and autoimmune disorders [6, 15-17]. 
With their roles in governing endothelial migration, Sema signaling has been implicated 
in cancer metastasis by promoting the neovascularization of tumors [18]. Furthermore, 
downstream molecules of Sema signaling, including Fyn and CRMP2, are associated 
with diseases. Fyn is overexpressed or hyperactive in many cancer types, including 
glioblastomas, melanomas, and breast cancers [19]. Hyperphosphorylated CRMP2 is 
found in Alzheimer’s disease, and may contribute to early pathogenesis [20]. 
Furthermore, CRMP2 is overexpressed in neuropsychiatric disorders, such as 
schizophrenia [21, 22]. Therefore, determining the mechanisms of these proteins can give 
a better understanding of the pathogenesis of diseases and cancers, which could lead to 
the identification of possible therapeutic targets. 
 
 In conclusion, Sema-Plxn signaling is conserved and functions in numerous and 
diverse tissue development as well as in pathologic conditions. Therefore, the impacts of 
elucidating the mechanisms of Sema6A and PlxnA2 signaling in vertebrate eye 
development can be applied to multiple systems and cellular processes in healthy and 
disease states. 
 
5.1.2. Working model of Sema6A-PlxnA signaling in zebrafish eye development 
 Together, the studies described in this dissertation have elucidated molecular 
mechanisms of Sema6A-PlxnA signaling that are critical for zebrafish eye development. 
Adding these insights to the field of existing literature allows for a more comprehensive 
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working model of the regulatory mechanisms governing Sema6A-PlxnA signaling 
(Figure 5.2). This model describes the receptor proximal events and major downstream 
cellular processes that occur in forward and reverse signaling. With the discovery of 
Sema6A ectodomain release, it also illustrates one mechanism of regulating signal 
direction. 
 
 When PlxnA receptors are unbound, the extracellular and intracellular domains 
are in autoinhibitory, inactive conformations [8, 23, 24]. However, upon binding of 
transmembrane Sema6A, PlxnA receptors change conformation such that the intracellular 
Rap1 GAP domain is active and forward signaling occurs [9, 23, 24]. This leads to the 
regulation of small GTPases, which governs integrin-mediated adhesion and cytoskeleton 
regulation [25]. We have shown that Fyn phosphorylates PlxnA1 and PlxnA2 in the GAP 
domain and the RBD linker region [26], however it is currently unknown if this 
phosphorylation event mediates GAP domain activity. Furthermore, it remains to be 
determined if Fyn-induced PlxnA phosphorylation occurs upon Sema6A ligand binding. 
Numerous cellular processes are known to be regulated by Sema6A-PlxnA signaling, 
including proliferation, differentiation, apoptosis and transcription [1, 27], however the 
downstream mechanisms are not well understood. The Sema6A-PlxnA binding 
interaction also initiates reverse signaling on the Sema6A-expressing cell. The tyrosine 
kinase Abl is recruited to the intracellular domain of Sema6A upon PlxnA binding and 
this interaction is necessary for PlxnA2-induced cellular collapse [28]. Ena/VASP 
proteins including Mena and EVL also interact with the intracellular domain of Sema6A 
[29] and could promote cellular collapse by regulating adhesion and migration. 
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Figure 5.2. Working Model of Sema6A-PlxnA Signaling in Zebrafish Eye 
Development. This schematic illustrates various signaling paradigms resulting from the 
Sema6A-PlxnA interaction. When Sema6A does not bind to PlxnA receptors, PlxnA is in 
an autoinhibitory conformation and forward signaling does not occur. When 
transmembrane Sema6A binds to PlxnA, bidirectional signal can occur, with forward 
signaling resulting in cellular processes such as integrin and cytoskeletal regulation, 
transcriptional regulation, as well as proliferation, differentiation and apoptosis. Less is 
known about the processes governed by reverse signaling, however, it is hypothesized 
that integrins and cytoskeletal dynamics are regulated. The ectodomain of Sema6A can 
be naturally released or via PKC activation, resulting in a functional soluble product, 
sSema6A. This would enable forward signaling with the absence of reverse signaling and 
represents one mechanism to regulate the direction of signaling. See Section 5.1.2. for 
more detailed information. 
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While transmembrane Sema6A binding to PlxnA can initiate bidirectional 
signaling, our discovery of a functional soluble Sema6A ectodomain proposes a 
mechanism to regulate the direction of signaling. We have shown that sSema6A can be 
produced naturally and through PKC activation, in a Mek/Erk-independent manner. This 
is hypothesized to activate a protease which subsequently sheds the ectodomain from the 
cell surface. Ligand-dependent ectodomain release could be another mechanism of 
inhibiting reverse signaling. We have also shown that the intracellular domain of 
Sema6A is phosphorylated at numerous PKC consensus motifs, suggesting direct-PKC 
phosphorylation and could present a mechanism of conferring protease resistance to 
Sema6A. In vivo experiments have begun to elucidate the functional importance of 
forward and reverse signaling during zebrafish eye development. We have shown that 
sSema6A is sufficient to maintain early eye field cohesion, although the specific PlxnA 
receptor transducing this signal remains unknown. Unpublished data from our lab also 
indicates that a Sema6A-Δcyt mutant, lacking the intracellular domain, rescues the 
Sema6A-morphant-induced decrease in retinal precursor cell proliferation (data from 
Caroline Dumas). Together, these results provide insight into the processes that are 
mediated by Sema6A-PlxnA forward signaling, including eye field cohesion and retinal 
precursor proliferation. Future investigations will determine if there are specific 
processes governed by reverse or bidirectional signaling, such as retinal lamination and 
optic tract formation. 
 
5.1.3. Sema6A and PlxnA2 have closely related family members to govern 
numerous biological processes 
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 While this dissertation has primarily focused on Sema6A-PlxnA2 signaling, the 
high conservation among the large Sema and Plxn families, as well as the high 
promiscuity between Sema and Plxn classes, suggests that the mechanisms we have 
elucidated may be conserved to regulate cellular processes in numerous systems. For 
instance, PlxnA2 is a receptor for Sema3, Sema5 and Sema6 class members, while the 
Sema6 molecules bind to PlxnA class members [3]. As these Sema classes regulate 
nervous system, cardiovascular and bone development, as well as immune system 
activation [1, 15], elucidating PlxnA2 receptor proximal mechanisms has broad 
implications. Interestingly, both Sema and Plxn families have expanded throughout 
evolution, as there are only five and two invertebrate Sema and Plxn molecules, 
respectively, and 21 and nine vertebrate Sema and Plxn molecules, respectively [30]. 
Determining if the invertebrate molecules have similar regulatory mechanisms, such as 
Plex-A phosphorylation and Sema-1 ectodomain release, would give insight on when 
these mechanisms arose throughout evolution. 
 
 Through duplication and divergence, the expansion of protein families can allow 
for increases in biological complexity and substrate specificity. As invertebrate Sema-
Plxn signaling is essential for neuronal and axonal guidance in nervous system 
development, vertebrate Sema-Plxn signaling has evolved to use similar downstream 
mechanisms to regulate cellular guidance in numerous tissues [5]. Although promiscuous, 
slight modifications in the sema domain allow for substrate specificity [31]. This would 
enable a single migrating cell to express multiple classes of receptors to be responsive to 
numerous ligands in various environments. By sequestering or inhibiting receptors, the 
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cell can spatiotemporally regulate its responsiveness to environmental signals in a rapid 
and energy efficient manner.  
 
 The addition of vertebrate co-receptors confers further specificity of Sema 
ligands. For example, PlxnA1 and PlxnA2 are both receptors for Sema3A and Sema6A, 
however, PlxnA1/A2 can only bind Sema3A in the presence of the Neuropilin (Np) co-
receptor Np1 [32, 33]. Furthermore, PlxnA2 transducing Sema3A and Sema3C signals, 
with the ligand specificity dependent on the Np expressed: Np1 allows for PlxnA2 to 
bind to Sema3A and Np2 allows for PlxnA2 to bind to Sema3C [32]. Together, this 
illustrates how the expression of specific Nps allows for the discrimination within the 
secreted Sema3 class while the presence or absence of Nps confers specificity between 
secreted and transmembrane Semas. As Nps are found only in vertebrates [5], this 
represents an additional mechanism of increasing biological complexity and substrate 
specificity of vertebrate Sema-Plxn signaling. 
 
5.1.4. Linking Sema6A, PlxnA and CRMP2 
We show that the cellular players of Sema6A-PlxnA signaling, including PlxnA2 
and Crmp2 are critical for zebrafish eye development. Although we have investigated 
these mechanisms in separate studies, pairing our results with what is currently known 
about Sema-Plxn signaling allows us to make inferences to link the molecular 
mechanisms of Sema6A, PlxnA, and CRMP2. By comparing knockdown phenotypes and 
expression profiles, we can hypothesize how these mechanisms cooperate to transduce 
Sema6A signaling. Future experiments can directly determine the link between the 
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molecular mechanisms of these cellular players by using sSema6A in biochemical 
experiments or through genetic in vivo studies.  
 
 We show that sema6A, plxnA2 and crmp2 are expressed in the developing retina. 
Specifically, sema6A is expressed in the RGC layer while plxnA2 and crmp2 are 
expressed in the retinal ganglion cells (RGC) and inner nuclear layer (INL) (see Figure 
4.1). In contrast, Sema6A has been found to be primarily expressed in the mouse INL 
layer, specifically in the ON sublayer [34, 35]. However, the expression and function of 
Sema6A and PlxnA2/A4 in the mouse retina can provide insight into the possible 
functions of Sema6A-PlxnA2 signaling in the zebrafish.  Murine Sema6A is expressed in 
the ON sublayer of the INL, repelling PlxnA4-expressing OFF bipolar cells and PlxnA2-
expressing OFF amacrine cells for proper retinal lamination [34, 35]. Sema6A-PlxnA2 
signaling may be acting similarly, with Sema6A-expressing RGCs repelling the PlxnA2- 
and Crmp2-expressing INL cells from ectopically migrating into the RGC layer. Indeed, 
qualitative analysis of Sofa1 zebrafish indicates that crmp2 morphants have an impaired 
INL (see Figure 4.5E, Ptf1a panel). 
 
We have previously shown that plxnA2 knockdown in zebrafish results in 
impaired lamination and smaller eye size [36]. Our findings indicate that crmp2 
knockdown phenocopies plxnA2 morphants. Sema6A is also expressed later in 
development, yet the role of Sema6A in late zebrafish eye development, such as retinal 
lamination, is not yet known. Similarly, Sema6A and PlxnA2 are essential in maintaining 
early eye field cohesion [27, 36]. Future experiments will also investigate if Crmp2 is 
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necessary for the early eye functions by observing crmp2 morphants or null zebrafish 
during earlier time points. The expression of CRMP2 is confined to the nervous system 
and thus it may be that Crmp2 does not play a role in early eye development before 26-28 
hpf, when neuronal differentiation begins. Indeed, crmp2 is not expressed at 36 hpf and 
in situ retina sections can determine if crmp2 is expressed at earlier time points (see 
Figure 4.2). Establishing the role of crmp2 in early eye development as well as Sema6A 
functioning during retinal lamination and optic tract formation would begin to give 
insight into the in vivo pathway of Sema6A signaling during zebrafish eye development. 
If sema6A, plxnA2 and crmp2 morphants show similar phenotypes, this could suggest that 
these molecules may be working in the same pathway. If, for example, crmp2 morphants 
do not have impaired early eye field cohesion, this would point to a Crmp2-independent 
pathway that is being regulating by Sema6A-PlxnA2 signaling. 
 
 Genetic manipulations in eye explant experiments would yield direct evidence 
of PlxnA2 and Crmp2 being involved in Sema6A-mediated functions in zebrafish eye 
development.  For example, PlxnA4 is another known Sema6A receptor and is also 
expressed during eye development, playing roles in retinal lamination [34, 35]. As 
PlxnA2 has a similar cohesion phenotype to Sema6A, it is the likely Sema6A receptor for 
this process. Future experiments can determine which PlxnA receptor is predominantly 
mediating Sema6A-dependent early eye field cohesion. Treating early eye field explants 
with sSema6A results in an increase in cohesion as measured by less ectopic cells (see 
Figure 3.5). If PlxnA2 is mediating this process, I hypothesize that sSema6A would not 
be able to maintain cohesion in PlxnA2 morphant eye explants. A similar experiment 
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using eye explants from crmp2 morphant or null zebrafish would establish the 
contribution of Crmp2 in sSema6A-mediated functions.  
 
Interestingly, we have also shown that decreasing Sema6A in zebrafish results in 
less proliferative cells in the developing retina (see Figure 1.5). At the cellular level, 
Sema signaling is known to regulate migration, differentiation and proliferation [1]. 
While all of these processes depend on cytoskeletal dynamics, it is not fully understood 
how Sema signaling governs these processes. Investigating the role of Crmp2 in the 
proliferation of retina precursor cells could give an understanding of how Sema6A 
mediates proliferation. If Sema6A influences proliferation via regulating cytoskeletal 
dynamics, decreasing Crmp2 may show a similar proliferation phenotype to Sema6A. 
However, if Sema6A is acting through a novel pathway to initiate proliferation, which 
may be the case as Crmp2 may not be expressed during this time, then Crmp2 may not be 
essential for this process. We have previously shown that the small GTPase Ras-like 11b 
is involved in Sema6A-mediated retina precursor cell proliferation [27], which could 
suggest that Sema signaling is regulating MAPK pathways. 
 
 In conclusion, we have shown that Sema6A, PlxnA2, and Crmp2 play critical 
roles in the development of zebrafish visual system. Linking this pathway in eye 
development in vivo is an important field of study moving forward. Additionally, we 
have identified functionally-significant molecular mechanisms of Sema6A and PlxnA2 in 
eye development. Future experiments can address the cellular contexts and signaling 
roles of these mechanisms. Specifically, the cellular and molecular roles of PlxnA 
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phosphorylation events in the context of Sema6A binding, the mechanisms and functions 
of Sema6A ectodomain release, and the cellular and molecular role of Crmp2 
phosphorylation in zebrafish eye development. The remaining sections of this chapter 
focus on how future experiments can address these questions. 
 
5.2. Determining the roles and contexts of PlxnA phosphorylation 
 
5.2.1. Does Fyn-mediated PlxnA phosphorylation occur upon Sema6A ligand 
binding? 
 While we have shown that PlxnA1 and PlxnA2 phosphorylation is mediated by 
Fyn, it is still not yet known whether or not this phosphorylation occurs in the context of 
Sema signaling. To address this, we can take advantage of sSema6A, the functional 
soluble ectodomain of Sema6A. Stimulating PlxnA2-expressing cells with sSema6A and 
measuring PlxnA2 tyrosine phosphorylation levels via immunoblotting will establish if 
PlxnA2 phosphorylation is occurring upon ligand binding. To further investigate this 
molecular process, we can determine if sSema6A simulation activates Fyn, if 
phosphorylation occurs at Y1605 and Y1677 and if Fyn is necessary for Sema6A-induced 
PlxnA2 phosphorylation. HEK293 cells have endogenous Fyn and pharmacological Fyn 
inhibition or the Src/Yes/Fyn-knockout cell line SYF mouse embryonic fibroblast (MEF) 
cells [37] would address if Src-family kinases mediate sSema6A-induced PlxnA2 
phosphorylation. Similar experiments could be conducted using bath application of the 
secreted Sema3A, a known ligand of the PlxnA1-NP1 and PlxnA2-NP1 receptor 
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complexes, to determine if PlxnA1 and PlxnA2 are phosphorylated upon Sema3A 
binding. 
 
5.2.2. What role does PlxnA phosphorylation play on PlxnA functioning? 
 PlxnA sequence analysis may give clues as to how phosphorylation may be 
affecting PlxnA functioning. The cytoplasmic domains of Plxns are predominantly made 
up of split GAP domains flanking a Rho GTPase-binding domain (RBD). Plxns are in an 
autoinhibitory conformation without ligand binding. Upon Sema binding as well as Rho-
family GTPase binding to the RBD, the intracellular domain of PlxnA adopts an open 
conformation that activates the GAP domain [8]. Y1677 is in the C-terminal split GAP 
domain. With this in mind, PlxnA phosphorylation could regulate the conformation and 
thus activity of the GAP domain, or recruit effector proteins for signal transduction.  
  
To test the hypothesis that PlxnA phosphorylation is necessary for Rap GAP 
activity, an in vitro Rap activity assay can be conducted. A photometrically-based assay 
was specifically designed to test Plxn-mediated Rap GAP activity [38]. When Rap 
hydrolysis occurs inorganic phosphate is released. Thus an in vitro assay that includes a 
modifiable substrate can measure Rap activity. The non-phosphorylated substrate MESG 
can be detected at 320 nm and when it reacts with phosphate, it is absorbed at 360 nm 
[38]. We could add GTP-bound Rap to WT or non-phophorylatable (Y-F) mutant PlxnA2 
constructs in addition to the MESG substrate and measure the absorbance values. 
Comparing WT and Y-F reactions would allow us to determine if phosphorylation is 
necessary for the PlxnA2 GAP activity. 
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 Additionally, PlxnA tyrosine phosphorylation may recruit effector proteins to 
enable signal transduction. SH2 domain-containing proteins, including kinases and 
adaptors, can interact with other proteins through phosphorylated tyrosine residues. To 
test if proteins are differentially binding, immunoprecipitation (IP) and mass 
spectrometry analyses can identify interacting partners of PlxnA2 WT and Y2F mutants. 
We have previously attempted this experiment and found no differences, however the cell 
line or amount of protein could have contributed to this negative result. Using a neuronal 
cell line such as N2A and increasing the amount of protein analyzed may allow non-
specific binding partners to be detected. Fyn can act as a positive control as it is known to 
bind to PlxnA2 [13]. Alternatively, PlxnA protein interactions may be too transient to 
detect using traditional co-IP methods. Recent technology has developed a cloning 
technique called proximity labeling to identify transient interactors [39, 40]. By fusing a 
H2O2-activatable biotin ligase to PlxnA, we could label proteins that come in proximity 
of PlxnA WT or Y2F and thus likely to interact [40]. Purifying biotin-labeled proteins 
using streptavidin beads and identifying them using mass spectrometry may be an 
alternative, more sensitive, method of identifying transient binding partners.  
 
5.2.3. Is PlxnA phosphorylation necessary for downstream signaling? 
 As PlxnA phosphorylation is necessary for zebrafish eye development, we 
hypothesize that is it crucial for initiating downstream signaling. Biochemical 
experiments could address this question by using known Sema-induced molecular outputs 
such as CRMP2 phosphorylation. A constitutively active PlxnA1 (CA-PlxnA1) has been 
developed that does not include the inhibitory extracellular region and can be used for 
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biochemical assays without ligand stimulation [41]. This would be especially useful as 
we do not yet know if PlxnA phosphorylation is mediated by ligand binding. 
Overexpressing CA-PlxnA1 results in growth cone collapse and inhibits axon outgrowth 
[41], implicating CRMP2-mediated functions. Therefore, it is likely that expressing CA-
PlxnA1 leads to the phosphorylation of CRMP2. Transfecting a CA-PlxnA1 Y2F mutant 
will enable us to determine the effect of PlxnA phosphorylation has on the activity level 
of CA-PlxnA1. Comparing CRMP2 phosphorylation via Western Blotting in CA-PlxnA1 
Y2F-expressing cells would allow us to determine if PlxnA phosphorylation is necessary 
for downstream signaling. We could also use growth cone collapse and axon outgrowth 
as cellular outputs for PlxnA Y2F signaling. 
 
5.2.4. What cellular processes are regulated by PlxnA phosphorylation? 
 Lastly, it is important to determine the cellular processes that may be regulated 
by PlxnA phosphorylation, including proliferation, migration and transcription. PlxnA2 
phosphorylation at Y1605 and Y1677 is necessary for zebrafish eye development, as the 
Y2F mutant cannot rescue the PlxnA2 morpholino-induced decrease in eye size. The 
smaller eye size could suggest impaired proliferation or increased cell death of retina 
precursor cells. Repeating this experiment using proliferation markers such as pHH3 or 
apoptosis markers such as cleaved-Caspase3 during early eye development would 
determine if proliferation is impaired or cell death is aberrantly increased in plxnA2 MO 
+ Y2F embryos. Similarly, investigating the early eye field cohesion and retinal 
lamination phenotypes in these embryos would give insight into what cellular processes 
PlxnA2 phosphorylation is mediating. Future experiments could also use cell culture 
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systems to determine if migration is impaired when PlxnA2 is unable to be 
phosphorylated at these sites. Lastly, we have previously shown that Sema6A-PlxnA2 
signaling regulates transcription of numerous genes involved in proliferation and 
migration [27]. Microarray studies could investigate if PlxnA phosphorylation is critical 
in regulating transcription by comparing the transcriptome of WT versus PlxnA2 Y2F 
mutant embryos.  
 
5.3. Investigating the nature of Sema6A ectodomain release 
 
5.3.1. Is sSema6A a dimer or monomer? 
A major question currently left unanswered is whether or not sSema6A is a dimer 
or monomer. To determine this, purified sSema6A from the conditioned media of 
Sema6A-expressing HEK cells can be denatured and subjected to SDS-PAGE with and 
without reducing agents. Observing an approximately doubled molecular weight in the 
non-reducing conditions would support a dimer. 
 
Sema dimerization is classically thought to be necessary for their functions [42], 
which  suggests that sSema6A may be a dimer. However, recombinant soluble Sema6A 
ectodomains (rsSema6A) have been shown to be monomers [43, 44], where activity may 
depend on rsSema6A concentration and/or cell type. The monomeric rsSema6A (10 
µg/mL) has an inhibitory effect on VEGF-induced endothelial cell migration [43], while 
it showed no effect (approximately 5 ng/mL) on sympathetic growth cone collapse [44]. 
In contrast, the secreted dimerized chimeric protein Sema6A-FC can collapse 
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sympathetic growth cones at approximately 20 pg/mL. Thus, one hypothesis is that 
dimerization positively affects activity. Would the monomeric rsSema6A be able to 
function on sympathetic growth cones if tested at much higher concentrations, in the 
µg/mL range? For our eye field cohesion assay, it would be interesting to do a dose 
response curve comparing the activities of sSema6A and Sema6A-FC. Determining if 
naturally-released sSema6A is a dimer or monomer would be interesting and important as 
Sema dimerization is traditionally thought to be necessary for signaling, yet rSema6A has 
been shown to be functional as a monomer in specific contexts. 
 
5.3.2. Does sSem6A mediate cellular collapse? 
The dimerized, secreted chimera Sema6A-FC can induce sympathetic neuron 
growth cone collapse [45] and binds to PlxnA4- or PlxnA2 -expressing COS7 cells [28, 
45], yet these studies do not measure cellular collapse. Sema3A can cause PlxnA1/NP1-
expressing COS7 cells to collapse within 60 minutes [12]. Interestingly, we have not 
been able to show sSema6A-induced cellular collapse by bath applying sSema6A 
conditioned media. This may be due to a low concentration of sSema6A. Likewise, 
different concentrations may be needed to produce an effect in different experimental 
conditions, as we show that the same amount of sSema6A maintains cohesiveness of 
early eye explants. Centrifugal concentration methods or adding a His tag and Ni
2+
 
purifying could be some ways to increase the concentration and thus provide better tools 
to stimulate cells. Interestingly, Sema3E-induced collapse of PlxnD1-expressing COS7 
cells was mediated by decreasing integrin-containing focal adhesions and thus only 
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collapsed when plated on fibronectin-coated coverslips [46]. Similarly, fibronectin may 
be necessary for Sema6A-PlxnA1-mediated COS7 collapse. 
 
An alternative hypothesis is that sSema6A may function through different 
receptors or require neuropilin co-receptors, which are cell-type specific. Perhaps 
sympathetic cells do not express the necessary machinery for rsSema6A to be functional. 
Support for this hypothesis could come from a negative collapse result at high rsSema6A 
concentrations, while being responsive to Sema6A-FC. However, testing sympathetic 
growth cone collapse using a COS co-culture method shows some functionality of the 
monomeric rsSema6A, in comparison of the negative collapse result seen in rsSema6A 
bath applications [44]. The authors suggest that this is a more sensitive system or that the 
culture conditions may be promoting dimerization [44]. With these studies in mind, it 
will be important to determine the receptors or co-receptors in which sSema6A signals. 
Recombinant sSema5A has been shown to signal through the transmembrane Sema5A 
receptors PlxnA1 and PlxnB3 [6, 47], while the secreted Sema3 class requires neuropilin 
(Np) co-receptors [48]. As we currently have a robust assay to test sSema6A function, we 
can use morpholinos or CRISPR to transiently reduce or stably knockout known Sema6A 
receptors, such as PlxnA1, PlxnA2, and PlxnA4 to determine which Plxn(s) are required 
for sSema6A-induced early eye field cohesion as well as determine if the neuropilins Np1 
and Np2 are necessary. For example, if Np1 is required for sSema6A-mediated eye field 
cohesion, stimulating Np1 morphant eye fields with sSema6A would inhibit the 
sSema6A-induced increase in eye field cohesion. 
 
 181 
5.3.3. What is the protease responsible for producing sSema6A? 
 While we show that sSema6A can be produced spontaneously as well as induced 
by PKC activity, the protease responsible is currently unknown. Based on other sSema 
studies, ADAM17 or βACE1 are likely candidates (see Table 1.3, pg. 32). ADAM17 has 
been shown to be sufficient in cleaving multiple Sema ectodomains, including Sema4D, 
Sema5A, Sema5B and Sema7A [6, 49-52]. Co-transfecting ADAM17 with Sema6A full-
length (FL) and measuring the amount of sSema6A detected in the CM would determine 
if ADAM17 is sufficient to produce sSema6A. Alternatively, aspartyl-proteases may be 
involved in Sema6A shedding as large-scale proteomic screens of βACE substrates 
identified Sema6A and Sema6D [10]. However, only one peptide for each of these 
proteins was identified and βACE-mediated Sema6 cleavage was not validated. It is also 
likely that many proteases are sufficient to cleave Sema6A, as knocking down ADAM17 
is not sufficient to inhibit Sema5B ectodomain release and multiple proteases have been 
shown to cleave Sema4D [49, 50, 53].  
 
5.3.4. Is Sema6A phosphorylation necessary for cleavage? 
 We show that Sema6A is phosphorylated in a PKC-dependent manner. 
Furthermore, PKC activation by PMA increases sSema6A production (see Figure 3.3). 
Therefore, it is possible that phosphorylation is one mechanism that PKC activity leads to 
Sema6A ectodomain release. To test this, we can mutate the RXXS serine residues 
predicted by mass spectrometry to alanines to render them unable to be phosphorylated. 
Comparing the sSema6A levels from FL and S-A mutants would allow us to determine if 
intracellular Sema6A phosphorylation is a mechanism to regulate cleavage. Additionally, 
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unpublished findings from our lab show that Sema6A lacking the cytoplasmic domain 
exhibits a drastic increase in sSema6A production compared to full-length Sema6A. This 
supports the hypothesis that the intracellular domains may be in a conformation that 
protects Sema6A from protease targeting. Indeed, serine/threonine phosphorylation status 
of Sema4D regulates sSema4D release, as staurosporine treatment increases sSema4D 
shedding [54]. Furthermore, Sema4D binds calmodulin through a specific binding site 
and dissociation of this complex is sufficient to initiate cleavage [55]. Using the 
Calmodulin Target Database [56] to predict potential calmodulin binding motifs in 
Sema6A shows no intracellular preference for calmodulin binding. However, Abl is 
known to bind to the intracellular domain of Sema6A [28] and Abl binding may confer 
cleavage resistance in a similar manner as calmodulin and Sema4D. In summary, 
Sema6A phosphorylation could confer cleavage susceptibility based on either 
conformation or through binding other effector proteins. This is an interesting avenue to 
pursue as regulating cleavage susceptibility is a crucial mechanism to constrain sSema6A 
production to specific spatiotemporal contexts. 
 
5.3.5. What is the effect of shedding Sema6A from the cell surface? 
Protein ectodomain release is a highly regulated process that only occurs in about 
2% of cell surface-associated proteins, including receptors, growth factors and cell 
adhesion molecules [57]. Shedding can occur to allow autocrine or paracrine signaling, 
increase protein turnover and inhibit signaling. As Sema6A can signal bidirectionally, 
ectodomain shedding could also regulate the direction of signaling by inhibiting reverse 
signaling and only allowing forward signaling to occur. Shedding of the Sema6A 
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ectodomain would render cells non-responsive to reverse signaling. This leads to consider 
how much of the phenotypes observed in Sema6A zebrafish morphants are due to reverse 
signaling. We have recently shown that forward signaling primarily regulates Sema6A-
mediated early eye field cohesion, as a Sema6A-Δcyt can rescue the sema6A morphant-
induced early eye field cohesion and retinal precursor cell proliferation phenotypes (data 
from Abagael Lasseigne and Caroline Dumas). Interestingly, Sema-1a is known to 
exhibit both forward and reverse signaling simultaneously to mediate photoreceptor axon 
migration in Drosophila [58]. It would be interesting to investigate Sema6A reverse 
signaling in late zebrafish eye development to determine the roles of bidirectional 
Sema6A signaling in different spatiotemporal contexts. 
 
5.3.6. What is the in vivo contribution of sSema6A? 
We have previously shown that sSema6A is produced during development using 
proteomic analysis of human and rat embryonic cerebrospinal fluid (CSF) [59]. It would 
be interesting to determine the predominant form of Sema6A in vivo. Does Sema6A 
predominantly act through the full-length transmembrane Sema6A or the naturally-
released soluble Sema6A variant? In fact, the relative in vivo contribution is not known 
for any of the soluble Semas.  
 
One way to address this is by mutating the cleavage site and expressing it in 
sema6A-deficient or null zebrafish. Sema6A is necessary for early eye field cohesion, 
retinal precursor cell proliferation and eye size [27, 36]. If Sema6A ectodomain release is 
critical, we would predict that the un-cleavable mutant would be unable to rescue the 
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phenotypes caused by decreasing or knocking out Sema6A. Determining the in vivo 
functional contribution of sSema6A will have broad impacts on the field, as this would 
determine the necessity of ectodomain processing of Semas in development as well as 
challenge the canonical view that membrane-bound Semas act through cell-cell contact. 
 
5.4. Investigating the Crmp2 mechanisms critical in eye development 
 
5.4.1. What are the mechanisms underlying crmp2 MO-induced optic tract 
impairment? 
 We show that crmp2 morphant zebrafish embryos exhibit impaired optic tract 
formation. However, we also observe impairments in the retinal ganglion cell (RGC) 
layer. Thus, there could be multiple reasons for this phenotype. Is impaired optic tract 
formation due to aberrant RGC axon guidance or stalling, ectopic tectum innervation, or 
is the weakened optic tract simply due to a thinning of the RGC layer? To determine if 
the optic tract phenotype is due to a reduced number of RGCs, we can do RGC cell 
counts to conclude if the decrease in optic tract intensity is similar to a decrease in RGC 
number. 
 
 Alternatively, the weakened optic tract could be due to a decrease in axon 
initiation and outgrowth. Cell culture studies have implicated Crmp2 function in axon 
initiation and outgrowth [60-62]. Dissociated retina cell cultures from uninjected control 
(UIC) or crmp2 morphant isl2b:GFP embryos could determine if the GFP+ RGC cells 
have fewer and/or shorter processes. It is also possible that the RGC axons do not 
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innervate the optic tectum appropriately. In C. elegans, unc-33 encodes for the CRMP2 
invertebrate homolog [11]. unc-33 mutants exhibit axonal guidance defects in sensory 
and motor neurons, leading to aberrant axonal branching, ectopically migrating axons and 
stalling axons [63, 64]. In the vertebrate visual system, axonal guidance is crucial for 
topographic mapping of the tectum. For example, nasal and temporal RGC axons 
innervate the posterior and anterior tectum, respectively [65]. This spatial organization is 
mediated by Ephrin signaling [65], which is known to induce Crmp2 phosphorylation via 
ROCK in DRG growth cone collapse [66]. Thus, Crmp2 may be crucial in proper 
patterning of the tectum, which occurs between 60-72 hpf in zebrafish visual system 
development [67]. Transgenic zebrafish lines such as the Zebrabow or lipophilic tracers 
such as DiI could be used to visualize individual cells and their axons to determine if 
RGC axons are migrating to their proper location in the tectum. 
 
5.4.2. What are the mechanisms underlying Crmp2-mediated retina lamination? 
 We have shown that injecting a morpholino targeting crmp2 leads to impaired 
retina lamination. In vivo studies investigating Crmp2 function in the mouse cortex can 
give insights into the possible mechanisms of Crmp2-mediated retina lamination in the 
zebrafish. Silencing Crmp2 expression impairs radial migration of cortical neurons as 
well as causes abnormal dendritic morphology [68, 69]. Qualitatively, crmp2 Sofa1 
morphants do not show severe migration phenotypes as the retina layers appear in 
appropriate locations (see Figure 4.5E). However, the amacrine cells (Ptf1a marker) and 
RGCs (Ath5 marker) layers show ectopic cells as well as horizontal cells (Ptf1a marker) 
and photoreceptor cells (Crx marker) are absent with higher doses of morpholino. These 
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cells are among the last to differentiate in the developing retina and observing the retina 
layers of Sofa1 crmp2 morphants after 72 hpf would determine if the absent cell layers 
are due to a developmental delay. 
 
 Alternatively, Crmp2 could be mediating dendritic patterning in the retina. 
Knockdown and knockout mice studies show that Crmp2 is crucial for the neurite 
morphology of migrating neuron and the organization of cortical cell dendrites [68, 69]. 
Crmp2 may have a similar function in the retina. This hypothesis is supported by the loss 
of the inner and outer plexiform layers (IPL and OPL), as visualized by H & E staining. 
The IPL and OPL are the primary synaptic layers of the retina and are thinner or absent in 
crmp2 morphants (see Figure 4.5A). As crmp2 mRNA is expressed in the RGC and INL 
cell layers during IPL and OPL formation, at around 60-72 hpf [67], immunofluorescence 
experiments could determine if Crmp2 is expressed in the RGC and INL cell dendrites.  
Furthermore, the Zebrabow line could be used to observe the dendritic morphology of 
individual retina neurons.  
 
5.4.3. Is Crmp2 phosphorylation necessary for zebrafish eye development? 
 While we have shown that Crmp2 is critical for zebrafish eye development, 
investigating the molecular mechanisms of Crmp2 functioning is an important area of 
future study. CRMP interactions with microtubules are regulated by phosphorylation and 
we hypothesize that phosphorylation at critical residues are necessary for Crmp2-
mediated functions in eye development. There are four sites that are phosphorylated 
downstream of Sema3A signaling, including the Cdk5-mediated priming of Ser522 and 
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the subsequent GSK3-directed phosphorylation of S518, T514, and T509 [20, 62]. We 
hypothesize that these regulatory mechanisms are conserved in Sema6A-PlxnA2 
signaling and necessary for zebrafish eye development. To this end, we have developed 
mutant constructs in which these sites are mutated to alanines (CRMP2 4A), rendering 
them unable to be phosphorylated, or mutated to aspartate (CRMP2 4D) to mimic 
phosphorylation. If Crmp2 phosphorylation is necessary for eye development, I predict 
that introducing CRMP2 4A mRNA in crmp2 deficient or null embryos will be unable to 
rescue Crmp2 mediated functions. Similarly, CRMP2 phosphorylation may be tightly 
regulated and the phosphomimic 4D mutant may be unable to rescue Crmp2-mediated 
functions as well.  
 
Initial experiments testing the necessity of Crmp2 phosphorylation in zebrafish 
eye development used morpholinos to decrease endogenous Crmp2 (see Figure 4.7). A 
crucial control in this experiment was the rescue with Crmp2 WT mRNA as exogeneous, 
morpholino-resistant mRNA should rescue the phenotypes observed in crmp2 morphant 
zebrafish. Indeed, this is the gold-standard control for indicating that a given morpholino 
has no off-target effects [70]. As indicated in the Chapter 4 discussion, there are many 
potential reasons as to why zebrafish Crmp2 WT mRNA cannot rescue endogenous 
crmp2 knockdown-induced phenotypes. With this in mind, a crmp2 null zebrafish line 
may be one way to overcome the challenges with using morpholinos. We are in the 
process of generating crmp2 null zebrafish using the CRISPR/Cas9 system (Figure 5.3). 
Injecting CRMP2 WT RNA into CRISPR embryos will determine if this approach will be 
a successful tool to study the in vivo function and importance of Crmp2  
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Figure 5.3. Generating crmp2 CRISPR zebrafish. This schematic illustrates the steps 
in developing stable crmp2 CRISPR zebrafish line. The germline-specific endonuclease 
nanos-Cas9 is co-injected with guide RNA (gRNA) targeted to exon 3 of the crmp2 gene. 
The gRNA recruits Cas9, which results in double-stranded breaks. Non-homologous end 
joining occurs in an attempt to repair the double-stranded break. This imprecise process 
generally leads to insertions or deletions (INDELs), resulting in no expression of 
functional Crmp2. This process occurs in the gametes of the F0 generation, where it is 
likely that each gamete encodes for a different mutation. Out-crossing F0 zebrafish leads 
to a mosaic population, where each heterozygous zebrafish expresses a different mutant 
crmp2. Validation testing occurs here and individual F1 zebrafish with specific and 
known mutations are out-crossed to produce a stable F2 line. Experiments will in-cross 
the F2 generation and collect the homozygous null embryos for experimental use. 
 
 189 
phosphorylation. If successful, it will be interesting to investigate the phenotype of 
injecting CRMP2 4A RNA into crmp2 CRISPRs. As PlxnA2 signaling is important in 
lamination while Ephrin signaling is involved patterning the optic tectum [36, 65], 4A 
may be unable to rescue the lamination phenotype but still able to rescue the optic tract 
impairments if they are mediated by Ephrin-Crmp2 signaling, which leads to CRMP2 
phosphorylation at S555 via ROCK, leading to a decreased affinity to tubulin [66, 71].  
 
Interestingly, the other Crmp isoforms cannot offset the effects of transiently 
decreasing Crmp2 using morpholinos, suggesting that Crmp2-containing heterotetramers 
are critical for optic tract formation, retina lamination and overall eye size. In situ 
hybridization for Crmp3 and Crmp4 indicates that Crmp3 has a similar expression pattern 
to Crmp2, being expressed in the RGCs while Crmp4 is expressed in the RGCs and INL 
at 48 hpf and exclusively in the INL by 72 hpf (data by Morgan McNellis). As knockout 
animals have been known to have compensation effects, Crmp2 CRISPR zebrafish lines 
may show less severe phenotypes due to the possible upregulation of Crmp3 and Crmp4. 
 
5.4.4. How is Crmp2 phosphorylation regulating cellular microtubule dynamics? 
 Cell culture systems and mouse genetic studies have demonstrated that CRMP2 
phosphorylation is crucial for its function in neurite outgrowth and morphology [20, 62, 
68, 69]. Additionally, immunofluorescence assays and immunoprecipitation experiments 
have shown that CRMP2 phosphorylation regulates its affinity to tubulin and 
microtubules [20, 62]. Furthermore, CRMP2 can promote microtubule polymerization in 
vitro [72]. While it is known that CRMP2 phosphorylation regulates its affinity to bind to 
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mitotic spindles [62], currently no high-resolution cellular studies have been conducted to 
determine how CRMP2 phosphorylation affects microtubule polymerization in the 
context of a migrating neuron. To determine how CRMP2 phosphorylation affects growth 
cone microtubule dynamics, we have started a collaboration with the lab of Laura Anne 
Lowery (Boston College). Her lab uses Xenopus neural tube or eye explants to investigate 
growth cone dynamics using high-resolution live cell imaging. By injecting GFP- or 
mCherry- tagged fusion constructs into Xenopus embryos and culturing tissue later in 
development, we can visualize both microtubules and a protein of interest during growth 
cone migration using spinning disk confocal microscopy. Preliminary results have shown 
that injecting CRMP2 WT or mutant RNA into Xenopus embryos yields no significant 
differences between WT, 4A and 4D mutants in polymerization rates in growing axons. 
However, the constructs that were used in this study were untagged; using GFP-tagged 
proteins will ensure that the CRMPs are being translated and trafficked to the growth 
cone machinery appropriately. Future work will use CRMP2-GFP constructs to better 
visualize where phosphorylated or unphosphorylated CRMP2 is localizing on 
microtubules and how it is affecting microtubule polymerization in growth cones.  
 
5.5. Final Remarks 
In conclusion, the reports described in this dissertation have elucidated 
functionally-significant molecular mechanisms of Sema6A-PlxnA2 signaling governing 
vertebrate visual system development. We have enhanced the understanding of the 
molecular processes that regulate Sema6A- and PlxnA2- mediated functions in early and 
late eye development. We have identified Fyn-mediated PlxnA phosphorylation sites that 
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are critical for PlxnA2 functioning as well as discovered a novel Sema6A variant, 
sSema6A, that is functional in early eye development. We have also characterized a 
novel role of Crmp2 in late eye development, mediating retina lamination and optic tract 
formation. 
 
Future work will extend our investigations into the mechanisms governing 
Sema6A-PlxnA2 signaling in vertebrate eye development. We will study the context of 
PlxnA phosphorylation in Sema6A signaling and the cellular processes it may govern; 
further characterize sSema6A and the in vivo functional role of sSema6A production; and 
investigate the mechanisms of Crmp2 in mediating its novel visual system functions. 
These exciting future directions will establish the molecular, cellular and developmental 
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